Sustainable C-H Functionalisation by Improved Catalyst Design by Heron, Callum
        
University of Bath
PHD








If you require this document in an alternative format, please contact:
openaccess@bath.ac.uk
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 17. Aug. 2021
 
  
Sustainable C–H Functionalisation by 
Improved Catalyst Design 
Callum John Heron 
A thesis submitted for the degree of Doctor of Philosophy 
University of Bath  
Centre for Sustainable Chemical Technologies 




Prof. Christopher G. Frost (Chemistry) 
Dr Emma Emanuelsson-Patterson (Chemical Engineering) 







Attention is drawn to the fact that copyright of this thesis rests with the author. A copy of 
this thesis has been supplied on the condition that anyone who consults it is understood 
to recognise that its copyright rests with the author and they must not copy it or use 
material from it except as permitted by law or with consent of the author. 
This thesis may be made available for consultation within the University Library and may 
be photocopied or lent to other libraries for the purposes of consultation effective 
from……………… 
























“The difficulty lies not so much in developing new ideas as in escaping from old ones.” 





 .................................................................................................................................................................  
ACKNOWLEDGEMENTS ......................................................................................................................... IX 
ABSTRACT .............................................................................................................................................. X 
PUBLICATIONS ...................................................................................................................................... XI 
ABBREVIATIONS ................................................................................................................................... XII 
INTRODUCTION ...................................................................................................................................... 1 
1.1 – CATALYSIS AND SUSTAINABILITY .......................................................................................................... 1 
1.2– METHODOLOGIES TO ACHIEVE C–H FUNCTIONALISATION .......................................................................... 3 
1.3 – DIRECTING GROUPS IN C–H FUNCTIONALISATION ................................................................................. 10 
1.4 – OVERVIEW OF RUTHENIUM CATALYSED ORTHO FUNCTIONALISATION REACTIONS .......................................... 12 
1.4.1 – C–C bond Forming Reactions ............................................................................................ 12 
1.4.2 – C–X Bond Forming Reactions ............................................................................................ 15 
1.5 – OVERVIEW OF META C–H FUNCTIONALISATION REACTIONS..................................................................... 17 
1.5.1 – Sterically Controlled Direct meta C–H functionalisation ..................................................... 18 
1.5.2 – Directing Group Controlled meta C–H Functionalisation .................................................... 21 
1.5.3 – Traceless Directing Group meta C–H functionalisation ...................................................... 24 
1.5.4 – Electrostatic Controlled meta C–H Functionalisation ......................................................... 28 
1.5.5 – σ Activation Enabled meta C–H Functionalisation ............................................................. 32 
1.6 – OVERVIEW OF PARA C–H FUNCTIONALISATION REACTIONS ..................................................................... 48 
1.6.1 – Template Assisted para C–H Functionalisation .................................................................. 48 
1.6.2 – Sterically Induced para C–H Functionalisation ................................................................... 52 
1.6.3 – Electronic Induced para C–H Functionalisation .................................................................. 54 
1.7 – AIMS AND OBJECTIVES ................................................................................................................... 62 
BIBLIOGRAPHY ..................................................................................................................................... 63 
CHAPTER 2 – Α-HALO CARBONYLS FOR META SELECTIVE PRIMARY C–H ALKYLATIONS ........................ 72 
2.1 – SYNTHESIS OF STARTING MATERIALS.................................................................................................. 78 
2.2 – OPTIMISATION OF REACTION USING A NICKEL CO-CATALYST ................................................................... 80 
2.3 – ROLE OF [NI] AND REOPTIMISATION OF CONDITIONS ............................................................................. 83 
2.4 – SCOPE AND LIMITATIONS ................................................................................................................ 86 
2.5 – MECHANISTIC CONSIDERATIONS ....................................................................................................... 90 
2.6 – CONCLUSIONS AND FUTURE WORK ................................................................................................... 99 
v 
 
BIBLIOGRAPHY ................................................................................................................................... 101 
CHAPTER 3 – RUTHENIUM CATALYSED REMOTE C4-SELECTIVE C-H FUNCTIONALISATION OF 
CARBAZOLES ...................................................................................................................................... 104 
3.1 – SYNTHESIS OF STARTING MATERIALS................................................................................................ 107 
3.2 – REACTION OPTIMISATION ............................................................................................................. 112 
3.3 – SCOPE AND LIMITATIONS .............................................................................................................. 119 
3.4 – MECHANISTIC CONSIDERATIONS ..................................................................................................... 123 
3.5 – CONCLUSIONS AND FUTURE WORK .................................................................................................. 126 
BIBLIOGRAPHY ................................................................................................................................... 128 
CHAPTER 4 – STUDIES INTO NEW COUPLING PARTNERS AND SUBSTRATES ....................................... 131 
4.1 – SYNTHESIS OF SUBSTRATES FOR STUDYING THE PROPOSED REACTION DESIGN ............................................ 134 
4.2 – REACTION OPTIMISATION ............................................................................................................. 135 
4.3 – MECHANISTIC CONSIDERATIONS ..................................................................................................... 142 
4.4 – CONCLUSIONS AND FUTURE WORK ................................................................................................. 144 
BIBLIOGRAPHY ................................................................................................................................... 146 
5 - EXPERIMENTAL ....................................................................................................................... 147 
5.1 – GENERAL .................................................................................................................................. 147 
5.2 – SYNTHESIS OF 2-ARYL PYRIDINE DERIVATIVES .................................................................................... 149 
5.2.1 – General Procedure A ....................................................................................................... 149 
5.2.2 – Synthesis of 2-(4-nitrophenyl)pyridine, 1b ....................................................................... 149 
5.2.3 - Synthesis of 2-(4-methoxypenyl) pyridine, 1c ................................................................... 150 
5.2.4 – Synthesis of 2-(4-(trifluoromethyl)phenyl) pyridine, 1d .................................................... 151 
5.2.5 – Synthesis of Ethyl 4-(pyridin-2-yl) benzoate, 1e ............................................................... 151 
5.2.6 – Synthesis of 2-([1,1’-biphenyl]-4-yl) pyridine, 1f ............................................................... 152 
5.2.7 – Synthesis of 2-(4-(trifluoromethoxy) phenyl) pyridine, 1g ................................................. 153 
5.2.8 – Synthesis of 2-(4fluorophenyl) pyridine, 1h ...................................................................... 154 
5.2.9 – Synthesis of 2-(4-chlorophenyl) pyridine, 1i ..................................................................... 154 
5.2.10 – Synthesis of 2-(4-bromophenyl) pyridine, 1j ................................................................... 155 
5.2.11 – Synthesis of  2-(4-(methylthio)phenyl) pyridine, 1k ........................................................ 156 
5.3 – OPTIMISATION FOR THE META ALKYLATION OF PRIMARY SUBSTRATES ....................................................... 157 
5.4 – SCOPE OF RUTHENIUM CATALYSED META C-H ALKYLATION OF PRIMARY SUBSTRATES .................................. 160 
5.4.1 – General Procedure A for the Formation of ethyl 2-(3-(pyridin-2-yl) phenyl) acetates ........ 160 
5.4.2 – General procedure B for the formation of ethyl 2-(3-(pyridine-2-yl) phenyl) acetates ....... 161 
vi 
 
5.4.3 – Synthesis of ethyl 2-(3-(pyridin-2-yl)phenyl)acetate, 1.1 .................................................. 161 
5.4.4 - Synthesis of ethyl 2-3-(1H-pyrazol-1-yl)phenyl)acetate, 1.2 .............................................. 162 
5.4.5 – Synthesis of ethyl 2-(3-(pyrimidin-2-yl)phenyl)acetate, 1.3 .............................................. 163 
5.4.6 – Synthesis of ethyl 2-(3-(5-fluoropyridin-2-yl)phenyl)acetate, 1.4 ...................................... 164 
5.4.7 – Synthesis of ethyl 2-(3-(5-ethylpyrimidin-2-yl)phenyl)acetate, 1.5 .................................... 165 
5.4.8 – Synthesis of ethyl 2-(3-(4-methylpyrimidin-2-yl)phenyl)acetate, 1.6 ................................. 166 
5.4.9 – Synthesis of ethyl 2-(3-(4-methylpyridin-2-yl)phenyl)acetate, 1.7..................................... 167 
5.4.10 – Synthesis of ethyl 2-(2-methoxy-5-(4-methylpyridin-2-yl)phenyl)acetate, 1.8 ................. 168 
5.4.11 – Synthesis of ethyl 2-(2-methoxy-5-(pyridin-2-yl)phenyl)acetate, 1.11 ............................. 169 
5.4.12 – Synthesis of ethyl 2-(2-(methylthio)-5-(pyridin-2-yl)phenyl)acetate, 1.12 ....................... 170 
5.4.13 – Synthesis of ethyl 2-(5-(pyridin-2-yl)-2-(trifluoromethyl)phenyl)acetate, 1.13 ................. 171 
5.4.14 – Synthesis of ethyl 2-(5-((pyridin-2-yl)-2-(trifluoromethoxy)phenyl)acetate, 1.14 ............. 172 
5.4.15 – Synthesis of ethyl 2-(2-ethoxy-2-oxoethyl)-4-(pyridin-2-yl)benzoate, 1.15 ...................... 173 
5.4.16 – Synthesis of ethyl 2-(4-(pyridin-2-yl)-[1,1’-biphenyl]-2-yl)acetate, 1.16 .......................... 174 
5.4.17 – Synthesis of ethyl 2-(2-fluoro-5-(pyridin-2-yl)phenyl)acetate, 1.17 ................................. 175 
5.4.18 – Synthesis of ethyl 2-(2-chloro-5-(pyridin-2-yl)phenyl)acetate, 1.18................................. 176 
5.4.19 – Synthesis of ethyl 2-(2-bromo-5-(pyridin-2-yl)phenyl)acetate, 1.19 ................................ 177 
5.4.20 – Synthesis of ethyl 2-(2-methoxy-5-(pyrimidin-2-yl)phenyl)acetate, 1.22 ......................... 178 
5.5 – MECHANISTIC EXPERIMENTS FOR THE META ALKYLATION WITH PRIMARY SUBSTRATES ................................... 180 
5.5.1 – Radical Inhibitor experiments ......................................................................................... 180 
5.5.2 – Testing Phosphonium salt as active coupling species in situ ............................................. 181 
5.5.3 – Mercury drop test ........................................................................................................... 181 
5.6 – SYNTHESIS OF CARBAZOLE AND TRYPTAMINE SUBSTRATES FOR TESTING ..................................................... 182 
5.6.1 – Synthesis of N-(2-(1H-indol-3-yl)ethyl)pyrimidin-2-amine, 2a ........................................... 182 
5.6.2 – Synthesis of N-(2-(1H-indol-3-yl)ethyl)-5-chloropyrimidin-2-amine, 2b ............................. 183 
5.6.3 – Synthesis of 2-(1H-indol-3-yl)-N-(pyridin-2-ylmethyl)ethan-1-ammonium chloride, 2c ...... 184 
5.6.4 – Synthesis of 3-((2-(1H-indol-3-yl)ethyl)amino)propanenitrile, 2d ...................................... 185 
5.6.5 – Synthesis of 9-(pyrimidin-2-yl)-9H-carbazole, 2e .............................................................. 186 
5.6.6 – Synthesis of 9-(pyridin-2-yl)-9H-carbazole, 2f .................................................................. 187 
5.7 – OPTIMISATION FOR THE C-4 ALKYLATION OF 9-(PYRIMIDIN-2-YL)-9H-CARABAZOLES ................................... 188 
5.8 - SCOPE OF RUTHENIUM CATALYSED C-4 C-H ALKYLATION OF CARBAZOLE SUBSTRATES.................................. 189 
5.8.1 – General Procedure C for the synthesis of methyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbazol-
4-yl)alkylate substrates .............................................................................................................. 189 
5.8.2 – Synthesis of ethyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbazol-4-yl)propanoate, 2.1 ......... 190 
5.8.3 – Synthesis of methyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbozol-4-yl)propanoate, 2.2 ...... 191 
vii 
 
5.8.4 – Synthesis of tert-butyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbazol-4-yl)propanoate, 2.3 .. 192 
5.8.5 – Synthesis of benzyl 2-methyl-2-(9-pyrimidin-2-yl)-9H-carbazol-4-yl)propanoate, 2.4 ........ 193 
5.8.6 – Synthesis of cyclohexyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbazol-4-yl)propanoate, 2.5 . 194 
5.8.7 – Synthesis of methyl 1-(9-(pyrimidin-2-yl)-9H-carbazol-4-yl)cyclohexane-1-carboxylate, 2.6
.................................................................................................................................................. 195 
5.8.8 – Synthesis of (perfluorophenyl) methyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbazol-4-yl) 
propanoate, 2.9 ......................................................................................................................... 196 
5.8.9 – Synthesis of methyl 2-(6-bromo-9-(pyrimidin-2-yl)-9H-carbazol-4-yl)-2-methylpropanoate, 
2.10 ........................................................................................................................................... 197 
5.8.10 – Synthesis of methyl 2-(6-chloro-9-(pyrimidin-2-yl)-9H-carbazol-4-yl)-2-methylpropanoate, 
2.11 ........................................................................................................................................... 198 
5.8.11 – Synthesis of methyl 2-methyl-2-(3,6,8-trichloro-9-(pyrimidin-2-yl)-9H-carbazol-4-yl) 
propanoate, 2.12 ....................................................................................................................... 199 
5.9 -  MECHANISTIC EXPERIMENTS FOR THE C-4 ALKYLATION OF 9-(PYRIMIDIN-2-YL)-9H-CARABAZOLES .................. 201 
5.9.1 – Deuterium Labelling Experiment ..................................................................................... 201 
5.9.2 – TEMPO Experiments ....................................................................................................... 201 
5.9.3 – Mercury Drop Test .......................................................................................................... 202 
5.10 – PARA-FUNCTIONALISATION OF ANILINE DERIVATIVES ......................................................................... 203 
5.10.1 – Optimisation for the para carboxylation of 5-chloro-N-phenylpyrimidin-2-amine ........... 203 
5.10.2 – Synthesis of 5-chloro-N-phenylpyrimidin-2-amine, 3a .................................................... 204 
5.10.3 – Synthesis of methyl 4-((5-chloropyrimidin-2-yl)amino)benzoate, 3.1 .............................. 205 
5.11 – SYNTHESIS OF RUTHENIUM COMPLEXES .......................................................................................... 207 
5.11.1 – Synthesis of [Ru(CO2Mes)2 η6-(p-cymene)] (Mes = 2,4,6-trimethylbenzene) .................... 207 
5.11.2 – Synthesis of [Ru(CO2Me)Cl η6-(p-cymene)] ..................................................................... 208 
5.11.3 – Synthesis of [Ru(CO2Me)2 η6-(p-cymene)] ...................................................................... 209 
5.11.2 – Synthesis of [Ru(CO2Ad)2 η6-(p-cymene)] (Ad = Adamantane) ........................................ 210 
5.11.5 – Synthesis of (rac)-[RuCl(p-cymene)(C6H4-2-C5H4N-κ-C,N)] ............................................... 211 
5.12 – SYNTHESIS OF OTHER REAGENTS ................................................................................................... 213 
5.12.1 – Synthesis of (2-ethoxy-2-oxoethyl)triphenylphosphonium bromide ................................ 213 
5.12.2 – Synthesis of potassium phenyltrifluoroborate ................................................................ 213 
5.12.3 – Synthesis of N-phenylpyridin-2-amine, 3b ..................................................................... 214 
5.12.4 – Synthesis of potassium 2,4,6-trimethylbenzoate (MesCO2K) .......................................... 215 
5.12.5 – Synthesis of pivaloyl-L-valine (Piv-Val-OH) ..................................................................... 216 









I would like to thank Prof. Christopher Frost for  firstly allowing me to undertake my PhD 
work within his group and for all the support, help and encouragement he has provided to 
me over my PhD. I would also like to thank Dr Antonine Buchard (Chemistry) and Dr 
Emma Emanuelsson-Patterson (Chemical Engineering) for useful discussions and help as 
my co-supervisors over my studies. I’d also like to thank the CSCT for the funding of my 
PhD project as well as extra-curricular activities that have allowed me to diversify my 
skillset greatly. 
I would also like to thank the Frost group past and present, who provided countless useful 
discussions, advice and ideas over my time here. In particular I’d like to thank Dr Barrie 
J. Marsh and Dr Jamie A. Leitch for their help with the writing of this thesis in particular 
for errors and reality checks; as well as Andy, Sinéad, Sam and last but most certainly not 
least  Dr Sean Goggins for his support and practical advice in the lab, as well as carrying 
of the chemistry football team. I’d also like to thank the various MChem students I 
supervised, for trying to carry out my half-witted ideas. 
I would also like to thank John Lowe and Catherine Lyall (NMR) for their invaluable help 
in various aspects of the NMR equipment. I would also like to thank  Prof. Frank Maarken 
for his loaning of electrochemistry equipment and Amelia Langley for helping me use 
said equipment and interpret the results gained from its use.  
Last but by no means least, I’d like to thank my parents: Anne and John and sister Catriona  
for their support as well as my best friends: Matt, Kirsty, Craig, and the GB2014 squad 
for their support and ears for countless moans and rants. I also would like to give a special 
thanks to Caroline, without her love, support and rants at me, I’d have struggled to write 






C–H functionalisation in a regioselective manner remains a great challenge in the field of 
catalysis. There exists a number of novel and unique methodologies to differentiate 
sterically and electronically similar C–H bonds. One key method to achieve such 
functionalisations is by use of Lewis basic directing groups, to direct a metal centre to 
insert into the desired C–H bond which can then be reacted in a desired manner of 
functionalisation under a set of reaction conditions.  
Chapter 2 reports the development of a methodology for the regioselective meta C–H 
primary alkylation of 2-phenylpyridine substrates using α-halo ester coupling partners, 
and some insights into the reasons for the observed regioselectivity and proposed catalytic 
cycle. 
Chapter 3 reports the application of ruthenium catalysed σ-activation to the remote C–H 
functionalisation of carbazoles at the C4 position using tertiary α-bromoester coupling 
partners. 
Chapter 4 reports the discovery of a new para selective carboxylation of aniline 






“α-Halo carbonyls enable meta selective primary, secondary and tertiary C–H alkylations 
by ruthenium catalysis.” A.J. Paterson, C.J. Heron, C.L. McMullin, M.F. Mahon, N.J. 
Press and C.G. Frost, Org. Biomol. Chem., 2017, 15, 5993–6000. 
“Ruthenium Catalysed Remote C4-Selective C–H Functionalization of Carbazoles via σ-
Activation.” J.A. Leitch, C.J. Heron, J. McKnight, G. Kociok-Köhn, Y. Bhonoah and 
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Introduction 
1.1 – Catalysis and Sustainability 
The construction of new C–C or C–X (X = heteroatom) bonds, is a key 
requirement in the development of synthetic organic methodologies, for the synthesis of 
new and unexplored molecular architectures. These substrates can possess desirable 
properties in the fields of pharmacology, biology, materials chemistry and supramolecular 
chemistry.  
Within this context, cross-coupling reaction methodologies , primarily utilising palladium 
(Pd) complexes have come to the forefront of the field.1–3 This domination has been driven 
by the fact that the Pd pre-catalysts used in such methods are, typically air and moisture 
stable. They also have relatively simple experimental set ups and work ups allowing for 
even greater convenience. Primarily though, Pd-catalysed cross-couplings benefit from 
the enormous scope of reagents and potential transformations possible, with 
demonstratable reliable efficiency. The use of this chemistry has been utilised on 
milligram to kilogram and even tonne scale processes by the pharmaceutical and fine 
chemical industries, becoming  the go-to method for the formation of C–C and C–X bonds 
at the present day (e.g. Buchwald-Hartwig couplings for N–C bond formation or Suzuki 
couplings for C–C bond formations).4–6  
Current pressures on terrestrial resources, means that ever more focus is being placed  
upon sustainable process, for the manufacture of materials and products. In a chemistry 
setting, this sustainability focus means that a process should adhere as closely as possible 
to the 12 rules of green chemistry.7 The use of Pd, relates to three of these rules, through: 
the more efficient catalysis, improved atom economy and the use of safer chemicals.8 
Notwithstanding the substantial advancements in Pd catalysed cross-coupling 
methodology, certain drawbacks have persisted, as Pd has a relatively low crustal 
abundance, specific ligands/additives are often required to permit reactivity, and finally 
its toxicity to humans and animals in the environment.8 In a bid to overcome some of 
these limitations, the use of other transition metals, both noble (Rh, Ir, Pt) and abundant 
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(Cu, Ni, Fe) have been investigated, as well as alternative methodological strategies to 
achieve these transformations.9,10 
 
Figure 1: The difference in synthetic pathways required to achieve the same transformation between: a cross-coupling 
(top path) or C–H functionalisation (bottom path) methodology. 
C–H functionalisation is one methodology, which can overcome some of the 
aforementioned disadvantages associated with classic cross coupling methodologies, as 
illustrated in Figure 1. Traditional cross-coupling methods require potentially multi-step 
pre-functionalisation of the substrates, prior to coupling. This facet reduces the atom 
efficiency of synthesising a desired molecule of interest, leading to more waste and 
purification steps.11 The benefits of C–H functionalisation over cross-coupling 
methodologies stem from the removal of one (or more) of the pre-functionalisation steps 
of the substrate molecules. This allows more streamlined synthetic procedures, reduction 
in time necessitated to access a target molecule, and potential variation to move away 
from highly pressured metal catalysts and ligand types.12 
In the research presented here, we have focused upon ruthenium (Ru) catalysis to achieve 
the C–H functionalisation reactions that are of interest to us, notably, through the use of 
Ru(II) complexes. Like many Pd complexes utilised in cross-coupling reactions, Ru(II) 
complexes are also air and moisture stable; many of which are also commercially 
available. Another advantage is the substantially lower cost of Ru, compared to the other 
noble metals  like Pd, Ir and Rh ($1788/ozt, $1480/ozt, $6000/ozt respectively, compared 
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with $250/ozt for Ru) (26/11/19 (NYSE)). Although all have similar crustal abundancies, 
the use of Pd in the automotive industry, Ir in the bulk chemical industry and Rh in the 
aerospace industry; means they are highly pressured resources. Comparatively Ru has 
relatively few commercial applications, leading to the lower described commodity price. 
Hence it is more sustainable, in an economic context and environmental context, as it is a 
less highly pressured resource. 
In the context of selective and sustainable C–H functionalisation methodologies, the 
following literature review will begin by first studying mechanistic aspects of how 
reactivity specific to this project occurs. Furthermore, how C–H functionalisation 
methods can be utilised for the catalytic functionalisation of aromatic and heteroaromatic 
systems - with a specific focus on the regioselectivity will be discussed.  
1.2– Methodologies to Achieve C–H Functionalisation 
In the context of C–H functionalisation the strategies developed to overcome some 
of the challenges associated with these transformations can be classed as either “innate” 
or “chelate assisted”. These challenges arise primarily from the high bond dissociation 
energy (BDE) of a typical C–H bond and the difficulties in differentiating between 
electronically and/or sterically similar C–H bonds in a molecule, the latter of which the 
innate reactivity of a typical C–H bond is dependent upon.13,14 Many early examples of 
C–H functionalisation reactions utilise this innate reactivity of the substrates to achieve 
the desired transformation. Some examples of this include: electrophilic aromatic 
substitutions (SEAr) on simple aromatics and heteroaromatics, free radical additions, and 
deprotonation of acidic C–H bonds.  
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Scheme 1: Innate C–H activation vs Directed C–H activation. 
More modern attempts to utilise this innate reactivity of C–H bonds has utilised transition 
metal (TM) catalysts that can directly insert into these C–H bonds, as shown in Scheme 
1. These carefully designed methodologies rely upon the desired C–H bond for the 
reaction being favoured by either being the least sterically encumbered, electronically rich 
or electronically poor, as depicted in Scheme 1, with many reviews on this reactivity 
having been published to date.15–17 Namely the methods that can be used to achieve these 
C–H activation events occur by: Electrophilic addition, oxidative addition, σ-bond 
metathesis or concerted metalation deprotonation (CMD). 
Electrophilic addition generally involves the use of late- or post-transition metals 
(such as Al, Zn, Au, etc.), usually in a strongly polar reaction medium or anhydrous strong 
acid.18 In this reaction type, the reactive species [Mx+2] proceeds through the presumed 
intermediate: [LnM
x+2(R)(X)]. The use of this reaction type typically leads to 
functionalised alkanes; however, the intermediates are often very difficult to detect 
spectroscopically. Examples of this can be seen for the Au(III) catalysed oxidative 
coupling of aryl silanes with arenes, or the Pd(II) catalysed oxidative coupling of 
arylboronic acids with arenes.19,20 
σ-Bond metathesis generally occurs with TMs containing the d0 electronic 
configurations, as well as lanthanides and actinides, with a few examples of group 4 and 
5 metals also known.21 The reaction is in equilibrium, although does not typically result 
in the interconversion of alkyl groups with each other as depicted in Scheme 2. There are 
some examples however, of interconversion between dihydrogen and metal alkyls with 
alkanes and metal hydrides are known.22,23 
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Scheme 2: Formation of a new C–C bond by σ-bond metathesis.  
Oxidative addition of a TM species into a C–H bond, occurs generally when using 
low-valent, electron rich complexes of noble, platinum group metals, proceeding by a +2 
net change in oxidation state of the metal. In this reaction type, as shown in Scheme 3 the 
reactive species [LnM
x] is coordinatively unsaturated and hence almost always unstable. 
This dictates that it is formed in situ either by thermal or photolytic decomposition of a 





Scheme 3: Example of a C–H activation by oxidative addition.24,25 
The final mentioned process, by which a TM catalyst can insert into a C–H bond, 
as mentioned previously is by a process known as concerted metalation deprotonation or 
CMD. CMD has received great interest in contemporary catalytic development, and work 
by Fagnou et al. and concurrently by McGregor et al. to elucidate this process and how 
the use of the metal catalyst and a suitable (carboxylate) ligand could allow the insertion 
of the metal into a C–H bond.26,27 Alternative names for this process have been termed: 
internal electrophilic substitution (IES) or ambiphilic metal-ligand activation 
(AMLA).28,29  
Despite these modern advances, the earliest proposal of a CMD-type mechanism was 
made by Winstein and Traylor, back in 1955 for the acetolysis of diphenylmercury in 
acetic acid, the proposed mechanism of which is shown in Scheme 4.30 This reaction is 
the reverse process to CMD, commonly referred to as protodemetallation.  
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Scheme 4: Representation of the proposed mechanism for the acetolysis of diphenylmercury(II).30 
Kinetic analysis of this protodemetallation reaction, suggested that the mercurial salt and 
the arene combined in a reversible fashion to form an intermediate, which then 
subsequently undergoes an irreversible proton transfer.31 From this kinetic analysis, it was 
found from the primary KIE values (c.a. 6.0 – 7.0) that the proton transfer step was the 
rate limiting step.  
This report for the protodemetallation process, then led to the first observation of the 
forward process, CMD in 1980 by Roberts and co-workers, detailing kinetic studies into 
the mercuration of arenes by Hg(O2CCF3)2.
31 Previous studies of this process found the 
proton transfer step of the reaction to also be rate limiting, by the discovery of a large 
kinetic isotope effect (KIE) of kH/kD ≈ 6.
32 Previous mechanistic explanations of this 
reaction had favoured a SEAr -type process, with discrete σ-complexes.
33–35 Roberts and 
co-workers proposed the following transition state for the rate determining step (RDS) for 
the mercuration of arenes, shown in Scheme 5, which follows very closely to the original 
mechanism proposed by Winstein and Traylor.30,31  
 
Scheme 5: Reagents and proposed transition state for the base-assisted mercuration of benzene.31 
Further investigative work by Olah and co-workers, indicated the presence of a weakly 
bounded intermediate by NMR studies, rapidly exchanging between a σ-complex and an 
η2 π-complex, as shown in the transition state (TS) in Scheme 5.35 From this data and 
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kinetic data collected by Roberts and co-workers,31 it was concluded that the C–H bond 
cleavage and the C–Hg bond formation both occurred concurrently. Despite these in-
depth studies the authors could not completely rule out an SEAr type mechanism.
31  
When discussing “chelation assisted” or “directing group” methodologies, these 
transformations use pre-existing functional groups on the molecule to direct a TM catalyst 
towards a desired C–H bond for functionalisation as seen in Scheme 1. This method 
overcomes the intrinsic issues with having multiple C–H bonds in a molecule, by lowering 
the energetic pathway of the desired reaction, through entropy reduction, placing the TM 
catalyst proximal to the desired C–H bond. Of these methodologies, there are two methods 
by which the TM catalyst can insert into a desired C–H bond, namely: oxidative addition 
and concerted metalation deprotonation (CMD).  
The use of Lewis basic directing groups to control the use of such reactivity was first 
reported in the 1960s, via the use of Pd complexes.36,37 This work by Cope et al. found 
that the choice of Pd catalyst was essential to achieve the desired reactivity, with 
[Pd(OAc)2]  found to be the most optimal, with the choice of the acetate ligand also 
playing a key role. It must be noted that the choice of carboxylate ligand used in C–H 
functionalisation reactions is essential to the system reactivity, by variation of the 
energetic pathway(s) that lead to the desired product.38–40  
Further mechanistic investigations demonstrate that the non-innocent acetate 
ligand first plays the role of aiding solvolysis of the reaction intermediates, with its larger 
effective volume compared to chloride. Secondly, the ability of an acetate group to 
fluxionate between a monodentate or bidentate ligation mode, allows the electrophilicity 
of the Pd complex to be favourably enhanced and can also act as an intermolecular base 
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Scheme 6: Mechanism for the cyclometallation of dimethylbenzylamine (DMBA) with [Pd(OAc)2].41 
Scheme 6 shows the mechanistic explanation by Ryabov et al. for the cyclometallation of 
N,N-dimethylbenzylamine (DMBA) with [Pd(OAc)2].
41 This mechanism was consistent 
with the observed negative slope of the Hammett plot they found (ρ = –1.6), inferring that 
there is a build-up of negative charge in the transition state of this reaction step, which 
indicates the simultaneous removal of the proton and formation of the Pd–C bond. This 
also fits the KIE (kH/kD) value of 2.2 and the negative calculated entropy of activation 
(ΔS‡ = – 60 kcal K
-1 mol-1) for the Pd(OAc)2[DMBA-H] complex.
41 
In 2005, Davies, Donald and McGregor reported an in-depth computational analysis 
which showed that the most thermodynamically accessible route proceeds via an agostic 
interaction between the acetate ligand and proton. This leads to a drop in pKa of the C–H 
bond, allowing for nearly barrierless proton transfer to the acetate. This is then followed 
by an acetate-assisted six-membered cyclic transition state as described in Scheme 7.27,29 
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Scheme 7: Computed reaction profile of DMBA-H with Pd(OAc)2. Values in kcal mol-1.27 
The first reports of utilising Ru(II) salts in a reaction, that involves a step involving 
a CMD type process was developed in 2008, by Dixneuf et al.42 This study reported the 
diarylation of 2-phenylpyridine, as shown under the conditions in Scheme 8. This work 
reported that the pyridine group acts as a “directing group” to direct the Ru-NHC catalyst 
towards the ortho C–H bond, via the intermediate in brackets in Scheme 8. The 
computational modelling indicated that a molecule of base, coordinated to the Ru acts as 
an internal base to make the removal of the ortho C–H bond very low in energy, even 
when using a weak base this mechanism was found to be strongly favoured.42 This work 
was found to utilise similar transitions states (TS) and bond lengths of molecules for other 
reactions, involving similar internal deprotonation events, leading to the conclusion that 
a CMD process was in operation.43,44  
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Scheme 8: Reaction conditions and proposed intermediate for the diarylation of 2-phenylpyridine.42 
1.3 – Directing Groups in C–H Functionalisation 
The use of directing groups that strongly coordinate a TM centre, most generally 
N-based directing groups, has facilitated the rapid expansion of a variety of directing 
groups. These are generally Lewis basic heteroaromatic groups, such as: pyrazoles, 
pyrimidine, triazoles, tetrazoles, oxazoline, and then acyclic derivatives, like ketimines 
for example. The structures of some of these directing groups are shown in Scheme 9.45  
 
Scheme 9: Examples of strongly coordinating directing groups. 
Through extensive study, a toolbox of C–C and C–X bond forming reactions have been 
developed, a summary of which are shown in Scheme 10. These transformations were 
initially achieved through the use of noble, platinum groups metals, such as: Pd,46 Rh,47 
and Ru.48 However, more recently there have been reports of these transformations, 
achieved through first row TMs, such as: Co,49 Mn,50 and Fe.51 
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Scheme 10: C–H functionalisation transformations reported, through the use of "strong" directing groups. 
Despite the plethora of advances using so-called strongly coordinating directing groups, 
one drawback of relying upon such directing groups is that they are generally not 
ubiquitous in organic molecules. To overcome this limitation the use of “weakly” 
coordinating directing groups (generally achieve coordination through a carbonyl (C=O) 
group), these are much more commonly encountered functional group motifs, examples 
of which include: carboxylic acids, aldehydes, esters, anilides and carbamates. The 
structures of some of these directing groups are shown in Scheme 11.  
 
Scheme 11: Examples of weakly coordinating directing groups. 
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The weaker coordination of the metal in these reactions makes cyclometallation events 
more energetically challenging, resulting in (to date) a less substantial toolkit of 
transformations are available to these substrates, when compared to the corresponding 
strong directing group substrates. These substrates almost exclusively reply upon the use 
of noble metals, such as: Pd,52 and Ru.53 
Directed or chelation assisted C–H activation has enabled the true scope of C–H 
functionalisation reactions to be realised. A huge majority of these examples result in a 
large scope of ortho selective C–H functionalisation transformations to be realised. 
However, in order to broaden this scope to include meta and para C–H functionalisation 
reactions, different techniques are necessitated. The next section will begin to discuss 
examples of such ortho C–H functionalisations (with specific focus on Ru catalysis), and 
the techniques subsequently developed to allow for meta and para C–H functionalisations 
to be realised.  
1.4 – Overview of Ruthenium Catalysed ortho Functionalisation 
Reactions 
1.4.1 – C–C bond Forming Reactions 
The formation of C–C bonds, in the synthesis of small, unfunctionalised 
molecules; are amongst the most prevalently used reactions used in the pharmaceutical 
and fine chemical industries at the present time. Numerous ortho C–H to C–C 
transformations have been demonstrated, utilising Ru(II) catalysis. 
The first such report of a such a Ru(II) catalysed transformation was made in 2002 by 
Inoue et al.54 for the ortho selective arylation of an aromatic ketimine, under the 
conditions shown in Scheme 12.  
 
 
13 | P a g e  
 
 
Scheme 12: ortho C–H Arylation of a ketimine.54 
This reaction uses the strongly coordinating ketimine directing group to allow the Ru to 
insert into the ortho C–H bond of the ketimine. This cyclometalated species then reacts 
with the aryl bromide in an oxidative addition/reductive elimination type process to 
arylate the ortho position and re-enter the catalytic cycle. The addition of 2 equivalents of 
a phosphine ligand per Ru atom, was found to aid this step of the reaction. For aryl 
bromides, this addition of phosphines was found to be more effective, and interestingly 
for using aryl chlorides, phosphine oxide ligands were found to be optimal.55 The scope 
of this reaction has since been expanded to include a wide variety of directing groups.48  
Direct ortho C–H alkylations have also been reported, using alkyl halides as 
coupling partners by Ackermann et al.56 Similarly as before, the Ru inserts into the ortho 
C–H bond via a CMD type mechanism, and an analogous oxidative addition/reductive 
elimination process occur to yield the ortho alkylated product. Several directing groups 
were also utilised, such as: oxazolines, pyridines, imines and pyrazoles, along with a 
variety of alkyl halides, under the conditions shown in Scheme 13.56 
 
Scheme 13: ortho C–H alkylation of a oxazoline.56 
This reaction was proposed to proceed via the mechanistic cycle shown in Scheme 14.57 
The ortho arylation, as depicted in Scheme 12 proceeds by a similar mechanism. 
However, this reaction has been limited to the use of primary alkyl halides, until a recent 
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report disclosed by Larrosa et al. showed that secondary alkyl halides can also be coupled 
by using a cyclometallated Ru complex, under relatively mild conditions.58 
 
Scheme 14: Proposed mechanism for the ortho C–H alkylation of an aromatic ketimine.57 
Further C–H activation alternatives to traditional SEAr-type mechanisms have 
been developed. These transformations obviate the need for stoichiometric amounts of 
Lewis acids and often proceed with complementary regioselectivity (through chelation 
assistance proximity, rather than traditional SEAr electronics). These include acylations, 
aminocarbonylations and alkoxycarbonylations, which utilise: acid chloride, carbamoyl 
chloride or chloroformate coupling partners respectively.59–61  
 
Scheme 15: Ru(II) catalysed ortho C–H alkenylations.62 
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Heck-type alkenylations have also been reported by Jeganmohan et al. using 
Ru(II) catalysis, under the conditions shown in Scheme 15.62 This proceeds by a normal 
CMD insertion of the Ru into the ortho C–H bond, followed by coordination of the alkene 
to the Ru, and inserts into the alkene by migratory insertion. β-Hydride elimination then 
rapidly proceeds, to release the Ru as Ru(0), necessitating the addition of an external 
oxidant to the reaction to allow for the system to be catalytic. This transformation has 
been reported for a variety of directing groups, such as: pyridines, pyrazoles, carboxylic 
acids and amides.63 
The analogous reaction, for the alkynylations has also been reported, allowing for the 
direct synthesis of heterocycles, with alkyne coupling partners.64 This methodology has 
been reported for the efficient synthesis of: isoquinolines, napthylpyridines, phenyl 
pyrimidines, phenyl hydrazines, pyridines, isoquinolones, isocoumarins and indoles.64 
1.4.2 – C–X Bond Forming Reactions 
The formation of C–C bond formation reactions cannot be understated in modern 
synthetic chemistry development. However, the selective and efficient construction of C–
X bonds is also of great importance. Recent advances in this area have focused upon 
utilising chelation assistance to couple the desired functional group or atom. One such 
example of this can be seen in the direct ortho C-H amidation of aromatic substrates, using 
sulfonyl azides as coupling partners, under the conditions shown in Scheme 16.65 This has 
been achieved on a variety of directing groups such as: amides, ketones, pyridines, 
pyrazoles and pyrimidines.65 
 
Scheme 16: Direct C–H amidation of aromatic ketones using sulfonyl azide coupling partners.65 
The direct C–H oxygenation of bonds is also of great interest, as the undirected 
synthesis of phenols from the corresponding arene, generally requires very harsh 
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conditions and high temperatures.66 The use of Ru(II) allows this oxygenation to be 
achieved under substantially milder conditions, as reported by Ackermann and co-
workers in 2012, under the conditions shown in Scheme 17.67 This transformation has 
been reported on a variety of substrates, such as: ketones,67 esters, Weinreb amides, 
carbamides and anilides.65 
 
Scheme 17: Directed ortho C–H hydroxylation of aromatic esters.67 
The ortho-oxygenations, thiolations and selenations of benzamide substrates have 
been reported, under Rh catalysis conditions by Yu et al.68 under oxidative conditions; 
following a similar mechanistic pathway to the aforementioned examples previously 
mentioned in this section. ortho-Aroylation reactions using Cu(II) catalysis are also 
known, under oxidative conditions.69 
ortho-Halogenation reactions have been described by Ackermann et al., utilising 
simple N-bromosuccinimide (NBS) or N-iodosuccinimide (NIS) reagents in a highly 
selective manner, on benzamide substrates.70 This transformation differs from the 
previous Ru mentioned so far, in that it requires a Ru(0) precatalyst, and that a single 
electron transfer occurs at some point in the mechanistic cycle, as addition of 2,2,6,6-
tetramethylpiperidin-1-yl)oxidanyl (TEMPO) results in termination of reaction.70 
The formation of C–B bonds is of particular use in synthesis, as such molecules 
can be further utilised in Pd cross-coupling reactions. Such a bond formation has been 
reported in 2017 by Ackermann and co-workers, utilising commonly encountered boron 
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This borylation methodology has been extended by Reek et al. using Ir catalysis, by 
creating a hydrogen bonding template to direct the Ir towards the ortho C–H bond 
preferentially over the meta or para protons.72 
 
Scheme 18: Ru(II) catalysed ortho borylation of 2-phenylpyridines.71 
A final example, reported by Tobita et al. involves the use of an unusual directing 
group in the form of an alkynyl entity, as shown in Scheme 19.73 This work found that an 
initial trans-hydrogenation step occurred first, followed by an ortho silylation. The ligand 
was found to play an essential role in this transformation, by stabilisation of the Ru 
species.73 
 
Scheme 19:Ru catalysed ortho silylation and trans-hydrogenation of aryl alkynes.73 
1.5 – Overview of meta C–H Functionalisation Reactions 
The ability to regioselectively functionalise specific C–H bonds is of high 
importance to contemporary synthetic development. The examples discussed in the 
previous section, discussed the formation of cyclometalated intermediates which then 




18 | P a g e  
 
The ability to regioselectively access meta functionalised benzene structures is also of 
great importance.47 The above methods relied upon proximity-based directing groups to 
impart selectivity, therefore accessing more remote positions requires the development of 
more elaborate techniques. For these reasons, often overcoming formation of unwanted 
regioisomers and low reactivity of the C–H bonds can be a great challenge. This next 
section will look to understand the methodologies that have succeeded in unlocking meta 
C–H functionalisation.  
1.5.1 – Sterically Controlled Direct meta C–H functionalisation  
The first reported regioselective example of meta C–H functionalisation was, to 
the best of our knowledge, reported by Smith et al. for the meta borylation of 1,3-
disubstituted arenes.74 This transformation utilises direct C–H activation, as described 
previously in Scheme 1, in this case instead exploiting the steric and electronic bias of the 
substrate.  
 
Scheme 20: Ir catalysed meta borylation of 1,3-disubstituted arenes.74 
In this report a vast excess of the arene is used as a reaction medium, and where the arene 
is a solid, cyclohexane was used as the solvent, under the conditions shown in Scheme 
20. Despite the elegant advance, this transformation uses a fairly high loading of Ir and is 
limited to only 1,3-disubstituted arene substrates, limiting its widespread applicability. 
Recent work by Chirik et al. demonstrated that this limitation of high catalytic loading 
can be overcame, through utilising a Co-based catalyst, achieving similar yields and 
selectivites.75 Hartwig and co-workers have applied the meta selective C–H borylation 
strategy to subsequent Pd catalysed alkylation and allylation chemistries to allow for a 
wide range of structurally diverse molecules.76 
Use of a directed C–H activation methodology has been achieved more recently, 
to enable meta borylations, as described by Nakao et al. through use of a bifunctional Ir-
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Lewis acid catalyst which forms a H-bonding network to direct the Ir to the meta C–H 
bond, under the reaction conditions shown in Scheme 21.77 This is allowed by the 
coordination of the amide nitrogen atom to the Al, this then brings the Ir proximal to the 
meta C–H bond, allowing for a regioselective outcome of >99:0:0 (m:o:p). 
 
Scheme 21: Reaction conditions for the meta borylation of arenes, using a bifunctional Lewis acid-Ir catalyst.77 
In 2009, Yu et al. reported the exploitation of the electronic bias of electron 
deficient arenes, to achieve a meta alkenylation, utilising a specific sterically encumbered 
pyridine ligand, under the conditions shown in Scheme 22.78 Despite the shown 
preference for the meta isomer, the competing para isomer was also observed in the 
majority of examples. A similar methodology has been explored computationally and 
experimentally by Wu and Zeng, utilising a different ligand subset (mono-N-protected 
amino acids).79 Sanford and co-workers have also reported the acetoxylation of 
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Scheme 22: Pd catalysed meta C–H alkenylation of electronically biased arenes.78 
The reactions discussed in this section so far, all require a vast excess of the arene 
substrate in the reaction, commonly using them as a solvent. Ritter and co-workers have 
described the C–H imidation of electronically biased arenes, utilising dual Pd/Ag 
catalysis, with the arene as a limiting reagent, under the conditions shown in Scheme 23.81  
 
Scheme 23: Pd/Ag catalysed meta C–H imidation of electronically biased arenes.81 
This work was shown to proceed only when a mixture of electron withdrawing (EWG) 
meta directing and electron donating groups (EDG) ortho/para directing groups were 
present to direct towards the meta C–H bond. This was shown to proceed through a radical 
mechanism, whereby the Ag salt engages in a single electron transfer (SET) process, 
which then subsequently reacts with the Pd catalyst.81 
 
 
21 | P a g e  
 
1.5.2 – Directing Group Controlled meta C–H Functionalisation 
Moving from direct C–H activation, as controlled by a substrates steric and 
electronic biases, the use of directed C–H functionalisation is by far the most commonly 
encountered method of achieving meta C–H functionalisation. The first use of directing 
group mediated meta C–H functionalisation was reported by Gaunt et al., who 
demonstrated the meta arylation of aromatic acetamides using an electrophilic Cu catalyst 
as shown in Scheme 24.82 
 
Scheme 24:Reaction conditions and proposed mechanistic explanation for the meta C–H arylation of acetamides.82 
This reaction has also been shown to be applicable for α-aryl carbonyl compounds 
utilising a Cu catalyst.83 Studies on the mentioned reaction using α-aryl carbonyl 
compounds have been shown to work at higher temperatures in the absence of a metal 
catalyst. It was concluded that the Cu catalyst and hypervalent iodine species interact to 
form the active catalyst to facilitate the transformation.82,83 
Another example of this directing group methodology was pioneered by Yu and 
co-workers, where a “U-shaped” directing group is utilised to facilitate meta alkenylation 
of arenes.84,85 The presence of the bulky tBu groups, as shown in the substrate molecule 
in Scheme 25, suggested to fix the geometry of the molecule, such that the nitrile directing 
group is proximal to the meta C-H bond, shown in the molecule. This approach is 
normally made difficult by the required rigid, cyclic transition state (TS) that becomes 
energetically unfavourable when the ring size is greater than seven, due to the entropic 
cost.85 The method developed by Yu et al. solves this problem by using a weakly 
coordinating nitrile group, which alleviates the generated ring-strain of the 12-membered 
palladacycle. A CMD process is then proposed by the authors, allowing the insertion of 
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the Pd into the C-H bond, followed by a classical Heck-type mechanism, with the Ag salt 
oxidising the Pd(0) generated back to Pd(II).  
 
Scheme 25: Pd(II) catalysed meta C–H alkenylation of toluene derivatives, using "U-shaped" template.84 
The use of aryl boronic acids/esters as coupling partners, under slightly modified reaction 
conditions has also be reported by Yu et al.84 A drawback of this methodology is the 
requirement of a bulky ligand to be attached to the substrate molecule, thus requiring two 
additional steps to install and remove the directing group. One iteration of this work by 
Tan et al. makes the installation and removal steps simpler by using a silyl ether (Figure 
2) linker to attach the directing group, which can then be removed simply by reacting with 
TsOH.86  
 
Figure 2: Si-based meta directing template developed by Tan et al.86 
From this point onwards, there has been a tremendous volume of reports from Yu 
and Maiti and co-workers, amongst many others. A summary of these templates and the 
transformations available to them, are shown in Scheme 26. Firstly, Maiti and co-workers 
reported the meta alkenylation phenylacetic acid derivatives (Scheme 26a).87 Li and co-
workers then showed that an in situ created phthalimide (from phenylethylamides 
derivatives) enabled meta selective alkenylation chemistry (Scheme 26b).88 Yu then 
reported that his U-shaped template was also amenable to the meta-alkenylation of 
phenylacetic acid derivatives (Scheme 26c).89  Maiti and co-workers demonstrated that 
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sulfonates could be used as linkers for this methodology and were shown to be able to 
undergo a Julia reaction give the di-vinylated benzene (Scheme 26d).90 Yu and co-
workers then reported that the use of a pyridine template enabled meta-alkenylation and 
iodination of benzyl alcohol derivatives. This was an important step as can potentially 
unlock other chemistry that pyridyl directing groups can carry out in Pd catalysis (Scheme 
26e).91 Li showed that amide linked templates could be used in meta-alkenylation 
reactions (Scheme 26f).92 Maiti and co-workers demonstrated that their sulfonate template 
from before was also amenable to meta-hydroxylation methodology (Scheme 26g)93 and 
that increasing the linker size maintained reactivity in remote functionalisation (Scheme 
26h).94  
 
Scheme 26: Summary of templates and transformations used in template-assisted remote meta-functionalisation. 
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The same group then demonstrated that a biaryl system (Scheme 26i),95 and 
phosphonate linkers (Scheme 26j),96 were tolerated in catalysis. They also demonstrated 
that sulfonates furnished with pyrimidine (Scheme 26k),97 and nitroquinoline (Scheme 
26l),98 granted access to meta functionalised arenes. 
More recent work by Maiti et al. has expanded the scope of this methodology to 
include the Pd catalysed selective meta alkylation, alkynylation, allylation, cyanation of 
aromatic amide derivatives.99 Recent work by the same group also recently disclosed the 
selective meta allylation of a broad variety of substrates using a pyrimidine-derived 
template DG.100 This work allows for the access of terminal allyl groups to be selectively 
coupled at the meta position on the substrates reported. 
 Recent work disclosed by Falck et al. reported the Fe catalysed meta amination of 
aromatic picolinates, under very mild conditions.101 This methodology utilises a very 
cheap and commonly found FeCl3 catalyst, with no complicated or expensive ligands 
required to enable reactivity. However, the substrate requires EWG groups in order to 
allow for reactivity. The presence of the Fe catalyst was shown to be vital for the reactivity 
of the system, under the conditions are shown in Scheme 27. 
 
Scheme 27: Fe catalysed meta amination of picolinates.101 
1.5.3 – Traceless Directing Group meta C–H functionalisation 
The use of a traceless directing group methodology to achieve meta 
functionalisation of aromatic substrates can be broken down as two subsequent ortho 
functionalisations. This concept was first demonstrated by Larrosa et al. to synthesise 
meta substituted benzoic arenes and phenols.102,103 This reaction is performed in one-pot, 
simplifying the procedure, and making it attractive to users due to the limitation of 
purification steps to an absolute minimum, particularly as the directing group cleavage 
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results in the energetically favourable release of CO2. Scheme 28 shows the developed 
reaction conditions for the traceless meta arylation of phenols. Steps i. and ii. involves the 
in-situ formation of a potassium phenolate and subsequent ortho carboxylation of this 
species, followed by a Pd catalysed ortho arylation at 130 °C, and  in situ decarboxylation 
leading to the desired product in good yields. Larrosa reported that the reaction is selective 
for the mono-arylated product exclusively, with no ortho or para products detected, nor 
the O-alkylated product.102 
 
Scheme 28: Reaction conditions for the meta arylation of phenolic substrates by a traceless directing group 
methodology.102 
This traceless directing group has also been extended to heterocyclic coupling partners 
such as thiophene- and furan-based molecules, with the most acidic proton in the 
heterocycle determining the regioselectivity on the heterocycle.104 However, this 
methodology requires that a blocking group be in place at the position adjacent to the  
carboxylic acid directing group to prevent the formation of the disubstituted product.  
A variation on this traceless directing group methodology was published by Yu et 
al. in which a norbornene is utilised as a transient ligand to facilitate the meta alkylation 
of various aromatic substrates, containing an amide-based directing group under the 
reaction conditions shown in Scheme 29.105 A quinolone-based ligand is required to 
minimise competing side reactions, thought to proceed via by reductive elimination on 
various catalytic intermediates as shown in Scheme 30.  
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Scheme 29: Reaction conditions for the meta alkylation of phenyl acetic amides using a transient directing group.105 
This transformation utilises the Catellani reaction.106 Were it was discovered that 
norbornenes react with aryl halides to perform bi- or tri-functionalisation of the arene, 
terminating with a C–H functionalisation of an ortho proton to the C–X bond. Yu et al. 
exploiting this mechanistic understanding to use norbornene as a transient or traceless 
directing group.  
The norbornene acts as a co-catalytic type terminating reagent to help prevent unwanted 
ortho functionalisation and di-functionalisation. The subsequent use of aryl halides as 
coupling partners and phenylacetamides with functionalisation at the α-position relative 
to the carbonyl, have also been shown with the use of a modified norbornene.107  
The proposed mechanism as shown in Scheme 30 begins by the CMD insertion of the Pd 
into the ortho C-H bond, directed by the acetamide group (I). From this point a molecule 
of norbornene inserts into the C–Pd bond (I to II), forming a new intermediate where the 
Pd is now proximal to the meta C–H proton. This intermediate then undergoes a second 
intramolecular CMD insertion to form the 5-membered palladacycle (II to III), this is the 
proposed intermediate which can lead to by-product formation (III).105,107,108 
Oxidative addition (III to IV) and then reductive elimination of the alkyl halide (IV to V) 
onto the palladacycle produces the meta substituted, norbornene inserted Pd intermediate 
(V). The expulsion of the norbornene from V, followed by protodemetallation of the meta 
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alkenylated product (VI), releases the product and regenerates the Pd(II) catalyst to re-
enter the cycle.107 
The use of transient mediators to selectively alkylate the meta position of an aromatic ring 
presents a novel combination of several smaller reactions into one process to selectively 
functionalise the meta position of a suitable arene ring. However, one drawback 
associated with this methodology, is it is limited to the use of primary alkyl halides. In 
comparison this methodology provides a nice complementary technique to the standard 
Friedel-Crafts alkylation methodology, which is limited to tertiary and some secondary 
alkyl halides (i.e. carbocation stabilising groups), with the added benefit of good 
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Scheme 30: Proposed catalytic cycle for the meta alkylation of phenylacetamides using a norbornene transient 
mediator.107 
1.5.4 – Electrostatic Controlled meta C–H Functionalisation 
A novel methodology to control the regioselectivity on the meta functionalisation 
of arene ring systems has been reported by Phipps et al. using ion pairing interactions to 
direct a metal catalyst to achieve regioselective functionalisation.110 This methodology 
uses an anionic group on the metal catalyst ligand, which can then interact with a cationic 
group on the substrate molecule (Figure 3). 
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Figure 3: Ion pair-directed borylation methodology.110 
This methodology allows for the use of benzylic amine substrates to be functionalised in 
a regioselective manner, and with complementary regiocontrol to what would be expected 
to the use of a standard SEAr type reaction, which wold result in a mixture of ortho/para 
products. This interaction is achieved using an easily formed alkylammonium salt of the 
benzylic amine, and a sulfonate bearing tether on the Ir ligand group. The choice of the 
pendant ionic sulfonate group on the ligand was based on the computational work done 
by Singleton, Maleczka and Smith et al.111,112 with a non-interacting counter ions (OTs-, 
[N (n-Bu)4]
+).  
This ion pairing interaction then allows the meta proton to be proximal to the Ir centre 
and oxidative addition/reductive elimination events occur to borylate the meta position, 
under the reaction conditions shown in Scheme 31.  
Control experiments showed that the presence of the cationic group was essential to 
achieve regioselective control. Regioisomeric mixtures of the para:meta products were 
observed from 4:1 – >20:1, with the average being >10:1. The transformation results in 
diborylation when using symmetrical, unsubstituted arenes and is also possible on 




30 | P a g e  
 
 
Scheme 31: Reaction conditions for the ion-pair directed borylation of quaternised benzylamines.110 
This methodology has been extended to substrates bearing hydrogen bond donor groups 
and longer chain aromatic amines, to achieve the same regioselectivities.113,114 Subsequent 
work by Phipps and co-workers has also expanded the range of aromatic substrates to 
include the use of phosphonium salts, which can then subsequently be functionalised after 
meta functionalisation.115  
The first proposal of utilising non-covalent interactions to achieve meta 
functionalisation was made by Kanai and co-workers in 2015. In this work they 
demonstrate the elegant meta borylation of benzamide derivatives, using Ir catalysis. The 
regioselectivity was controlled using a meticulously designed ligand, which was shown 
to form a H-bond between the urea (ligand) and carbonyl (substrate), as shown in Scheme 
32.  This example highlights the power of non-covalent templates as the ligand is used in 
such small amounts (1.5 mol.%). Low amounts of competing para selectivity were also 
observed with this reaction methodology.116  
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Scheme 32: Ir catalysed meta-borylation using a non-covalent template.116 
Yu et al. have also published work whereby a Pd complex both directs and 
activates the meta C-H bond to be alkenylated with an olefin coupling partner (Scheme 
25). This work mimics the role that metal containing enzymes in vivo, whereby the metal 
centre coordinates the substrate molecule to a specific geometry around the metal ligand. 
This orientation then allows for the Pd to be directed to the meta C–H bond, under the 
reaction conditions shown in Scheme 33.  
The use of a Cu(II) species is thought to play a dual role as an oxidant for the Pd, as well 
as also being able to act as the anchor point for the substrate, as shown un Scheme 33. 
However, Pd can also coordinate to the ligand as the anchor point. The acylated glycine 
residue is known as an effective ligand class for the promotion of CMD type reactions 
when coordinated to Pd.117,118  
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Scheme 33: Reaction conditions for the meta alkenylation of 3-phenylpyridine using a template directed 
methodology.119 The circled proton is the one that reacts with the Pd in situ. 
1.5.5 – σ Activation Enabled meta C–H Functionalisation 
The examples mentioned in the previous section have achieved meta selective C–
H functionalisation through the use of substrate sterics, traceless directing groups, 
electrostatic interactions or use of large ligands to direct the catalyst towards the meta 
proton. This occurs by making the TS necessary for the competing ortho functionalisation 
too high in energy, or through a transient blocking of the ortho position.  
Another method for the meta functionalisation is through a technique known as σ-
activation. As outlined previously, the insertion of Ru into C–H bonds, using a suitable 
directing group has been widely established for a number of years, leading to ortho-
functionalised structures. However, in 2011 this methodology was used for the first time 
in a catalytic fashion to yield a meta product by Frost et al. as shown in Scheme 34.120  
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Scheme 34: Conditions for the Ru(II) catalysed meta sulfonation of 2-phenylpyridine.120 
As shown in Scheme 34, the reaction conditions for this transformation are relatively 
simple, in comparison to those shown for the traceless directing group and directing group 
methodologies (Scheme 25 and Scheme 28 respectively). It was originally suggested that 
this proceeded through an electrophilic-type mechanism, with the C–H bond cleavage 
being shown to be kinetically relevant in the reaction cycle, although no mechanism was 
proposed at the time.120 
Several ruthenium complexes were studied for this transformation; however, none were 
found to be as effective as [RuCl2(p-cymene)]2. Proof for the reaction proceeding through 
a σ-Ru-CAryl complex was found when isolating and reacting such an intermediate with 
sulfonyl chloride.120 There is precedence for this type of reactivity in similar complexes, 
as seen with the modification of fac-(tris(2,2’-phenylpyridine)) iridium (III) chloride, 
commonly employed as an air stable photocatalyst in photochemical 
transformations.121,122 
After this initial publication, a transformation involving σ-aryl Ru(II) complexes 
was reported by Ackermann and co-workers in 2013, detailing their work on the meta-
selective coupling of secondary alkyl halides to 2-phenylpyridine, as shown in Scheme 
35. 
 
Scheme 35: Conditions for the meta selective secondary alkylation of 2-phenylpyridine.123 
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This expansion into the large and diverse selection of  secondary alkyl halides made the 
scope of this transformation much more amenable to a more diverse group of possible 
substrates and coupling partners. During the optimisation of this reaction it was found that 
the addition of a carboxylate co-ligand was found to improve both the isolated yields and 
regioselectivity due to the more facile synthesis of a σ-aryl Ru(II) complex 
intermediate.26,48,123  
 
Scheme 36: Originally proposed alkylation of 2-phenylpyridine using secondary alkyl halides by Ackermann et al.123 
The use of electron donating or withdrawing substituents at the para position on the arene 
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Ackermann and co-workers proposed that an SEAr type mechanism was in operation, due 
to the observation that enantioenriched secondary alkyl halides resulted in racemic 
mixtures after reaction, along with the observation that electron rich arene derivatives 
react preferentially. From this data, the catalytic cycle shown in Scheme 36 was proposed. 
Following these two seminal reports, the use of tertiary alkyl halide was initially 
published by Frost et al. in 2015, in the meta selective alkylation of 2-phenylpyridine 
using tertiary alkyl halides.124 This paper cast doubt upon the proposed mechanism shown 
in Scheme 36, by the inclusion of the result that addition of the radical inhibitor TEMPO 
((2,2,6,6-tetramethylpiper-1-yl)oxyl) resulted in a dramatic decrease in the observed 
conversions. This result indicated that there is likely a radical involved in a part of the 
catalytic cycle.  
The use of a bromoadamantane as a coupling partner as well as tertiary α-bromo esters, 
also showed that the mechanism likely involved a radical addition step, as SN2 type 
additions are sluggish on steric grounds, SN1  type reactions are disfavoured due to the 
positive charge left α to the ester carbonyl; therefore a mechanism involving a radical 
addition is most likely, with many examples reported using a radical formed by such an 
ester being utilised in the substitution of aromatics, heteroaromatics and olefins.125–127 
The catalytic cycle that considers this inclusion of this radical species is shown in Scheme 
37, whereby CMD occurs as previously discussed, and the Ru catalyst playing a second 
order role in the meta C–H bond cleavage, as subsequently proposed by Ackermann et 
al.128 in the CMD complex and a second Ru complex facilitating the homolytic cleavage 
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Scheme 37: Proposed catalytic cycle for the meta alkylation of 2-phenylpyridine using tertiary α-halo esters.124 
 Subsequent work by Frost et al. has more recently re-examined their original meta-
sulfonation work in a mechanistic examination of the process.132 As shown in Scheme 38, 
the mechanism for this transformation is proposed to proceed via a Ru CMD complex 
with the 2-phenylpyridine. This complex then activates the position para to the C–Ru 
bond by inductive and mesomeric effects, due to the much higher bond polarisation.104 
The activation of this position allows it to react with the sulfonyl chloride radical.105  
 
 
37 | P a g e  
 
 
Scheme 38: Proposed mechanism for the meta C–H sulfonation of 2-phenylpyridine.132 
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The use of coordinating solvents such as MeCN were found to give optimal results, this 
indicated that an electron rich Ru species may be the optimal catalyst for the 
transformation; this raises the possibility of what happens to the p-cymene ligand in this 
reaction, the loss of which in situ was thought to be a potential deactivation pathway.108  
Performing this reaction in the absence of sulfonyl chloride indicated that no p-cymene 
dissociation occurred, until 1.5 equivalents were added. After a short period of time , 
dissociation was observed. However, the exact role of p-cymene in the reaction is still 
unknown.132 
An interesting further expansion to this methodology was achieved by Greaney et 
al. and separately by Ackermann et al. in using photocatalysis to achieve a meta selective 
alkylation shown in Scheme 39.133 This is made possible by the ruthenium being 
employed in a dual role, between enabling formation of a CMD intermediate, and then 
photoexcitation of this CMD complex to then initiate homolytic cleavage of the C–X bond 
on the coupling partner.134 This radical then reacts in an identical manner shown from the 
“radical addition” as shown in Scheme 37. This reaction is advantageous in comparison 
to the thermal meta alkylation methodologies, in that it has higher functional group 
tolerance, a broader substrate scope and most crucially a much lower reaction temperature 
(e.g. room temperature).133,134 
The computational results indicated that for a CMD complex as shown in Scheme 39 that 
the Ru(III) complex gave a larger selectivity profile, using the difference in Fukui indices 
between the desired meta position and undesired ortho position.134–136 Experimental 
evidence to support this first order role of the Ru-CMD complex was the observation that 
the fluorescence quenching of the CMD complex upon increasing concentrations of the 
alkyl halide coupling partner.133,134 Cyclic voltammetry (CV) experiments also showed 
that there was a reversible oxidation event from a Ru(II) species to a Ru(III) species, 
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Scheme 39: Reaction conditions and mechanism for the photoactivated meta C-H alkylation of 2-phenylpyridine.133  
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Work by Ackermann and co-workers has proposed that the addition of carboxylate 
and/or phosphine ligands to the reaction manifold, when performing a meta selective 
functionalisations, via Ru(II)-σ complexes helps to stabilise the formation of a Ru–C 
singlet bond, which in turn stabilises the functionalised aromatic system, between 
functionalisation and rearomatisation as shown in Scheme 40.137  
 
Scheme 40: Proposed stabilisation mode as a singlet species for a benzylated arene ring, through using a σ-activation 
methodology.137 
Computational analysis of this process supports the conclusions, with a 20 kcal mol-1 
stabilisation in energy when calculating the energy difference between the triplet radical 
and singlet carbene. This work allowed for the late stage functionalisation of highly 
sensitive fluorescent dyes, drugs, lipids, peptides, nucleosides and carbohydrates with 
high regioselectivity and functional group tolerance.137 
 In a variation of the alkylation methodologies reported, a recent publication by 
Cui and co-workers reported the meta selective difluoroalkylation of 2-phenoxypyridines 
by Ru catalysis. They mechanistically propose to proceed through a similar scheme to that 
shown in Scheme 37, using a simple RuCl3 catalyst, which forms a cyclometalated 
intermediate that activates the meta position.138  
Beyond alkylations, alkenylations and arylations, the ability to attach other 
reactive functional groups in a chemo- and regioselective manner is also of great interest. 
The ability to halogenate the meta position regioselectivity has been reported by Greaney 
et al. for the meta bromination of 2-phenylpyridine using NBS (Scheme 41),139 and Huang 
et al. separately.140 The analogous chlorination utilising N-chloro-2,10-camphorsultam 
(Scheme 42) by Zhang et al.141 The ability to regioselectively install these halides is of 
great use, due to their synthetic applicability in potential cross-coupling reactions.2,142  
 
 
41 | P a g e  
 
 
Scheme 41: Conditions for the meta bromination of 2-phenylpyiridne.139 
The bromination occurs via a similar mechanistic cycle to that shown in Scheme 37, using 
NBS instead of an alkyl halide, a bromination protocol utilising a heterogeneous Ru 
source has also been reported.143  
Computational calculations by Ackermann et al. on the meta alkylations and bromination 
of purine bases has given insight to the role of the Ru in these meta alkylation and 
bromination reactions.136 The observed first order role of the Ru concentration in the meta 
C–H alkylation and bromination reactions, suggested that a Ru(II/III) pathway may be in 
operation, rather than a second order reaction, whereby two molecules of Ru are involved 
in the formation of the active radical species.143,144  
 
Scheme 42: Reaction conditions for the meta chlorination of 2-phenylpyridine.141 
The analogous chlorination however, as shown in Scheme 42 is intriguing due to the use 
of a Ru(0) precatalyst, which results in a slightly differing mechanistic explanation of the 
process, as seen in Scheme 43. The Ru(0) precatalyst is oxidised by the oxidant to the 
active Ru(II) species which then undergoes a CMD process with the 2-phenylpyridine, to 
form a cyclometalated intermediate.  
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Scheme 43: Proposed mechanism for the meta-chlorination of 2-phenylpyridine.141 
The chloride source then undergoes homolytic cleavage to produce the chloride radical 
which then attacks the position para to the C–Ru bond. This radical intermediate is then 
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oxidised and deprotonated to facilitate rearomatisation of the system, followed by 
protodemetallation to release the product and catalyst to begin the cycle again. 
Mechanistic studies indicate a reversible ortho metalation step and the meta C–H bond 
cleavage is not involved in the rate determining step (RDS).141 This work also includes 
the use purine base and benzodiazepine derivatives as substrates, both pharmaceutically 
relevant motifs. 
The use of a Ru(0) precatalyst has also been utilised in the meta nitration of 2-
phenylpyridine as reported by Zhang et al. with the use of strongly oxidising conditions.145 
Subsequently, more mild conditions were published by Huo et al. which allows the 
transformation to proceed under milder conditions, thus making it more amenable to 
general useage.146 A mechanistic proposal hypothesised by Zhang et al. is shown in 
Scheme 44.  
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Scheme 45: Reaction conditions for the meta selective alkylarylation of 2-phenylpyridine.147 
A recent report by Liang et al. on a alkylarylation of alkenes provides a novel new 
methodology on a three-component reaction, utilising the σ-activation methodology to 
achieve meta functionalisation as shown in Scheme 45.147 The reaction shows a wide 
tolerance to a range of different functional groups such as halogens and esters , as well as 
a variety of acrylates, vinylarenes and vinylferrocene. The mechanistic investigation for 
this reaction proposed that a Ru(II) CMD complex reacts with the alkyl halide, via an 
inner sphere halide transfer process to form a Ru(III) CMD complex, which then reacts 
para to the Ru–C bond as with similarly to shown in Scheme 37. This Ru(III) CMD 
complex was proposed by DFT  is responsible for the meta selectivity.147 
The use of carbon tetrabromide as a coupling partner has also been reported by Greaney 
et al. with MeOH added to the reaction conditions, resulting in an overall meta 
carboxylation under the conditions shown in Scheme 46.148 This occurs by the formation 
of the ·CBr3 radical, which then reacts at the meta position with a CMD complex, the 
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Scheme 46: Proposed mechanism and reaction conditions for the meta carboxylation of 2-phenylpyridine.148 
The carboxylation work was further extended to a meta acylation reaction by Wang et 
al.149 This work utilised phenylglyoxylic acid as a known C-centred acyl radical 
precursor, when reacted with a suitable single electron oxidant, collapses to produce CO2 
and the desired acyl radical, which then reacts in the normal manner of a radical addition 
reaction para to the C–Ru bond, to yield the overall meta acylated product, under the 
conditions shown in Scheme 47. 
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Scheme 47: Conditions for the meta acylation of 2-phenylpyridine.149 
Recent work disclosed by Cui et al. presented a meta carboxylation methodology that uses 
a similar coupling partner to allow for a meta formylation.150 This work used a CHBr3 
coupling partner under the conditions shown in Scheme 48. This follows a similar 
mechanistic path to that shown in Scheme 46. However, instead of methanolysis to form 
the carboxylated product, the coupled –CHBr2 moiety reacts with the base to form the 
formylated product plus CO2.  
 
Scheme 48: Conditions for the meta formylation of 2-phenylpyridine.150 
Benzylations, utilising toluene derivatives as a coupling partners have also been used by 
Shi et al.151 This methodology requires the use of an alkyl iodide initiator to form the 
desired benzylic radical which can then react in a radical addition fashion, para to the C–
Ru bond, followed by SET, rearomatisation and protodemetallation to yield a meta 
benzylated product. Examples of using complementary conditions to regioselectively 
select between the ortho and meta positions has also been shown by Zhao et al., by use of 
readily available Ru catalysts and oxidants shown in Scheme 49.152 
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Scheme 49: Complimentary conditions for the ortho or meta benzylation of 2-phenylpyridine.152 
1.6 – Overview of para C–H Functionalisation Reactions 
The ability to achieve para regioselective functionalisations of aromatic systems 
represents, perhaps the most difficult position to functionalise. This is in large part due to 
the distal nature of the C–H bond from any potential directing groups. Due to this 
difficulty, may examples of para C–H functionalisation have used more direct C–H 
activation methods to achieve the desired regioselectivity, based upon the steric and 
electronic nature of substrate molecules.153 Despite these difficulties, methods have been 
developed to achieve this C–H functionalisation that utilise directing group methods.  
1.6.1 – Template Assisted para C–H Functionalisation 
Similarly, to the work Yu et al. of using a “U-shaped” template to direct a TM catalyst 
towards the meta C– bond for functionalisation, this methodology has been elaborated 
upon by Maiti and co-workers, allowing for the realisation of a para alkenylation reaction 
as shown in Scheme 50. 
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Scheme 50: para C–H functionalisation of toluene derivatives via template assistance.154 
In the mechanistic explanation for this reaction, they proposed that they utilised the 
Thorpe-Ingold effect, and a longer chain length to enact selectivity for the para position 
over the ortho and meta positions. Despite this, a mixture of regioisomers was nearly 
always found, with para:others varying between 5:1 to 20:1. The same paper also 
described conditions for the para acetoxylation of same templated structures. The 
recovery of the template portion is vital to allow for good atom economy post C–H 
functionalisation, and found that treatment with TBAF allowed for the cleavage of the Si–
Cbenzyl bond in excellent yields, with near quantitative recovery of the Si–O cleaved phenol 
derivative.154 
Further work published by the same group in 2016, proposed the para C–H alkenylation 
of phenol derivatives.155 This methodology was achieved, through switching then benzyl 
methylene group for an oxygen, as shown in Figure 4.154 The reaction conditions for this 
para selective alkenylation are similar to those shown in Scheme 50. The cleavage of this 
substrate is easily achieved by reaction with p-TSA, to produce the para substituted 
phenol and silanol-based template in good yields.155 
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Figure 4: Substrate modification to allow for the para alkenylation of phenol substrates.155 
As seen so far, the use of these non-covalent templates can be a powerful method of 
achieving para C–H functionalisations. In 2017, Chattopadhyay reported the Ir catalysed 
para C–H borylation of benzoates using a dual salt/Lewis basic chelation agent model to 
achieve this para selectivity.156 The reaction is shown in Scheme 51, and was found to 
proceed under optimised conditions on a range of substrates with regioselectivities of 
para:other of 9:1 to 99:1, with the majority >20:1. They proposed that the mechanism 
based on insights of using the preformed potassium alkoxide (OK) salt and comparing it 
to the OMe substituted ligand (cannot form the non-covalent interaction). Here, high 
conversions were observed in both cases however the salt gave selectivity of para:meta 
of 33:1, cf. 1.9:1 for OMe. 
 
Scheme 51: Ir catalysed para C–H borylation of benzoates using a salt templated non-covalent interaction.157 
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Another example of template assisted para C–H functionalisation was published in 2019 
by Phipps and co-workers, utilising an ion-pairing interaction, to direct an Ir catalyst 
towards the para C–H bond for functionalisation, in a manner akin to that shown in Figure 
3.158 This reaction was found to work on a variety of aniline, benzylamide, phenol, benzyl 
alcohol, aryl and benzyl sulfonate substrates, under the conditions shown in Scheme 52. 
 
Scheme 52: Ir catalysed para selective C–H borylation of anilines, benzylamides, phenols and benzyl alcohols.158 
This work found it was necessary to first convert the desired substrate into the 
corresponding sulfonamide or sulfate analogue, before then borylating under the 
conditions in Scheme 52, and then treating with HCl in MeOH to transform back to the 
corresponding alcohol or amide. Selectivites for para:meta were found between 3:1 to 
>20:1, with bulky ammonium cations found to enhance this selectivity.158 
 A final recent example of para functionalisation, using a hydrogen-bonding 
template, was disclosed by Maiti et al. for the para selective cyanation of toluene 
scaffolds, as well as a few examples of phenol scaffolds.159 This methodology utilises Pd 
catalysis, through the conditions shown in Scheme 53. It was shown through NMR studies 
and XRD structures of reaction intermediates, of the OMe and iPr groups on the Tem 
group increase the reactivity of the system as shown on Scheme 53. This allows the CN 
group to become proximal para C–H bond of the substrate, through hydrogen bonding 
interactions with the solvent (HFIP). They then show that this template can then be easily 
cleaved in postreaction.159 
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Scheme 53: Conditions for the Pd catalysed para cyanation of toluene scaffolds.159 
1.6.2 – Sterically Induced para C–H Functionalisation 
The use of sterics to influence the regioselective outcome of para C–H functionalisation 
reactions, tends to rely upon pre-existing sterically demanding functionality on the 
structure. Methods that utilise this methodology are however, susceptible to 
regioselectivity issues, due to the distal nature of the steric group(s).17,160 
There are two reports to date which have attempted to overcome these regioselectivity 
issues in recent years. The first by Itami, using a bulky metal ligand to control the 
orientational approach of the substrate towards the metal centre. This report detailed in 
2015, reported the para selective C–H borylation of alkylbenzene and silylbenzene 
derivatives.161 Under the conditions in Scheme 54, they use an incredibly sterically 
demanding bidentate phosphine ligand to favour the para over the meta functionalisation. 
Computational analysis of this reaction has also been done, modelling reactivity in the 
pocket of the Ir-ligand complex.162 
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Scheme 54: Ir catalysed para C–H borylation, using a bulky Ir catalyst.161 
Preliminary work by Nakao et al. on the C4-alkylation of pyridines, using a bulky Al 
Lewis acid, to enable C4 selective metalation and functionalisation,163 led them to 
consider the para selective functionalisation of arenes, using a similar method. There 
methodology involved using a dual Al/Ni system to allow for the para C–H alkylation of 
benzamides and aromatic ketones.164 The demonstrated that coordination of the carbonyl 
to a bulky Lewis acidic aluminium centre, coupled with a bulky nickel system enabled 
steric clash between the two, leading to selective para-selective C–H functionalisation, an 
example of this to achieve a para selective alkylation is shown in Scheme 55. Following 
this the same group then reported the use of sulfones as substrates for the same reaction 
methodology.165 
In 2017, Nakao et al. utilised this chemistry, to enable a para selective C–H borylation of 
benzamides.166 The same Al Lewis acid employed previously was used again, however, a 
different Ir precatalyst and bipyridyl ligand were used. This borylation strategy was also 
applied to allow for the C4 borylation of pyridine substrates in the same paper.  
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Scheme 55: Ni/Al catalysed para C–H alkylation of arenes.165 
1.6.3 – Electronic Induced para C–H Functionalisation 
A majority of para C–H functionalisation reactions to date, have utilised the electronic 
biases of substrates to dictate regioselectivity. Here, substituents which can place electron 
density on the para position of an arene can enable interaction with electrophilic metal 
centers or substrates. 
The first such example of this type of para C–H functionalisation was described by Gaunt 
et al. in 2011, in the Cu-catalysed para arylation of anisole and aniline derivatives shown 
in Scheme 56, utilising hypervalent iodine salts.167 
 
Scheme 56: Conditions for the para arylation of aniline derivatives.167 
Mechanistic studies indicated that this reaction also proceeds in the absence of a Cu 
catalyst, albeit with lower isolated yields, longer reaction times and elevated temperatures. 
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The role of the Cu catalyst is believed to lower the barrier of formation of the highly 
electrophilic aryl cation. 
Suna and co-workers have also utilised electronically activated aromatic substrates under 
Cu catalysis to achieve a para selective amination of electron rich arenes, in an Ullman-
type cross-coupling fashion.168 This methodology uses a hypervalent iodine species to 
react with the desired para proton initially in an SEAr mechanism, to provide a pseudo 
halogen-type group. The Cu coordinated to the amine to be coupled, then reacts in a 
Cu(I/III) cycle to insert into the C–I bond, before then undergoing a reductive elimination 
to yield the para aminated product, the reaction conditions are shown in Scheme 57. The 
insertion of Cu into the C–I bond is proposed by DFT calculations by Sanford et al.169 
 
Scheme 57: Conditions for the para amination of electron rich arenes.168 
Subsequent work by Zhang and co-workers reported the para selective sulfonimidation 
of anilide derivatives, utilising N-fluorobenzenesulfonimide (NFSI) as the 
sulfonimidation source using ortho methoxyanilides substrates.170 Mechanistically a 
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Scheme 58: Conditions for the Pd catalysed para-sulfonimidation of anilides.170 
More recent work by Ritter et al. reported upon a method to achieve a para amination of 
electron rich arene rings.173 This methodology used computational methods to explain the 
observed regioselectivity. They proposed that the selectivity was dictated by a “charge-
transfer radical addition” where TS interactions between the SOMO of the coupling 
partner and the LUMO of the arene, enable electron shuttling, depicted in Scheme 59. 
This involved using Fukui indices to explain the relatively nucleophilicity of each atom 
as a simple model to explain the observed regioselectivity.174,175 Using the calculated 
electron affinity of various amine radicals, it was found that theoretically and 
experimentally that the higher the electron affinity, the higher the para selectivity 
experimentally.176,177 They demonstrated that the greater electron affinity of the coupling 
partner (more positive), the higher selectivity of functionalisation. This was rationalised 
as the higher electron affinity, the more readily the coupling partner will accept an electron 
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Scheme 59: Pd/Ru catalysed para C–H amination of electron rich arenes.173 
Work by Ackermann et al. from 2013 showed that Ru catalysis can also allow for the 
para selective oxygenation of anisole derivatives (Scheme 60). The reaction is thought to 
proceed via a radical type mechanism, as the addition of TEMPO resulted in significantly 
reduced yields.  
 
Scheme 60: Conditions for the para oxygenation of anilsoles.178 
Waser and Brand described the para alkynylation of aniline derivatives, using Au 
catalysis, again as described previously in this section, utilising hypervalent iodine 
reagents. This transformation achieves incredibly high selectivites, under mild conditions 
as shown in Scheme 61. 
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Scheme 61: Conditions for the Au catalysed para alkynylation of anilines.179 
The use of cyclometalated species to achieve para functionalisation have recently been 
reported, the first by Manolikakes et al., describing the para sulfonation of bespoke 
anilide derivatives.180 The reaction is suggested to proceed through a cyclocuparated 
intermediate, which could allow SET with the arene ring. A radical cation, centred on the 
arene could then react with the sulfonyl radical, formed through reaction with a 
stoichiometric oxidant and sulfonate salts as shown in Scheme 62.  
 
Scheme 62: Conditions for the para selective C-H sulfonylation of anilides.180 
A second example of this methodology also utilises a Cu catalyst in the para sulfonation 
of 2-amino-napthalene derivatives by Lu et al.181 as shown in Scheme 63.  
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Scheme 63: Cu Catalysed para tosylation of aminonaphthalene derivatives.181 
This methodology uses tosyl chloride as the coupling partner, to react with the substrate 
in a SET type fashion. This work used DFT and Fukui Indices to explain both the reaction 
mechanism and regioselectivity observed for the reaction product. This report also 
reported the unoptimised para selective acetoxylation, bromination, iodination, 
sulfonimidation and trifluoromethylation of the 2-aminonaphthalene derivatives.181 
In 2017, work from within our group reported the para C–H alkylation of aniline 
derivatives using a radical methodology, as shown in Scheme 64.182   
 
Scheme 64: Optimised conditions for the para selective C-H alkylation of aniline dertivatives.182 
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During the optimisation it was also discovered that increasing the reaction temperature 
resulted in the sole formation of the meta product. Under the optimised conditions no 
regioselectivity issues were reported, with excellent chemoselectivity also observed. 
 
Scheme 65: Summary of DFT free energies (kcal mol-1) relative to the most stable intermediate for the competing C-H 
and N-H activations of 5-chloro-N-phenylpyrimidin-2-amine at [Ru(p-cymene)(O2CR)]+ in dioxane, when R = Me 
(acetate) or OH (carbonate).182 
During mechanistic studies, it was determined that the regioselectivity could be changed 
between meta and para by simple addition or removal of an acetate ligand. DFT 
calculations were used to elucidate the causation of this switch in mechanism, the results 
of which are summarised in Scheme 65. These calculations hinted that use of a 
carboxylate ligand caused the C–H activation to become more favourable and when a 
carbonate ligand is used the N–H activation pathway becomes more favourable. These 
theoretical calculations are in alignment with deuterium labelling experiments as well. 
Addition of stoichiometric amounts of TEMPO to the reaction causes a complete 
shutdown of reactivity, suggesting a radical pathway.  
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Scheme 66: Proposed catalytic cycle for the para difluoromethylation of ketoximes.183 
Subsequent work by Zhao et al. on the para difluoromethylation of aromatic ketoxime 
derivatives proposed an alternative mechanistic pathway.183 Their examination of the 
frontier orbitals involved in the reaction intermediates and transition states, suggests that 
C-H activation occurs preferably (through their use of N-Ac-L-Iso as a ligand, as 
suggested by Frost and co-workers to facilitate preferable C-H activation.182) with the 
resulting intermediate having an optimal SOMO/LUMO overlap between the para 
(LUMO) and the SOMO of the ·CF2CO2Et radical; this results in the mechanistic proposal 
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shown in Scheme 66. This methodology has also been extended to include examples of 
anilide, indoline and tetrahydroquinoline derivatives by Zhao et al.184 
1.7 – Aims and Objectives 
At the outset of the following research, the major aims were to develop techniques which 
could allow for the control of site selectivity in C–H functionalisation, using a variety of 
substrates and coupling partners, focusing primarily on Ru-catalysed σ-activation. To this 
end, the results of this thesis will be split into three distinct chapters, which will focus on 
the distinct regioselective and functionalisation goals as depicted below. 
 
The first section will focus upon the meta selective, primary C–H alkylation of 2-
phenylpyridine and derivatives, the realisation of this methodology and some mechanistic 
insights into the transformation. 
The second section will focus upon the C4 selective alkylation of a carbazole derivative, 
the realisation of this transformation and mechanistic insights into this reaction will be 
focussed on.  
The third and final section will focus on our efforts to achieve a para selective 
carbonylation of aniline derivatives, focussing on our attempts to enhance the reactivity 
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Chapter 2 – α-Halo Carbonyls for meta 
Selective Primary C–H Alkylations  
 
At the time of carrying this work out, the coupling partners reported for the meta-
alkylation of 2-phenylpyridine were limited to secondary and tertiary alkyl halides and  
the analogous α-halo esters.1–3 The reason for this limited scope of alkylations is due to 
the proposed mechanism of reaction, which involves the formation of a C-centred radical 
species on the coupling partner. These species are stabilised by the effects of 
hyperconjugation with the non-bonding orbitals of an adjacent atom or functional group.4 
The regioselective meta functionalisation of arene rings, utilising directing groups had at 
the time of this work been limited to: alkylation (tertiary and secondary only),1,2,5 
nitrations,6 sulfonations,7 brominations,8,9 and benzylations.10,11 Since the completion of 
this work this has been expanded further to include carboxylations,12 alkylarylations,13 
mono- and difluoro-alkylations,14,15 chlorinations and iodination,16,17  and acylations.18  
The use of primary alkyl halides has been reported by Ackermann et al. as an observable 
by-product for the ortho alkylation of 2-phenylpyridine substrates, this observation is the 
first report of such a meta primary alkylation, shown in Scheme 67.19 
 
Scheme 67: Conditions used for the first report of meta-alkylation.19 
As shown in Scheme 68, the first step of the cycle shows the Ru inserting into an ortho 
C–H bond, as directed by a Lewis basic directing group, with the expulsion of a molecule 
of carboxylic acid.20,21 The next step of the cycle shows a radical formed by an inner 
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sphere electron transfer with another molecule of Ru in situ., reacting with the 
cyclometallated phenylpyridine at the meta position.2,9 However, there are also examples 
of this process occurring under photolytic conditions.22,23 The next step shows the process 
of a single electron transfer (SET) to a Ru(III) species in situ,9,11 followed by 
deprotonation to restore the aromaticity of the system. The final step of the cycle shows 
the protodemetallation of the Ru catalyst from the functionalised substrate, with acetic 
acid.   
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Scheme 68: Mechanistic explanation for the meta selective secondary and tertiary alkylation of 2-phenylpyridine.2,24 
Work within our group had shown that α-halo ester coupling partners were effective for 
secondary and tertiary meta alkylation reactions.2 We became intrigued as to how these 
substrates could be applied to include primary α-halo ester coupling partners.  
The use of α-halo esters as coupling partners reduces the likelihood of electrophilic type 
reaction mechanisms, due to the destabilisation of any positive charge at the α-carbon and 
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stabilises the formation of radicals at this same position, as shown by the formation of the 
alkyl radical in Scheme 68. 
Preliminary investigations carried out within our group demonstrated that the use of 
primary alkyl halide coupling partners (such as ethyl 2-bromoacetate) under the meta-
alkylation conditions as shown in Scheme 69, led to a mixture of ortho and meta products 
in low yield, with negligible observable regioselectivity between ortho and meta, arising 
from a competing two-electron process, shown in Scheme 70. 
 
Scheme 69: Initial results of using primary alkyl halide coupling partners to access meta-alkylated products. 
A likely mechanistic pathway leading to the ortho alkylated product is shown in Scheme 
70. This process begins by an identical CMD process, allowing the Ru to insert into the 
ortho C–H bond of the substrate. This Ru-CMD complex then undergoes oxidative 
addition into the C–Br bond of the coupling partner, rapidly followed by reductive 
elimination to yield the ortho alkylated product and the catalytically active Ru(II) species. 
This side reaction represents, a manner in which we hypothesis the ortho regioisomer is 
being competitively formed in situ.  
We attributed this lack in selectivity to the fact that an in-situ generated primary alkyl 
halide radical is not sufficiently stabilised by hyperconjugation, or that two-electron 
oxidative addition into the C–Br bond by a Ru(II) centre is competitive.2 This proposed 
radical addition of a tertiary radical to the meta position would initially suggest that use 
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Scheme 70: Mechanistic pathway that leads to the ortho alkylated product, when using primary -halo ester coupling 
partners. 
Work done within our lab sought to identify a suitable additive to the reaction, that would 
reduce the rate of this competing two-electron process, that leads to the ortho alkylated 
product, whilst simultaneously allowing for the meta addition of the coupling partner. 
Pleasingly, it was shown that the use of Pd based additives were effective in amplifying 
meta-selectivity and subsequent optimisation studies afforded an increased yield of C–H 
functionalised product and meta-selectivity up to 18:1 (Scheme 71) in good yields.26 The 
regioselective bias shown for the meta isomer suggests that this process for ortho 
functionalisation is kinetically more sluggish and that the intermediates leading to this 
product are reversibly formed as suggested by Itoh et al. for the oxidative 
addition/reductive elimination of allylic halides onto Ru(II) complexes under the reaction 
conditions shown in Scheme 71.27 
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Scheme 71: Optimised conditions for the meta primary alkylation of 2-phenylpyridine using a palladium co-catalyst.26 
The aim of the work carried out in this chapter was to achieve a regioselective meta 
alkylation of 2-phenylpyridine (1a) and related directing groups and variants thereof, 
using a co-catalyst to achieve this aim, whilst minimising formation of the ortho 
regioisomer.  The use of an additive to increase the nucleophilicity of the desired position 
of reaction, or formation of a new coupling partner in situ amenable to radical formation, 
was in our view the best way to achieve this transformation, precluding the use of complex 
directing groups, which would then necessitate the addition of two extra steps to couple, 
then remove the directing group. The ability to achieve this transformation with 
comparable/lower catalytic loadings and a more economically sustainable cocatalyst than 
Pd to achieve the same regioselective and atom economical outcomes was of great 
importance to us, which lead us to initially base metal complexes to this end. The 
investigation of what was occurring mechanistically through use of experimental and 
computational modelling was also utilised, to allow for deeper understanding of this 
process. [Pd(PPh3)4] allowed this regioselectivity to be flipped in favour of the meta 
product. 
Progressing from these results, we were interested in exploring more sustainable 
alternatives to this system as it necessitated the dual catalytic system constituting two 
noble/platinum group metals. As previous studies have elucidated the key role Ru plays 
in σ-activation methodologies, we identified that an alternative for the Pd co-catalyst may 
be sought. The results herein were carried out in a joint project with Dr Andrew J. 
Paterson, however, with a main focus on my contributions.  
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This reaction methodology has the potential for the rapid synthesis of a library of 
compounds and for the late stage functionalisation of drug candidates, two examples 
which contain the phenylpyridine motif are shown in Figure 5.  
 
Figure 5: Pharmaceuticals containing the 2-phenylpyridine motif. 
2.1 – Synthesis of Starting Materials 
2-Phenylpyridine (1a) was chosen as our model substrate, due to its well explored 
“strong” directing group properties and precedent for meta functionalisation of this 
substrate via σ-activation methodologies in the literature.2,3,7 To investigate the effects of 
electronic variations on the reaction, it was necessary to prepare a range of 2-
phenylpyridine substrates.  
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Scheme 72: Scope and results for the synthesis of para substituted 2-phenylpyridine substrates. 
Previous work within our group and literature precedent utilising various para-
substituted, 2-phenylpyridine derivatives were prepared via a Suzuki cross-coupling 
reaction between 2-bromopyridine and various 4-substituted phenylboronic acids.2,28,29 
Utilising the reported conditions for the syntheses of these substrates, resulted in good to 
excellent yields as shown in Scheme 72, with the exception of the bromo- and iodo- 
substrates, in which cases significant levels of homo-coupled by-products were observed. 
Due to the limited utility of the iodo- substrates as an example, its synthesis was not 
explored further.  
For all the other substituted examples utilised in Section 2.4, these examples were already 
available in house, having been prepared during the course of another project.26 
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2.2 – Optimisation of Reaction Using a Nickel Co-Catalyst 
We believed that an oxidative addition event by the Pd co-catalyst and subsequent 
interaction with a ruthenacycle was responsible for the observed regioselectivity. On 
conducting a literature search we became aware of a 2013 report by Chatani et al. showing 
that the addition of Ni(II) salts with the addition of PPh3 as a ligand, could facilitate the 
ortho addition of primary alkyl halides when using benzamide and acrylamide directing 
groups for both activated and unactivated alkyl halide species.30 In their mechanistic 
explanation, they proposed that oxidative addition of Ni(II) into the C–X bond meant that 
the reaction proceeded via a two-electron pathway (Ni(0)/Ni(II) or Ni(II)/Ni(IV)) 
process.31,32 For these reasons we believed that a Ni-based system could provide the key 
to unlocking a more sustainable method. 
We commenced our study into more sustainable co-catalysts with Ni salts in place of 
[Pd(PPh3)4]. Our investigation started by using the optimal conditions from the Pd 
reaction and replacing the Pd with a range of Ni complexes, as seen in Table 1. 
 
Table 1: Selected results from the investigation of Ni co-catalysts for the meta functionalisation of 2-phenylpyridine. 
IY – Isolated Yield. 
Entry  Co-catalyst Conversion to 2.1 (%) (IY) 
(m:o) 
1 NiCl2·6H2O n.r 
2 Ni(OAc)2·4H2O n.r 
3 [NiBr2(PPh3)2] 59 (33) (8:1) 
4 [NiCl2(PPh3)2] 61 (38) (9:1) 
5 [NiCl2(dppf)] <5 
6 [Ni(COD)2] n.r 
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Gratifyingly, good conversion and modest regioselectivity for 1.1 were observed when 
employing Ni(II) co-catalysts bearing a phosphine ligand (Table 1). A range of other Ni 
co-catalysts were studied but shown to be unreactive under the reaction conditions. The 
use of Ni(0) was attempted in the hypothesis that the Ni may be undergoing a two-electron  
process with the alkyl halide coupling partner to directly activate it. However, the lack of 
reaction led us to believe that the Ni could play a different role, which will be discussed 
in a later section in more detail. Use of different phosphine ligands for the Ni co-catalyst 
also proved to be ineffective at increasing conversions (Entries 5 and 7, Table 1). 
However, in this regard we were limited to electron rich phosphine-based ligands, due to 
the reported instability of such complexes bearing electron deficient phosphine ligands.33 
After screening Ni co-catalysts, we began to investigate the optimal Ru source for this 
transformation as shown in Table 2.  
 
Table 2: Results from catalyst screen for the meta alkylation of 2-phenylpyridine. IY – Isolated Yield. 
Entry Ru source Conversion to 2.1 (%) (IY) 
(m:o) 
1* [RuCl2(p-cymene)]2 61 (38) (9:1) 
2* [RuCl2(benzene)]2 12 
3 RuCl3·xH2O <5 
4 RuCl3(PPh3)2 <5 
5 [Ru(1,10-phen)3]·2Cl
- 0 
*-5 mol.% dimer used 
[RuCl2(p-cymene)]2 gave the best results for conversion to 1.1, from the catalysts 
screened. Ru(III) sources proved to be ineffective under the reaction conditions used; and 
the use of a Ru photocatalyst, with non-labile ligands showed no reactivity at all. This 
result hints that the formation of a CMD complex (an intermediate that is formed when a 
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metal species undergoes concerted metalation deprotonation (CMD) with a suitable 
substrate) is vital to the reactivity and that the Ru is directly used in this step.21,34,35 
The screening of carboxylate ligands to facilitate insertion of the Ru into the ortho C–H 
bond was investigated next, with a selection of carboxylic acid/carboxylate salts tested, 
with the results shown in Table 3. 
 
Table 3: Selected results from the optimisation of the carboxylate/carboxylic acid ligand for the meta 
functionalisation of 2-phenylpyridine. IY – Isolated Yield. 
Entry  Carboxylate/Carboxylic 
Acid 
Conversion to 2.1 (%) (IY) 
(m:o) 
1 KOAc 0 
2 AdCO2H 65 (54) (19:1) 
3 9-AnthCO2H 7 
4 PhCO2H 37 
5 MesCO2H 61 (38) (9:1) 
6 PivCO2H 58 (40) (6:1) 
7 Piv-Val-OH 16 
 
As seen in Table 3, the bulky acids: PivCO2H, MesCO2H and AdCO2H gave the best 
conversions to 1.1, these results mirror the previous work done in the group by Paterson 
et al.26 The optimisation of this reaction component also gave the most dramatic 
improvement in both isolated yields and observed regioselectivities.  
The use of Piv-Val-OH as utilised by Yu et al.,36 and later by Ackermann et al.24 
successful in facilitating the CMD process between the (sp2)C–H bond and the metal 
catalyst was found to be ineffective for these reaction conditions, giving a low conversion 
to the desired product.  
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The use of different bases showed that using alkali carbonate bases gave the best results, 
with K2CO3, Cs2CO3 and Na2CO3 giving near identical results (61%, 62% and 59% 
respectively). We decided to use K2CO3 as the base for this reaction, due to its common 
use already in similar σ-activation methodologies,7,20,37  
The optimisation of the reaction solvent found that 1,4-dioxane was the best solvent, with 
other solvents giving inferior results. It could be hypothesised that this is due to the 
mixture of polar and non-polar reaction components, and the need for a solvent that would 
allow for the dissolution of both in situ. 
2.3 – Role of [Ni] and Reoptimisation of Conditions 
Upon optimisation of the reaction conditions we carried out more control experiments, in 
an effort to better understand the effect of each component upon the reaction. The results 
of these control experiments are shown in Table 4. The addition of Ru to the reaction is 
critical for the reactivity of the whole system as its removal results in zero reactivity. The 
addition of the carboxylic acid ligand, to aid the CMD process of the Ru into the ortho 
C–H bond is essential to allow the turnover of the Ru to allow the reaction to proceed at 
higher yield and regioselectivity. The removal of the Ni resulted in a loss of 
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Table 4: Results of control experiments upon reaction conversions and regioselectivities. IY – Isolated Yield. 
Entry Parameter changed Conversion to 2.1 (%) (IY) (m:o) 
1 No [Ru] 0 
2 No AdCO2H 15 (2.5:1) 
3 No [Ni] 19 (1:1) 
4 NiCl2·6H2O + 2PPh3 53 (30) (9:1) 
5 NiCl2·6H2O 0 
6* PPh3 60 (57) (20:1) 
*-20 mol.% added 
When we added the two components of the Ni source separately (Entry 4, Table 4), we 
seen that the reaction occurs with good regioselectivity, but lower than our observed “gold 
standard.” We then looked at the effect of the Ni and whether it formed a heterobimetallic 
complex in situ with the Ru to form an active catalytic species,15 or whether it was 
dissociating a PPh3 ligand that then coordinated to the Ru allowing for the more powerful 
direction towards the desired meta C–H bond (Entries 5 and 6, Table 4). As seen in Table 
4 (Entry 6) the addition of  PPh3 alone resulted in a much higher conversion than that 
observed with the Ni conditions, with a comparably high regioselectivity.  
We then decided to reoptimise the reaction conditions for use with a phosphine ligand. 
Results from this optimisation are shown in Table 5. The use of alkyl phosphine ligands 
resulted in little to no observed reactivity, possibly due to increased strength of the σ-
donation, resulting in much slower rates of ligand exchange required for reactivity.38 The 
use of phenyl phosphine derivatives, bearing an EWG para to the P gave good 
regioselectivities, with reduced yields than compared those seen with PPh3. 
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Table 5: Selected results from the optimisation for the meta alkylation of 2-phenylpyridine. IY – Isolated Yield. 
Entry Phosphine Ligand Conversion to 2.1 (%) (IY) 
(m:o) 
1 PPh3 60 (57) (20:1) 
2 PCy3 0 
3 P(4-F(C6H4))3 52 (38) (15:1) 
4 P(4-(CF3)(C6H4))3 44 (21) (16:1) 
5 dppe <5 
6 dppf <5 
7 P(n-Bu)3 <5 
 
The use of bidentate phosphine ligands such as dppf and dppe (Entries 5 and 6, Table 5) 
also gave poor yields; comparable with the results seen for the alkyl phosphine ligands 
(Entries 2 and 7, Table 5).  
We next began to examine the optimal carboxylate ligand for the Ru, to aid the CMD 
process. The results of this are shown in Table 6, it was found that MesCO2H was the 
optimal ligand in this regard, with the previously used AdCO2H for the nickel reaction 
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Table 6: Selected results from the carboxylate ligand optimisation for the meta alkylation of 2-phenylpyridine when 
using a phosphine ligand. IY – Isolated Yield. 
Entry  Ligand  Conversion to 2.1 (IY) (%) 
(m:o) 
1 AdCO2H 29 
2 KOAc 54 
3 MesCO2H 60 (57) (20:1) 
4 PivCO2H 0 
5 Piv-Val-OH <5 
 
The choice of base, solvent and reaction temperature remained the same as previously 
used for the Ni conditions. Interestingly, an increase in reaction concentration resulted in 
much diminished yields, whereas such an effect when using the Ni co-catalyst, gave no 
such observable effect in this regard. Inclusion of air in the reaction lead to much 
diminished conversions by 20%, but no effect upon the regioselectivity of the reaction, 
but not a complete reduction in reactivity. 
2.4 – Scope and Limitations 
With two sets of optimised conditions in hand, we sought to explore the substrate scope 
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Scheme 73: Directing group scope. 
In all cases, near complete regioselectivity for the desired meta product was observed 
(19:1 or greater (m:o)). Entries 1.9 and 1.10 gave no reaction under the conditions tested 
as the methyl group present in the pyridine rings creates a highly strained system upon 
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The use of pyrimidine and pyrrole rings as directing groups work well for this 
methodology. However, the addition of extra functional groups to the heterocyclic portion 
of the molecule appears to lead to diminished yields, with no effect upon the observed 
regioselectivity of the isolated product. This could possibly be due to the electronic and 
steric effect that these groups confer upon the initial coordination of the Ru catalyst.  
We then investigated the effect of substituting the arene ring and its effect upon the 
regioselectivity from changing the sterics and electronics of it as shown in Scheme 74. In 
general, the use of electron donating groups (EDG) lead to superior regioselectivity as 
seen with Entries 1.11, 1.12 and 1.16 in Scheme 74, due to the stabilisation of the partial 
positive charge located in the transition state on the arene ring. Comparatively the use of 
electron withdrawing groups (EWG) lead to inferior regioselectivities, with the exception 
of the NO2 substituted example (1.20) which is presumed to be too deactivated to react 
under this methodology. This can be attributed to their destabilising effect for SEAr to 
occur at the ortho position directly adjacent to the strongly  EWG.39,40  
The examples bearing methyl groups in the ortho or meta positions were unreactive under 
the conditions attempted, despite their effectiveness as substrates in other reported Ru 
catalysed alkylations.3,24 The dimethylated example (1.26) afforded no product either, due 
to its inability to form a cyclometallated complex with the Ru catalyst.  
After exploring the effects of substitution on the aromatic ring systems of the substrate, 
we looked at the effect of using an α-chloro ester coupling partner. To our delight this 
furnished the desired meta product, 1.1 in 48% yield with an equal 19:1 (m:o) 
regioselectivity under the conditions shown in Scheme 75. 
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Scheme 74: Scope of substituted arene ring 
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Scheme 75: Reaction conditions used for the meta  alkylation of 2-phenylpyridine using an α-chloro ester coupling 
partner. 
The use of activated α-halo ester coupling partners led us to question whether analogous 
coupling partners, lacking an adjacent group to enable captodative stabilisation, could be 
utilised under these reaction conditions. However, upon the testing of such coupling 
partners we found that no regioselective preference for the meta position was observed, 
with a 46% yield of the ortho alkylated product instead isolated as shown in Scheme 76. 
This could be explained by the relative instability of primary alkyl radicals, resulting in a 
two-electron process being the most likely pathway; whereas the ester substrate radical, 
formed by homolytic cleavage of the C–Br bond, is much more stable, due to the donation 
of the C=O π bond donation into the vacant p-orbital of the adjacent radical.41 
 
Scheme 76: Results of using an unactivated primary alkyl halide coupling partner. 
2.5 – Mechanistic Considerations 
Our initial thoughts upon the discovery that only a catalytic amount of PPh3 was needed 
to achieve the desired yields and regioselectivities; was that the PPh3 was either acting as 
a ligand or activating the coupling partner to be more amenable to the reaction conditions. 
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To this end we sought to determine whether the formation of a phosphonium salt was the 
responsible coupling partner, under the reaction conditions shown in Scheme 77.  
 
Scheme 77: Reactions to probe the role of PPh3 in the reaction. 
Under the sets of reaction conditions shown in Scheme 77, no conversion of starting 
material to any products was observed. This result indicated to us that the PPh3 was acting 
as a ligand for the Ru, forming an intermediate responsible for the observed meta 
selectivity in situ.  
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This hypothesis is also backed up by Ackermann et al. in the difluroromethylation of 2-
phenylpyridine which was published whilst this work was being undertaken. This work 
found that a phosphine source was required to achieve the desired meta selectivity shown 
in Scheme 78.15 Similar work by Wang et al. suggested that the addition of a Pd(0) co-
catalyst was responsible for the formation of such a radical species, resulting in the 
formation of an unusual Pd(I) species, in a Pd(0)/Pd(I) catalytic cycle; albeit with no 
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Figure 6: Relative nucleophilicity Fukui indices (fA-) calculated for the shown substrates. Calculations were 
performed at the BP86/6-13G** &SDD(Ru) level of theory. Fukui indices were calculated with NBO total atomic 
charges from the optimised neutral structure.26 
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Work by Paterson et al. gave an indication that the role of the phosphine in the reaction, 
was one as a ligand for the Ru, in the intermediate labelled Ba in Figure 6. This 
intermediate was proposed by computational analysis of the various cyclometallated Ru 
complexes that could be formed in situ under the reaction conditions (Figure 6). From 
Figure 6 it can be seen that looking at 2-phenylpyridine (1a), the most nucleophilic 
position is C10 as identified on the compound, due to the increased electron density from 
the inductive effects of the pyridine ring. However, upon cyclometallation this 
nucleophilicity switches to the meta C11 position, as shown in intermediates Ba and Ca 
in Figure 6, which matches the observed experimental regioselective outcome of the 
reaction. 
Comparison of the phosphine containing cyclometallated substrates (Ba and Ca) shows a 
similarity in electronic properties to that of Aa. Further computational work, carried out 
independently by Greaney et al.22 and Ackermann et al.23 suggested that analysis of the 
Ru(III) analogues of the possible cyclometallated intermediates was a the more likely 
cause for the observed regioselectivity trends between the ortho and meta regioisomers. 
However, our computational analysis was only used for the  potential Ru(II) 
intermediates. However, recent work by Greaney and Ackermann independently, shows 
stronger enhancement for the observed regioselectivity when compared to their 
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Table 7: Reactions with TEMPO. 





1.1 (R1 = R2 = H), 1.1a (R1 = R2 = Me). 
a 3 equivalents of TEMPO added. b No PPh3 
added. 
Use of the radical scavenger (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO) can be 
used to help identify whether a reaction involves formation of a radical. Our analysis used 
both a primary and tertiary coupling partner under the conditions shown in Table 7. 
The addition of TEMPO to the tertiary coupling partner (2b) results in the complete 
shutdown of reaction, in line with previous results observed using this coupling partner 
and suggesting the formation of a radical species in situ.1,2,12 However when using the 
primary coupling partner (2a) the addition of 1 equivalent of TEMPO appears not to shut 
the reactivity down completely. This complete shutdown of reactivity only occurs when 
3 equivalents of TEMPO were added. This suggests that the mechanistic cycle for the 
formation of the meta product does not involve the formation of a radical, and this shut 
down of the reactivity may be due to the oxidation of the Ru catalyst to an unreactive 
Ru(III) that has not cyclometallated with the 2-phenylpyridine or alternatively the 
TEMPO reacts with the coupling partner in a radical SN2 type reaction, removing it from 
the reaction completely.   
To test this hypothesis, we performed DPV measurements on a variety of Ru complexes 
as shown in Figure 7. We performed these measurements to determine whether the 
TEMPO was a strong enough oxidant to oxidise the Ru(II) to Ru(III).  
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As seen in Figure 7 there is an oxidation peak at 680 mV that corresponds to an oxidation 
event from a Ru(II) species to an Ru(III) species. In the cases of [RuCl2(p-cymene)]2 and 
the Ru-CMD complex this oxidation occurs at a much lower potential than the other listed 
complexes c.a. ~650 mV, with the other tested complexes oxidising at a higher potential 
around 900 mV. The oxidation of TEMPO is reported at 490 mV (vs SCE) by Stahl et 
al.42 This corresponds to an inability to oxidise the measured Ru species in situ. However, 
given the large excess of TEMPO in comparison to the Ru in the reaction, the deactivation 
is most likely due to quenching of the organic radical formed in situ and the reaction still 
proceeds in the case of Entry 1, Table 7, similarly to work by Greaney and 
Ackermann.22,23 
 
Figure 7: Differential Pulse voltammetry (DPV) at 10 mVs-1 in MeCN with NH4BF4 ([0.1 M] in MeCN) with a 
substrate concentration of [0.1 mM]. Voltages reported are in reference to SCE. Structures of compound tested in 
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To this end we propose the following mechanistic cycle, based the evidence we collected, 
and the work of other groups on similar reactions which is shown in Scheme 79. 
The proposed catalytic cycle begins by the dissociation of the dimeric Ru species into two 
monomeric biscarboxylate Ru complexes, the active resting state of the catalyst in situ. 
This complex then reacts with the 2-phenylpyridine in a CMD process to insert in to the 
ortho C–H bond and form the first intermediate. A molecule of PPh3 then ligates to the 
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Scheme 79: Proposed catalytic cycle for the primary meta alkylation of 2-phenylpyridine. 
This intermediate then activates the position para to the C–Ru bond to electrophilic attack 
and reacts with the alkyl halide coupling partner to form a Wheland-type intermediate, 
which is then quickly deprotonated to allow rearomatisation of the aromatic ring. The 
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final step is then protodemetallation of the meta substituted intermediate, followed by 
dissociation of the PPh3 to form the active catalyst and re-enter the cycle.  
To confirm that the reaction was reactive, under a homogeneous regime, we also carried 
out a mercury drop test, under the conditions shown in Scheme 80.43 This involves the 
addition of a small amount of mercury, which then acts to engulf any heterogeneous 
particles in situ and render them unreactive, thus showing whether a reaction is completely 
homogeneous, or whether a bi-phasic heterogeneous regime is in operation. 
 
Scheme 80: Reaction conditions used for the mercury drop test. 
The mercury drop test showed a large drop in conversion to meta  product, with little 
effect upon the regioselectivity. This indicates that a Ru aggregate in situ may be 
responsible for the observed reactivity. 
This result lines up with the use of a heterogeneous Ru_SiO2 catalyst used by Ackermann 
et al. for the meta bromination of purine bases.44 We then employed the same Ru_SiO2 
catalyst employed by Ackermann et al. and to our delight found that we achieved a 15% 
conversion to the meta product, with a 15:1 regioselectivity (meta:ortho). However, we 
did not pursue this result further as we decided not to properly analyse the made catalyst, 
and we therefore cannot attribute the conversion to the heterogeneous catalyst or leaching 
of the Ru into the solution.  
2.6 – Conclusions and Future Work 
In summary, we have investigated the use of primary α-halo carbonyls as versatile 
coupling partners for the direct meta primary alkylation of arene rings. This procedure is 
operationally simple to perform and has been shown to be possible with several substrates, 
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with the capacity for further synthetic elaborations to be realised. Either a Ni catalyst, 
bearing a phosphine ligand or sole phosphine ligand source was found to be crucial for 
the regioselective installation of the primary alkyl group at the meta position on the arene 
ring. The use of straight chain alkyl halides resulted in solely the ortho product, in contrast 
to the use of the privileged α-halo carbonyl coupling partners. 
An investigation into the use of α-chloro carbonyl coupling partners may yield more 
regioselectivity for the meta position, as indicated by results by Itoh et al. by increasing 
the energy required to form the Ru(IV) oxidative addition intermediate, formed on the 
catalytic cycle for the formation of the ortho regioisomer.27 
Experimental and computational mechanistic analysis highlight a dual activation 
pathway, whereby cyclometallation with the ruthenium catalyst activates the substrate at 
the position para to the Ru-C bond and is responsible for the meta selectivity observed. 
Through use of computational analysis, electrochemical measurements and control 
experiments we were able to propose a catalytic cycle for this transformation. However, 
further experimental work is required to fully prove our conclusions. 
The expansion of the set of coupling partners and substrates that can be utilised using our 
developed σ-activation methodology would be of key utility and interest to groups 
interested in this regioselective transformation, under relatively mild conditions. The use 
of heterogeneous catalysis, as indicated by mercury drop experiments, may allow for 
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Chapter 3 – Ruthenium Catalysed 
Remote C4-selective C-H 
Functionalisation of Carbazoles  
 
This work was started by our desire to expand the application of σ-activation 
methodologies to a broader range of substrates as seen previously with 2-phenylpyridine 
and  derived substrates, to allow more commonly encountered structural motifs found in 
medicinal and materials chemistry to be utilised, such as N-pyrimidylaniline, as 
investigated by Ackermann et al.1 Previous work from our group reported the C3/C6 
alkylation of indoles (Figure 8).2 This work was found to proceed initially by alkylation 
at the C3 position, the Ru then undergoes CMD at the C2 position of the indole, as directed 
by the pyrimidine and ester functional group to form the intermediate shown in Figure 9 
as suggested by computational analysis of the reaction.  
 
Figure 8: Reaction conditions for the one-pot C3/C6 functionalisation of indole substrates.2 
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Figure 9: Computationally proposed intermediate responsible for the C6 alkylation.2 
Following on from this work, we became interested to see how the reactivity of different 
heterocyclic systems, i.e. biologically relevant indole containing motifs, such as 
tryptamines and carbazoles. Carbazoles are a fused tricyclic heteroaromatic with 
important applications in drug discovery,3–5 sensing,6,7 and organic functional materials 
such as OLEDs (Figure 10).8,9 The vast majority of these techniques have been achieved 
by attaching a “directing group” via the N–H portion of the substrate.10 
 
Figure 10: Molecules of commercial and academic interest containing the carbazole or tryptamine motifs. 
The use of tryptamine substrates in C–H activation methodologies, utilising the intrinsic 
amine group as a directing group is already known. Examples of this methodology are 
limited to C2 functionalisation, including: the Ru catalysed C2 silylation of unprotected 
tryptamines,11 the Pd catalysed norborene mediated C2 alkylation of unprotected 
tryptamines,12 and the Hg catalysed  C2 vinylation of unprotected tryptamines.13 
However, to date there are no examples of using a CMD intermediate, akin to that shown 
in Figure 9 to access C4-C7 functionalised tryptamine derivatives.  
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The C1, C2, and SEAr functionalisation of carbazoles is already well known in literature, 
through a variety of synthetic techniques. C1 functionalisation can be achieved by 
utilising a directing group to direct functionalisation; this has allowed the formation of a 
number of C–C and C–X bonds to be created using a variety of catalytic systems.10,14–16 
C2 functionalisation has been explored in an elegant report by Baran and co-workers using 
a sterics-defined C2-selective C–H iridation and subsequent C–H functionalisation. This 
example formed part of a wider study on the functionalisation on related indole 
heteroaromatics.17 C3 functionalisation has also been widely studied, due to the 
nucleophilic character of this carbon, enabling SEAr chemistries to be employed.
18 
The ability to direct the cyclometallation of a Ru species towards the C1 position of a 
carbazole system allows us to potentially utilise a σ-activation methodology to selectively 
functionalise the C4 position of a carbazole system. This methodology would block 
functionalisation of the C2 position on steric grounds. The functionalisation of C3 would 
be discouraged, on electronic grounds of a C1–Ru bond, which would dominate the 
electronic structure of such an intermediate.  
 
Figure 11: Thought process for carbazole substrates. 
Carbazoles in particular are important classes of biological molecules. In particular, 
carbazoles with bulky groups attached at the C2 and/or C3 position were shown to exhibit 
inhibitory action on a protein involved in the function of neurons in vivo.19 The ability to 
functionalise this C3 and C4 position has also been shown to increase the anti-tumor 
activity of carbazole derivatives against pancreatic cancer cell lines. Selective 
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functionalisation the C4 position allows for a much greater exploration of the effect of 
functionalisation at this position alone, on various cell lines.20 
Initially this work was done currently with investigations into N-pyrimidylindoline, the 
structure of which is shown in Figure 12. This substrate bore no reactivity under the 
conditions tried, however, it led us to believe that a directing group must be attached to 
the indole structure through the N position to drive the Ru to cyclometallate at the C7 
position. This led us to begin investigating carbazole structures, which contain two 
aromatic rings, held together in a “bowl” type shape. This makes the pyrimidine group 
more proximal to the desired C1 position  on the carbazole, meaning a CMD process could 
occur more easily, allowing us to investigate the σ-activation chemistry of such a 
substrate. 
 
Figure 12: Structure of the indoline functional group, bearing an N-bound pyrimidine directing group, directing a 
potential Ru catalyst to cyclometallate at the C7 position. 
The work discussed herein constitutes, to our knowledge, the first known example  that 
allows the direct access to C–H functionalisation at the C4 position of carbazole 
derivatives.21 This work is part of a joint study with Dr J. A. Leitch, however this chapter 
will be focused upon my own contributions to this work.21 
3.1 – Synthesis of Starting Materials 
The beginning of this project sought to identify a suitable directing group that could be 
easily coupled with the tryptamine, via the non-aromatic N–H bond, which could then be 
used to successfully functionalise the C4–C7 position of the system, via the methodology 
shown in Figure 13.  
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Figure 13: General idea for the application of σ-activation methodologies on tryptamine substrates. 
We initially began by looking at the use of pyrimidine directing groups to direct a Ru 
catalyst to undergo CMD with the indole heterocycle. The synthesis of these substrates 
proceeded smoothly, utilising methodology by Moody et al., yielding the 2a and 2b in 
good yields as shown in Scheme 81.22 
 
Scheme 81: Reaction conditions for the synthesis of 2a and 2b. 
However, when subjected to a variety of reported conditions, reported for the C–H 
functionalisation of indoles and 2-phenylpyridine substrates, shown in Scheme 86; no 
reactivity was observed using 2a; and 2b resulted in the alkylation of the pyrimidine ring, 
at the “–R” position as seen in Scheme 81. We then decided to try other directing groups, 
such as pyridine, 2c. The synthesis proceeded smoothly in excellent yield, as shown in 
Scheme 82 to isolate the HCl salt of 2c.23 
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Scheme 82: Reaction conditions for the synthesis of 2c. 
The use of the aforementioned alkylation conditions (Scheme 86) resulted in no observed 
reactivity when using 2c as a substrate. We questioned whether the use of a non-aromatic 
directing group would aid the reactivity. We decided to use a nitrile group to test this, 2d. 
The synthesis of 2d is shown in Scheme 83 under conditions reported by Prasad et al.24 
 
Scheme 83: Reaction conditions for the synthesis of 2d. 
The use of a nitrile group also resulted in no observable reactivity under the conditions 
shown in Scheme 86, and with this we decided to focus our attentions towards carbazole 
substrates. We began by employing a pyrimidine group in the N–H position (Scheme 84), 
which had superior activity to the corresponding pyridine in the previous work on indoles 
done within our group.2 The procedure we used to access this motif for the desired 
carbazole example (2e) was adapted from a route by Kambe et al. shown in Scheme 84. 
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Scheme 84: Synthesis of 9-(pyrimidin-2-yl)-9H-carbazole, 2e.16 
This synthetic pathway proceeds via deprotonation of the N–H bond of the carbazole, 
which then reacts through an SNAr type reaction to displace the chloride leaving group, 
yielding 2e as shown in Scheme 84. We then turned our attention to a pyridine analogue 
of 2e, however, there are no known literature examples of synthesising this via analogous 
SNAr type reactions and attempts to adapt the above method were largely unsuccessful. 
To synthesise 9-(pyridine-2-yl)-9H-carbazole, 2f, we used a protocol reported by Xu et 
al.25 by which a Pd catalyst is used to perform a tandem ortho arylation and then 
annulation reaction to form the desired product 2f, under the conditions shown in Scheme 
85.  
 
Scheme 85: Synthesis of 9-(pyridin-2-yl)-9H-carbazole, 2f.25 
As seen in Scheme 85, the initial step of this synthesis involves an SNAr reaction between 
aniline and 2-bromopyridine under reflux overnight to yield pyridylaniline in good 
yield.25 This is then subjected to the conditions reported by Xu et al. to yield product 2f.25 
It must be noted however, that a small amount of uncyclized by-product was formed 
during the reaction (~5%), that was not possible to separate via chromatographic methods, 
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however, we still decided to use it to test its feasibility as a substrate for our reaction 
conditions. 
Our investigation of reaction conditions tested for each substrate used optimised 
conditions, reported for a variety of methodologies that we had developed in our group 
for meta alkylation and dual C3/C6 alkylation of indoles.2,21,26,27 These conditions are 
shown in Scheme 86.  
As stated before, the use of these reaction conditions resulted in no observable products 
when utilising substrates 2a–2d and 2f. Compound 2b is an exception to this observation 
however, with a small observation of tryptamine containing by-product observable by 
NMR (<5%) and polymeric species. Attempts to isolate this by-product were unsuccessful 
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Scheme 86: Reaction conditions used to test tryptamine derivatives. 
3.2 – Reaction Optimisation 
Optimisation of the reaction began by using product 2e as our standard substrate, using 
reaction conditions previously developed within our group, for the C6 alkylation of 
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indoles (Conditions 3 from Scheme 86).2 To our delight, using these conditions we 
managed to isolate the C4 alkylated product in a 48% yield, under the reaction conditions 
shown in Scheme 87. 
 
Scheme 87: Initial reaction conditions for the C4 alkylation of the carbazole substrate. 
With this promising result in hand, we commenced our optimisation studies by varying 
the Ru catalyst. The use of a preformed Ru acetate monomer complex was also shown to 
work (entry 6, Table 8) albeit in lower yields than those observed from using the Ru dimer 









114 | P a g e  
 
 
Table 8: Results from the optimisation of the Ru catalyst. IY – Isolated Yield. 
Entry Ru Source NMR Conversion to 
2.1 (IY) (%) 
1 [RuCl2(p-cymene)]2 68 (48) 
2 RuCl2(benzene)]2 <5 
3a RuCl3·xH2O 0 
4a RuCl3(PPh3)2 11 
5a [Ru(1,10-phen)3]·2Cl
- 0 
6a [Ru(OAc)2(p-cymene)] 63 (36) 
a 10 mol.% of catalyst used 
Following this, we looked at the choice of base in the reaction mixture. Pleasingly, an 
increase in product formation was observed using the mesitylcarboxylic acid, potassium 
salt, MesCO2K (Entry 1, Table 9). The use of inorganic bases (Entries 2 and 4, Table 9) 
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Table 9: Results from the optimisation of the base. IY – Isolated Yield. 
Entry Base NMR Conversion to 
2.1 (IY) (%) 
1 KCO2Mes 80 (61) 
2 KHCO3 25 
3 NaCO2Ad 58  
4 K2CO3 0 
5 NaCO2Mes 70 (60) 
6 K3Citrate 45  
 
We studied the effect of changing the cation used with the base (potassium vs. sodium), 
but little effect was observed with regards to product formation, with potassium 
performing marginally better. The use of a base with more of an ability to extract more 
than one proton, such as potassium citrate tribasic (Entry 6, Table 9), also gave inferior 
results. This suggested that bulky monobasic bases, were the ideal candidates for this 
reaction methodology.  
We next began to look at the optimisation of the acid on the reaction, using a variety of 
organic and inorganic acids. Interestingly, despite the basic additive used, we found that 
AcOH gave rise to the highest conversion to the product, with MesCO2H and AdCO2H 
giving slightly inferior conversions and yields, with some selected results shown in Table 
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Table 10: Results from the optimisation of the acid. IY – Isolated Yield. 
Entry Acid  NMR Conversion to 2.1 
(IY) (%) 
1 AcOH 80 (61) 
2 MesCO2H 64 (51) 
3 AdCO2H 66 (50) 
4 HCl 17 
5 CF3CO2H 15 
 
The equivalents of acid added to the reaction became our next area of exploration for the 
optimisation of this reaction. Our previous work benefitted from the use of an equimolar 
quantity of acid and base,2 however, in this case when changing the acid/base equilibrium, 
notably the use of less acid led to higher reaction conversions (Entry 2, Table 11), with 1 
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Table 11: Optimisation of acid equivalencies. IY – Isolated Yield.  
Entry Equivalents of AcOH added NMR Conversion to 2.1 
(IY) (%) 
1 0.5 80 
2 1 84 (68) 
3 2 80 (61) 
4 4 68 
5 8 <5 
 
The optimisation of the reaction solvent gave perhaps one of the most interesting 
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Table 12: Optimisation of the reaction solvent. IY – Isolated Yield. 
Entry Solvent NMR Conversion to 2.1 
(IY) (%) 
1 2-MeTHF 55 
2 Toluene 0 
3 MeCN 72 (55) 
4 AcOH 31 
5 1,4-Dioxane 84 (68) 
6 2-Butanone 55 
 
We found that our original choice of 1,4-dioxane as our reaction solvent was superior to 
the other solvents tested. Despite this, the use of toluene (Entry 2, Table 12) showed a 
21% conversion to a C3 alkylated product.  
Control experiments without the Ru catalyst (Entry 5, Table 12) demonstrated low 
amounts of C3-alkylated products (<10%). For these reasons, we believe the result in 
toluene is due to an inefficient background SEAr reaction. 
Lowering of the reaction temperature to 100 °C led to a significant drop in conversion 
(61%). Interestingly, the use of [Ru(CO2Mes)2(p-cymene)] as a catalyst gave comparably 
excellent yields under the conditions shown in Scheme 88. This catalyst system was also 
shown to be more effective for certain substrates (see later).The presence of air in the 
reaction led to a complete drop-off in reactivity, with no products observed.  
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Scheme 88: Optimised conditions for the C4 alkylation of carbazoles using a Ru monomer catalyst. 
3.3 – Scope and Limitations 
We began exploring the reaction conditions employing both the commercially available 
dimer (conditions A) and the pre-synthesised monomer (conditions B) (Scheme 89). 
 
Scheme 89: Optimised conditions for the C4 alkylation of carbazoles.21 
A variety of ester substituents were shown to be very well tolerated in the remote 
functionalisation methodology (2.1–2.7, 2.9), with impressive yields up to 92% for the 
tert-butyl ester variant, 2.3. It was noteworthy to note that tert-butyl bromide, utilised by 
numerous groups in σ-activation methodologies was not amenable to this methodology, 
2.6 (Scheme 90).26–31 
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Scheme 90: Scope of C4 alkylation of carbazoles.21 
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When we investigated the use of the difluoro ester coupling partner, as utilised by 
Ackermann and Xu independently,30,32 as seen with 2.8, we found no conversion to the 
desired product, even upon the addition of a co-catalytic amounts of PPh3 which have 
been shown to be vital in such transformations. Further studies on the remote C4-selective 
sulfonation, alkylation and bromination, using reported σ-activation protocols were also 
ineffective. We believe this highlights the uniqueness of the transformation we have 
achieved. 
The synthesis of decorated carbazoles still remains a challenge and therefore limited 
variation on the aromatic rings in the scope could be achieved. However, when using 
mono bromo- and chloro- (2.10 and 2.11 respectively) examples we have shown that these 
are also effective substrates for the transformation, with the regioselectivity for the non-
functionalised ring exclusively. The trichlorinated example (2.12) gave poor yields, but 
this may be more a function of its poor solubility under the reaction conditions, rather 
than a facet of the transformation reactivity.  
 
Figure 14: SCXRD structure of the C4 alkylated product 2.1, confirming the regioselectivity of functionalisation, the 
hydrogen atoms have been omitted for clarity. CCDC 1574475. Colour Scheme – Grey: Carbon, Blue: Nitrogen, Red: 
Oxygen. Crystals for this structure were grown by Dr J. A. Leitch.  
 
 
122 | P a g e  
 
To confirm the regioselectivity of the reaction, we obtained a crystal structure of the EtO- 
ester product 2.1, as shown in Figure 14. The use of other directing groups such as pivalate 
or pyridine in place of the pyrimidine led to no observable reaction, demonstrating the 
necessity of a strongly coordinating directing group. The use of 2,3-dialkylated indoles 
and indolines (Scheme 91) led to no reaction under the developed conditions. We believe 
this is due to the indole substituent at the C2 position interfering with the stable and planar 
cyclometallate or the Et at the C3 position blocking the C4 position sterically thus, 
preventing addition of the radical. 
 
Scheme 91: Failed substrates under reaction conditions.21 
The cleavage of directing groups is often a desirable property in the investigation of DG 
enabled C–H functionalisation methodologies. In the case when a pyrimidine is attached 
to the substrate via a C–C bond, this cleavage is generally not possible. However, when 
attached through a heteroatom, this removal is more straightforward. Heating the substrate 
with NaOEt in DMSO is an often utilised method for the removal of such pyrimidine DGs 
as shown in Scheme 92. However, in the presence of an ester group, means this 
methodology would most likely result in the de-esterification of the substrate.   
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Scheme 92: General conditions used to cleave pyrimidine directing groups as shown on a pyrimidine-indole substrate. 
More recent methodologies published by Chatani et al. have also shown that the removal 
of a pyrimidine DG from benzimidazoles can be achieved under the reaction conditions 
shown in Scheme 93.33 
 
Scheme 93: Deprotection of pyrimidines on benzimidazole substrates.33 
3.4 – Mechanistic considerations 
Our investigation into the role of the ruthenium source in this reaction began by 
consideration of the directing groups attached to the carbazole nitrogen. When submitting 
N-benzylcarbazole under the developed conditions no product was observed under the 
developed conditions seen in Scheme 94, demonstrating that a directing group is required. 
This is reinforced by the observation, that the omission of Ru in the reaction also led to 
no reaction at the desired C4 position, and only a small amount of the C3 alkylated product 
was isolated. These two pieces of information, along with the data from Scheme 91 lend 
themselves towards a σ-activation pathway in the way that they completely change the 
innate reactivity of the substrate molecule and its fundamental regioselectivity under a 
given set of conditions. 
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Scheme 94: Reaction conditions used to test N-benzylcabazole as a reaction substrate. 
However, to probe this hypothesis further we ran a radical trapping experiment using 
TEMPO, whereby we observed a reduced conversion of product when using catalytic 
amounts (30 mol.%). The use of stoichiometric amounts of TEMPO (1 equivalent and 3 
equivalents) led to similar observations whereby we observed conversions of 15% and 
0% respectively. These results suggest a single electron transfer process being present 
under the reaction conditions. We then decided that it would be of interest to run H/D 
scrambling experiments using isotopically labelled acetic acid (AcOD) (Scheme 95). 
 
Scheme 95: Deuterium labelling experiment. 
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Deuterium incorporation was observed at both at the C1 and C8 positions in both the 
starting material, d2-2e (20%) and product, d2-2.1 (19%). These observations lend 
themselves to a reversible C-H activation at both ortho-positions, under the conditions 
shown in Scheme 95. Gratifyingly, the lack of scrambling at the C5 position in the product 
and at the C4/C5 position in the product rules out a readily reversible C-H metalation at 
these positions and lends itself to a C1 σ-activation protocol. 
The addition of mercury into the reaction, as discussed in the previous chapter resulted in 
no change in conversions or observed regioselectivity. This result suggests a 
homogeneous catalytic regime is in operation. 
From these mechanistic considerations, and previous insights into similar methodologies, 
a plausible mechanism for the remote C4 alkylation of carbazole derivatives is proposed 
(Scheme 96). 27,29 
We propose that the ruthenium monomer undergoes a reversible CMD type insertion into 
the C-H at the C1 position ortho to the pyrimidine directing group. A single electron 
transfer process with an equivalent of a Ru species via an outer-sphere process to form 
the stabilised tertiary alkyl radical, α to the ester group. This radical then interacts with 
the sterically encumbered ruthenacycle species at the para position to the metal centre via 
a σ-activation process (most likely due to a shift in electron density to the C4 position).34 
Another SET process to reform the Ru(II) species and proton abstraction enables 
rearomatisation of the heterocyclic system. Protodemetallation then occurs to regenerate 
the catalyst and release the functionalised carbazole derivative.  
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Scheme 96: Plausible mechanism for the C4 alkylation of carbazole derivatives. 
3.5 – Conclusions and future work 
In this section we have presented the remote C4-selective C-H alkylation of carbazole 
derivatives, at the time and to date the only example of the selective C4-functionalisation 
of the carbazole heteroaromatic. We have demonstrated that furnishing the carbazole 
heteroaromatic with a pyrimidine directing group is essential to allow the σ-activation 
process, whereby a stable and planar ruthenacycle at the C1 position, allows the 
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interaction of the para position (C4) with a tertiary alkyl radical. We also demonstrated 
the unique reactivity of α-halo carbonyl coupling partners cf. aliphatic alkyl halides. 
Further investigations of the tryptamine substrates shown, utilising an easily 
added/cleaved blocking group on the indole N-atom, would remove a Lewis acidic, 
blocking group from coordinating to the Ru and leading to deactivation.  
In future it would be of interest to extend the scope of available coupling partners to 
regioselectively couple to the carbazole ring system, under similarly mild conditions. 
Particularly attempting to utilise some of the other reported coupling partners, utilised in 
σ-activation reactions coupling partners which have been reported already in the 
literature.35–38  
It would also be of interest to utilise a more easily cleavable directing group than 
pyrimidine, to allow for a more expansive set of derivatives that could be synthesised 
more easily from the C4 alkylated products, this could be achieved by use of 
computational modelling to examine potential directing groups that could be utilised. To 
this end the use of a more easily cleaved directing group, such as a sulfonamide could be 
used for this purpose, the cleavage of which is easily achieved under mild conditions 
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Chapter 4 – Studies into New Coupling 
Partners and Substrates 
 
The work discussed in the following section began as an attempt to investigate alternative 
coupling partners for the recently published methodology for the selective para alkylation 
of aniline derivatives, 3a, with tertiary α-halo esters, with the Ru coordinated via the two 
N-atoms as shown in Scheme 62 (Section 1.6.3). The reaction conditions for this 
transformation are shown in Scheme 97.1 
 
Scheme 97: Optimised conditions for the Ru catalysed para-selective C–H alkylation of aniline derivatives.1 
To build on previous work carried out in the group and expand the range of functionality 
that could be successfully and selectively coupled to such substrates, we began to examine 
different radical precursors as coupling partners that could be successfully coupled at the 
para position of the aniline, with potentially similar electronic and electrochemical 
properties to α-halo ester substrates.1–5 To this end, we were inspired by a study from 
Greaney and co-workers, using CBr4 as a coupling partner for the meta carboxylation of 
2-phenylpyridine (1a), under the conditions shown in Scheme 98.6 The mechanistic 
explanation of this carboxylation is shown in Scheme 45 (Section 1.5.5).  
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Scheme 98: Optimised conditions for the Ru catalysed meta carboxylation of 2-phenylpyridine.6 
Anilines are ubiquitous in many biologically relevant motifs, with examples of this shown 
in Figure 15.7,8 This relevance therefore makes the use of such substrates for 
functionalisation reactions of great interest and importance in the area of transition metal 
mediated C–H activation reactions. 
 
Figure 15: Selected examples of biologically relevant compounds containing the aniline motif. 
As a vast majority of previous σ-activation based transformations have generated the 
formation of C(sp3)–C(sp2) bonds, this elegant approach using an acyl surrogate 
particularly interested us as a route into the selective construction of C(sp2)–C(sp2) bonds. 
Notably, reaction conditions for this transformation are unusual in that the use of the 
commonly used Ru(II) sources commonly used in σ-activation methodologies and the 
previous chapters of this thesis did not give the desired reactivity; only simple 
RuCl3·xH2O gave any observable conversion. This is the first example that we are aware 
of that such a transformation has been achieved.  
We were intrigued to see whether we could marry together the above report with our para-
selective C–H functionalisation method, resulting in a para selective carboxylation of 
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anilines. We hypothesis that a mechanism similar to the one shown in Scheme 99, would 
be in action. This would begin by a coordination of the Ru to the two N atoms on the 
substrate, as proposed by computational analysis of the para selective alkylation by Frost 
et al.1 The CBr4 would then undergo an SET process with a Ru species in situ to form a 
CBr3 radical, which would then react at the most electrophilic position on the arene ring 
(para). A rearomatisation would then occur with the formed Br- anion acting as a base 
and the Ru(III) species formed by the radical formation would be reduced back to Ru(II). 
A molecule of acid formed in situ would then remove the Ru from the molecule by 
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Scheme 99: A hypothetical mechanistic explanation for the para selective carboxylation of 5-
chloropyrimidinenanliline (5–CPA), 3a. 
4.1 – Synthesis of Substrates for Studying the Proposed Reaction 
Design 
We identified an N-pyrimidylaniline derivative as our model substrate for method 
development (5-CPA), 3a.1 This substrate is readily synthesised in one step using easily 
sourced starting materials as shown in Scheme 100. From previous studies, we were aware 
that the blocking of the 5-position on the pyrimidine ring with a chloro group was found 
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to be necessary, due to the observed competing alkylation of this position when it is 
unprotected.1 
 
Scheme 100: Synthesis of 5-chloro-N-phenylpyrimidin-2-amine (5-CPA), 3a.1 
We also synthesised a similar pyridine variant of this substrate, 3b, under the conditions 
in Scheme 101. 
 
Scheme 101: Synthesis of N-phenylpyridin-2-amine (PPA), 3b. 
4.2 – Reaction Optimisation 
Preliminary reaction investigations using substrate, 3b, testing a series of reaction 
conditions demonstrated this structure afforded no productive C–H functionalisation 
products. Due to this, we decided to use 3a (5-CPA) as our model substrate, based on its 
previous use within the group.   
We first began this optimisation process by looking at the optimal catalyst for the process, 
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Table 13: Selected results for the catalyst optimisation on the para-carboxylation of 3a. IY – Isolated yield. 
Entry Catalyst NMR Conversion 
(IY) (%) 
1 RuCl3·xH2O 34 (20) 
21 [RuCl2(p-cymene)]2 20 
3 [Ru(OAc)2(p-cymene)] 12 
4 [Fe(acac)3] 19 
5 Fe2O3 29 
6 FeCl2 Trace 
7 FeCl3 33 (23) 
8 ZnCl2 0 
9 AgCl 0 
101 No catalyst 5 
1- 5 mol.% used, 2- 48 h 
With a desired substrate in hand, we began to investigate the catalyst activity for this 
reaction. Initially we began by testing various Ru(II) sources and to our delight, from the 
first conditions we observed conversion to the desired para carboxylated product. 
Interestingly, addition of no catalyst at all resulted in a 5% conversion to the para product, 
this resulted also in formation of significant amounts of the N-carboxylated product c.a. 
20%, 3.2, as well as requiring a longer reaction time, these two products under the used 
reaction conditions are shown in Scheme 102. 
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Scheme 102: Products formed when the reaction is run in the absence of a catalyst. 
As a matter of curiosity during this optimisation we wanted to check whether this 
reactivity was inherent for Ru only, or if it was a facet of group 8 metals in general, the 
results of this are shown in Table 13. To our surprise, the use of FeCl3 gave a slightly 
improved isolated yield when compared to RuCl3, and therefore we decided to proceed 
further with this result as Fe based catalysts are more sustainable in an economical and 
environmental sense. The use of Fe(II) and Fe(III) catalysts have been reported previously 
by Mukminov and co-workers, for the carboxylation of  benzofurans.9 Use of different 
Lewis acids also proved unreactive under the conditions tested.  
We next elected to vary the amount of catalyst utilised in the reaction medium. As seen 
in Table 14, a surprising inverse trend was observed where higher quantities of catalyst 
suppressed reactivity. The results gathered here indicate that the iron catalyst might play 
further, alternative roles in the reaction, and in higher quantities promote alternative 
pathways. More information must be collected to ascertain this, however. It must be noted 
also that the reaction proceeds, albeit very sluggishly and in low yield in the absence of 
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Table 14: Results from optimisation of catalyst loading for the para carboxylation of 3a. IY – Isolated Yield. 
Entry mol.% of catalyst used NMR Conversion (IY) 
(%) 
1 5 37 (18) 
2 10 33 (23) 
3 15 26 
4 20 21 
5 25 18 
6 30 15 
7 100 0 
 
Furthermore, reducing the number of CBr4 equivalents had no positive effect upon the 
reaction outcome.  
We next began to optimise the solvent choice used in conjunction with MeOH. Results 
by Greaney et al. showed a large decrease in yields when moving away from using simple 
alcohols as co-solvent.6 Some preliminary results in the lab also showed that using other 
alcohols for this reaction gave no observed product, therefore the scope of the alcohol co-
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Table 15: Selected results from the solvent optimisation of the para-carboxylation of 3a. IY – Isolated Yield. 
Entry Solvent NMR Conversion (IY) 
(%) 
1 MeCN 0 
2 DCE <5 
3 2-Butanone 17 
4 Toluene 17 
5 2-MeTHF 27 (20) 
6 H2O 0 
7 HFIP 17 
 
The use of MeCN resulted in no observable reaction (Entry 1, Table 15), this may be due 
to the coordinative saturation of the Fe in situ making the kinetics of ligation with the 
substrate very slow.10 The use of other polar solvents also led to poor conversions, 
although the use of 2-MeTHF (Entry 5, Table 15) gave good results, with yields 
comparable to using 1,4-dioxane as solvent. The use of water gave no observable reaction. 
The effect of the solvent ratios on the reaction also became of interest to us, in our attempts 
to increase the yields. The results of this study are shown in Table 16. As seen in Table 
16, decreasing the concentration of MeOH in the solvent mixture led to a complete 
shutdown in reactivity. However, increasing the MeOH concentration led to an increase 
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Table 16: Results for the optimisation of the solvent ratio, for the para carboxylation of 3a. IY – Isolated Yield.  
Entry  a:b NMR Conversion (IY) 
(%) 
1 1:2 0 
2 1:4 0 
3 1:5 0 
4 1:10 0 
5 2:1 <5 
6 4:1 48 (20) 
7 5:1 39 
8 10:1 0 
 
The variation of reaction concentration of was next investigated, with the results as shown 
in Table 17. The use of either 0.50 M or 0.17 M  (Entry 2 and 4, Table 17) as the 
concentration resulted in identical isolated yields of the desired product. With a view to 
efficient use of materials during the optimisation, we decided the use of 0.50 M as our 
standard concentration would be used. The used of vigorously dried solvents also led to 
no observable reaction. This might indicate that residual moisture in the solvents aid in 
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Table 17: Results from the concentration optimisation of the para-carboxylation of 3a. IY – Isolated Yield. 
Entry Concentration (mol L-1) NMR Conversion (IY) 
(%) 
1 1.0 <5 
2 0.50 44 (23) 
3 0.25 10 
4 0.17 33 (23) 
5 0.10 11 
6 0.01 <5 
 
After exhausting all avenues to us, in terms of optimisation of reaction parameters; we 
then decided to investigate the effect of conversion against reaction time. Our initial 
thought was that the reaction could have very poor kinetics, and therefore by increasing 
the time we may begin to realise larger isolated yields. The results of this investigation 
are shown in graphical form in Figure 16. The graph in Figure 16 show that a maximum 
conversion to the desired para product is achieved after approximately 40 hours. 
However, upon using a 48 hour reaction time we still only achieved a 23% isolated yield, 
identical to the best yield achieved using a 16 hour reaction period.  
Dropping of the reaction temperature from 120 °C to 90 °C resulted in only trace 
conversion to the desired product. The presence of oxygen in the reaction led to a small 
conversion to para product, albeit under much diminished conversions. Analogously, 
increase of the reaction temperature from 120 °C to 160 °C also resulted in no 
improvement of reaction yield or conversion.  
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Figure 16: Graph showing conversion of starting material (3a) to para product (3.1) over time. 
4.3 – Mechanistic Considerations 
In an effort to try and understand the role of Fe in this reaction we questioned whether a 
separate Fe complex or a free, uncoordinated FeCl3 molecule was responsible for the 
formation of the ·CBr3 radical in situ. We decided to add a series of ligands which could 
enhance the redox properties of the Fe centre, in order to alter the HOMO-LUMO of the 
























Conversion to para product (3.1) over time 
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Table 18: Results from the ligand screen for the para-carboxylation of 3a. IY – Isolated Yield.  
Entry Ligand Ligand Equivalents 
(mol.%) 
NMR Conversion (IY) 
(%) 
1 2,2’-bipy 10 20 
2 2,2’-bipy 20 27 (12) 
3 1,10-phen 10 16 
4 1,10-phen 20 7 
5 PyBox-Ph 10 5 
6 PyBox-Ph 20 7 
 
As seen in Table 18, the addition of ligands to the reaction led to reduced conversions, 
and in the case of our best observed result (Entry 2, Table 18) reduced isolated yields.  
An observation of the reaction vessel after cooling, showed the presence of small, 
heterogeneous particles, presumable formed by the aggregation of the Fe. This 
observation made us question whether the reaction was at all homogeneous or 
heterogeneous, or whether the aggregation of the metal particles was a by-product from a 
catalyst deactivation pathway. To answer the first question, we performed a mercury drop 
test, under the conditions shown in Scheme 103.  
 
Scheme 103: Mercury drop test on the para-carboxylation of 3a. 
As shown in Scheme 103 the addition of mercury resulted in little, to no effect upon the 
observed conversions or yields. This result implies that the reaction proceeds via a 
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homogeneous regime. Attempts at growing an adduct of the substrate with the FeCl3 have 
not yet, yielded diffraction quality crystals.  
At this point we pondered whether a directing group was required for this transformation, 
or whether the electronics of the substrate were a more important aspect towards 
yield/regioselectivity. To this end, we decided to use acetamide as a model comparison, 
due to similar electronic influences of the ring, similar pKa of the N–H and that it contains 
a metal coordinating group.1 This reaction is shown in Scheme 104. 
 
Scheme 104: Testing acetamide, 3c, as a reaction substrate. 
The use of acetamide as a substrate yielded no reactivity. This suggests that the 
coordination of Fe in the system is critical to the observed regioselectivity of the product. 
4.4 – Conclusions and Future Work 
The para-carboxylation of aniline derivatives, as discussed in Section 4.1 gives an avenue 
for future investigation, with an isolated yield of 23% under lead conditions. The ability 
to regioselectively couple together two substrates together, is of potential benefit to any 
possible molecules of interest containing such a motif. Figure 17 shows two potential 
post-synthetic modification routes that coupled be applied to the para-carboxylated 
substrate.  
 
Figure 17: Examples of potential post-synthetic modifications on para-carboxylated substrates. 
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The scope of the catalysts tested for this transformation would be an ideal place to begin 
any future work on this transformation, by extending the scope of such catalyst to other 
transitions metals and main-group Lewis acids, in an effort to elucidate whether this 
reaction is specifically catalysed by Fe, or if it is a Lewis acid catalysed transformation.  
The use of computational modelling based on recent work by Ritter et al. would also be 
of interest, in an attempt to gain more understanding of this transformation, with regards 
to whether a Fe(II)/Fe(III) redox couple is in operation, or whether a redox neutral process 
is occuring.11,12 Further investigation of new and possibly fruitful coupling partners to 
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5 - Experimental  
5.1 – General  
All reagents were used were purchased from Sigma-Aldrich, Acros Organics, Alfa-Aesar 
or Strem Chemicals without further purification, unless otherwise stated. All solvents 
used were purchased directly from VWR or Sigma-Aldrich without further purification. 
All dried solvents used (except EtOH), were dried and deoxygenated by passing over 
anhydrous activated alumina columns using an Innovative Technology Inc. Ps-400-7 
solvent purification (SPS) and stored under an atmosphere of nitrogen prior to use. EtOH 
was dried and deoxygenated by storing over dried 4 Å molecular sieves (Sigma-Aldrich) 
for 2 days and purging with a stream of argon gas for 30 mins. 
 Temperatures quoted are external. Solvents were removed under reduced pressure using 
a Büchi-Rotorvapor apparatus.  
Analytical thin-layer chromatography (TLC) was performed on aluminium-backed plates 
coated with Alugram® SIL G/UV254 purchased from Macherey-Nagel and visualised 
with ultraviolet light (254 nm). Silica gel column chromatography was performed using 
60 Å, 200-400 mesh particle size silica gel purchased from Sigma-Aldrich. Samples were 
loaded as saturated solutions in an appropriate solvent system.  
All NMR measurements unless otherwise stated were performed at 25 °C (unless 
otherwise stated) on a Bruker 300 MHz or Agilent Technologies 500 MHz spectrometer 
(1H NMR at 300 MHz or 500 MHz, 13C NMR at 126 MHz or 75 MHz and 19F NMR at 
470 MHz and 11B at 160 MHz and 31P at 202 MHz). All 13C spectra are 1H decoupled 
unless stated otherwise. Shift values were reported in parts per million (ppm) relative to 
Si(CH3)4 or set internal solvent signals. 
1H chemical shifts are reported in ppm relative to 
Si(CH3)4 (δ 0) and were referenced internally with respect to the residual protic solvent 
impurity for CDCl3, d
6-DMSO, d3-MeOD or CD3CN (δ 7.27 for CHCl3, δ 2.62 for DMSO, 
δ 3.49 for MeOH, δ 1.94 for CH3CN). 
13C chemical shifts are reported in ppm relative to 
SiMe4 (δ 0) and were referenced internally with respect to the solvent for CDCl3, d
6-
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chemical shifts are reported in ppm relative to CFCl3 (δ 0). 
31P chemical shifts are reported 
in ppm relative to 85% H3PO4 in H2O (δ 0). 
11B chemical shifts are reported in ppm 
relative to 15% BF3·Et2O in CDCl3 (δ 0). NMR data are presented in the following format: 
chemical shift, (number of apparent nuclei by integration, multiplicity [app = apparent, 
br=broad, d=doublet, t=triplet, q=quartet, dd=doublet of doublets, dt=doublet of triplets, 
dq=doublet of quartets, ddd=doublet of doublets of doublets, m=multiplet], coupling 
constant [in Hz], assignment). 
Mass spectra were obtained using a micrOTOF electrospray time-of-flight (ESI-TOF) 
mass spectrometer (Bruker Daltonik) collecting data in the positive mode and using 
acetonitrile as a solvent. The peaks quoted correspond to the calculated exact mass, the 
correct isotope patterns are present where the peak is quoted. Infrared (IR) spectra were 
recorded on a Perkin-Elmer 1600 FT (Fourier transform) IR spectrophotometer, with 
absorbencies as reciprocal wavelength (ν [in cm-1]). Melting points were obtained on a 
Bibby Sterilin SMP10 melting point machine and are uncorrected.  
All differential pulse voltammograms (DPV’s) were run in HPLC grade acetonitrile with 
ammonium tetrafluoroborate (NH4BF4), [0.1 M] as a supporting electrolyte. The 
concentration of samples was 100 μM throughout. Experiments were carried out using a 
Metrohm Autolab PGSTAT30 potentiostat controlled by a laptop running General 
Purpose Electrochemical System (GPES) software. All electrochemical experiments were 
run under ambient conditions (STP). A three-electrode cell was employed which consisted 
of a glassy carbon working electrode, a Pt wire auxiliary electrode and a saturated calomel 
electrode (SCE) reference electrode. A scan rate of 10 mV s-1 was used, unless otherwise 
stated. Cited potentials are referenced relative to a saturated calomel electrode (SCE). The 
electrochemical cell was not degassed before use on all experiments.   
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5.2 – Synthesis of 2-Aryl Pyridine Derivatives 
5.2.1 – General Procedure A 
 
To an oven-dried, round bottomed flask equipped with a magnetic stirrer and condenser 
was added palladium tetrakis(triphenylphosphine) (1 mol.%), potassium carbonate (2 
eq.), boronic acid (1.5 eq.) and ethanol (0.05 M). The flask and condenser were then 
purged with argon for c.a. 15 mins, and the 2-bromopyridine reagent (1 equiv.) were then 
added via syringe through a rubber septum located at the top of the condenser. The 
reaction was then heated to 100 °C and refluxed for 16 hours. After cooling the reaction 
to room temperature, the reaction mixture was filtered through a plug of celite, washing 
the solids with ethyl acetate. The crude reaction mixture was then dried over MgSO4, 
filtered and concentrated under reduced pressure to yield crude product. The crude 
product was then purified by flash chromatography (40-60 Petroleum Ether/EtOAc) to 
yield the desired product.  
5.2.2 – Synthesis of 2-(4-nitrophenyl)pyridine, 1b 
 
General Procedure A was followed using: 2-bromopyridine (0.43 mL, 4.5 mmol), 4-
nitrophenyl boronic acid (1.00 g, 6.0 mmol), [Pd(PPh3)4] (52 mg, 0.045 mmol), K2CO3 
(1.24 g, 9.0 mmol) and EtOH (90 mL). Column chromatography (5% EtOAc/ Hexanes) 
yielded an amorphous yellow solid 1b, 90% (806 mg).  
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1H NMR (500 MHz, CDCl3): δ 8.76–8.75 (1H, m, C(5)-H), 8.34–8.32 (2H, m, C(8)-H), 
8.19–8.17 (2H, m, C(2)-H, C(6)-H), 7.84–7.82 (2H, m, C(7)-H), 7.36–7.33 (1H, m, C(1)-
H).  
13C{1H} NMR (126 MHz, CDCl3): δ 154.9 (ArC), 150.1 (ArCH), 148.1 (ArC), 145.2 
(ArCH), 137.1 (ArCH), 127.7 (ArCH), 124.0 (ArCH), 123.5 (ArCH), 121.2 (ArCH).  
These are in accordance with literature data.1  
5.2.3 - Synthesis of 2-(4-methoxypenyl) pyridine, 1c 
 
General Procedure A was followed using: 2-bromopyridine (0.47 mL, 4.95 mmol),4-
methoxyphenyl boronic acid (1.00 g, 6.6 mmol), [Pd(PPh3)4] (57 mg, 0.05 mmol), K2CO3  
(1.37 g, 9.9 mmol) and EtOH (55 mL). Column chromatography (5% EtOAc/ Hexanes) 
yielded an amorphous white solid, 1c, >99% (917 mg). 
1H NMR (500 MHz, CDCl3): δ 8.67–8.64 (1H, ddd, J = 4.8, 1.7, 1.3 Hz ,C-(5)-H), 7.95 
(2H,  d, J = 8.9 Hz, C(8)-H), 7.73–7.65 (2H, m, C(1)-H, C(6)-H), 7.19–7.15 (1H, ddd, J 
= 7.2, 4.8, 1.3 Hz, C(2)-H), 7.00 (2H, d, J = 8.9 Hz, C(9)-H), 3.87 (3H, s, C(11)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 160.4 (ArC), 157.1 (ArC), 149.5 (ArCH), 136.6 
(ArCH), 132.0 (ArC), 128.2 (ArCH), 121.4 (ArCH), 119.8 (ArCH), 114.1 (ArCH), 55.3 
(OCH3).  
These are in accordance with literature data.1 
 
 
151 | P a g e  
 
5.2.4 – Synthesis of 2-(4-(trifluoromethyl)phenyl) pyridine, 1d 
 
General procedure A was followed using: 2-bromopyridine (0.38 mL, 3.95 mmol), (4-
(trifluoromethyl) phenyl) boronic acid (1.00 g, 5.27 mmol), [Pd(PPh3)4] (46 mg, 0.04 
mmol), K2CO3 (1.09 g, 7.9 mmol) and EtOH (60 mL). Column chromatography (5% 
EtOAc/ Hexanes) yielded a white amorphous solid, 1d, 89% (785 mg). 
1H NMR (500 MHz, CDCl3): δ 8.75–8.71 (1H, d, J = 4.7 Hz, C(5)-H), 8.13–8.10 (2H, m, 
C(8)-H), 7.83–7.76 (2H, m, C(1)-H, C(2)-H), 7.73 (2H, d, J = 8.2 Hz, C(9)-H), 7.30 (1H, 
dd, J = 4.7, 1.4 Hz, C(6)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 156.1 (ArC), 149.8 (ArCH), 143.0 (ArCH), 138.1 
(ArCH), 131.3 (q, J = 32.5 Hz, ArC), 127.8 (ArCH), 124.9 (q, J = 3.8 Hz, ArCH), 123.7 
(q, J = 272.0 Hz, Ar-CF3), 122.9 (ArCH), 121.0 (ArCH).  
19F NMR (470 MHz, CDCl3): δ -62.62 (s, 3F).  
These are in accordance with literature data.2 
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General procedure A was followed using: 2-bromopyridine (0.38 mL, 3.86 mmol), (4-
(ethoxycarbonyl) phenyl) boronic acid (1.00 g, 5.15 mmol), [Pd(PPh3)4] (45 mg, 0.039 
mmol), K2CO3 (1.07 g, 7.72 mmol) and EtOH (60 mL). Column chromatography (5% 
EtOAc/ Hexanes) yielded an amorphous white solid, 1e, 79% (689 mg).  
1H NMR (500 MHz, CDCl3): δ 8.73 (1H, d, J = 4.8 Hz, C(5)-H), 8.16–8.13 (2H, m, C(8)-
H), 8.08–8.06 (2H, m, C(9)-H), 7.79–7.77 (2H, m, C(1)-H, C(2)-H), 7.31–7.27 (1H, m, 
C(6)-H), 4.41 (2H, q, J = 7.1 Hz, C(12)-H), 1.42 (3H, t, J = 7.1 Hz, C(13)-H). 
13C{1H} NMR (126 MHz, CDCl3): δ 166.6 (C=O), 156.4 (ArC), 149.9 (ArCH), 143.4 
(ArC), 137.2 (ArC), 130.9 (ArCH), 130.2 (ArCH), 127.0 (ArCH), 123.0 (ArCH), 121.2 
(ArCH), 61.2 (C(17)), 14.5 (C(18)).  
These are in accordance with literature data.3 
5.2.6 – Synthesis of 2-([1,1’-biphenyl]-4-yl) pyridine, 1f 
 
General procedure A was followed using: 2-bromopyridine (0.36 mL, 3.79 mmol), [1,1’-
biphenyl]-4-yl boronic acid (1.00 g, 5.05 mmol), [Pd(PPh3)4] (44 mg, 0.038 mmol), 
K2CO3 (1.05 g, 7.58 mmol) and EtOH (60 mL). Column chromatography (5% EtOAc/ 
Hexanes) yielded an amorphous pink solid, 1f, 92% (803 mg). 
1H NMR (500 MHz, CDCl3): δ 8.73–8.71 (1H, m, C(5)-H), 8.10–8.07 (2H, m, C(8)-H), 
7.79–7.76 (2H, m, C(9)-H), 7.74–7.71 (2H, m, C(12)-H), 7.67 (1H, dd, J = 2.2, 1.4 Hz, 
C(1)-H), 7.67–7.65 (1H, m, C(14)-H), 7.49–7.45 (2H, m, C(13)-H), 7.39–7.35 (1H, m, 
C(2)-H), 7.25 (1H, dd, J = 4.8, 2.2 Hz, C(6)-H).  
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13C{1H} NMR (126 MHz, CDCl3): δ 157.0 (ArC), 149.7 (ArCH), 141.7 (ArC), 140.6 
(ArC), 138.3 (ArC), 136.7 (ArCH), 128.8 (ArCH), 127.5 (ArCH), 127.4 (ArCH), 127.3 
(ArCH), 127.1 (ArCH), 122.1 (ArCH), 120.4 (ArCH). 
These are in accordance with literature data.4 
5.2.7 – Synthesis of 2-(4-(trifluoromethoxy) phenyl) pyridine, 1g 
 
General procedure A was followed using: 2-bromopyridine (0.35 mL, 3.64 mmol), (4-
(trifluoromethoxy) phenyl) boronic acid (1.00 g, 4.86 mmol), [Pd(PPh3)4] (42 mg, 0.036 
mmol), K2CO3  (1.01 g, 7.28 mmol) and EtOH (60 mL). Column chromatography (5% 
EtOAc/ Hexanes) yielded a white solid, 1g, 93% (807 mg).  
Melting point: 53–55 °C.  
1H NMR (500 MHz, CDCl3): δ 8.70 (1H, ddd, J = 4.8, 1.8, 1.0 Hz, C(5)-H), 8.04–8.01 
(2H, m, C(8)-H), 7.79–7.70 (2H, m, C(1)-H, C(2)-H), 7.32–7.31 (2H, m, C(9)-H), 7.27–
7.26 (1H, m,  C(6)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 156.1 (ArC), 149.9 (ArCH), 149.8 (q, J = 2.4 Hz,  
ArC), 138.0 (ArCH), 136.9 (ArCH), 128.4 (ArC), 122.4 (ArCH), 121.0 (ArCH), 120.4 (q, 
J = 255 Hz, Ar-OCF3), 119.9 (ArCH).  
19F NMR (470 MHz, CDCl3): δ -57.77 (3F, s).  
These are in accordance with literature data. 5 
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5.2.8 – Synthesis of 2-(4fluorophenyl) pyridine, 1h 
 
General procedure A was followed using: 2-bromopyridine (0.51 mL, 5.36 mmol), (4-
fluorophenyl) boronic acid (1.00 g, 7.15 mmol), [Pd(PPh3)4] (62 mg, 0.054 mmol), K2CO3 
(1.48 g, 10.72 mmol) and EtOH (60 mL). Column chromatography (5% EtOAc/ Hexanes) 
yielded a white solid, 1h, 62% (580 mg). 
Melting point: 40–42 °C.  
1H NMR (500 MHz, CDCl3): δ 8.68 (1H, ddd, J = 4.8, 1.6, 0.9 Hz, C(5)-H), 7.98 (2H, 
dd, J = 8.7, 5.4 Hz, C(8)-H), 7.77–7.72 (1H, m, C(1)-H), 7.68-7.64 (1H, m, C(2)-H), 7.22 
(1H, ddd, J = 7.4, 4.8, 1.1 Hz, C(6)-H), 7.18-7.14 (2H, m, C(9)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 164.5 (d, J = 248 Hz, ArC-F), 156.5 (ArC), 149.7 
(ArCH), 136.8 (d, J = 4.1 Hz, ArCH), 128.6 (d, J = 9.0 Hz, ArCH), 122.0 (ArC), 120.2 
(ArCH), 115.5 (d, J = 21.6 Hz, ArCH), 110.0 (ArCH). 
19F NMR (470 MHz, CDCl3): δ -113.23 (1F, ddd, J = 21.6, 9.0, 4.1 Hz).  
These are in accordance with literature data.6  




155 | P a g e  
 
General procedure A was followed using: 2-bromopyridine (0.46 mL, 4.79 mmol), (4-
chlorophenyl) boronic acid (1.00 g, 6.39 mmol), [Pd(PPh3)4] (55 mg, 0.048 mmol), 
K2CO3 (1.32 g, 9.58 mmol) and EtOH (60 mL). Column chromatography (5% EtOAc/ 
Hexanes) yielded an amorphous white solid, 1i, 86% (782 mg).  
Melting point: 49–51 °C.  
1H NMR (500 MHz, CDCl3): δ 8.69 (1H, ddd, J = 4.8, 1.8, 1.0 Hz, C(5)-H), 7.95 (2H, d, 
J = 8.4 Hz, C(8)-H), 7.77–7.69 (2H, m, C(1)-H, C(2)-H), 7.46–7.43 (2H, d, J = 8.4 Hz, 
C(9)-H), 7.24 (1H, ddd, J = 7.4, 4.8, 1.2 Hz, C(6)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 156.2 (ArC), 149.7 (ArCH), 137.8 (ArC), 136.8 
(ArC), 135.1 (ArCH), 128.9 (ArCH), 128.2 (ArCH), 122.3 (ArCH), 120.3 (ArCH).  
These are in accordance with literature data.7 
5.2.10 – Synthesis of 2-(4-bromophenyl) pyridine, 1j 
 
General procedure A was followed using: 2-bromopyridine (0.36 mL, 3.73 mmol), (4-
bromophenyl) boronic acid (1.00 g, 4.98 mmol), [Pd(PPh3)4] (43 mg, 0.037 mmol), 
K2CO3 (1.03 g, 7.46 mmol) and EtOH (50 mL). Column chromatography (5% EtOAc/ 
Hexanes) yielded an off-white solid, 1j, 18% (161 mg). 
Melting point: 60–62 °C.  
1H NMR (500 MHz, CDCl3): δ 8.72 – 8.71 (1H, d, J = 4.8 Hz, C(5)-H), 8.08 – 8.07 (2H, 
d, J = 8.1 Hz, C(8)-H), 7.78 – 7.77 (1H, m, C(1)-H), 7.68 – 7.65 (1H, m, C(2)-H), 7.49 – 
7.45 (2H, d, J = 8.1 Hz, C(9)-H), 7.25 – 7.23 (1H, m, C(6)-H). 
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13C{1H} NMR (126 MHz, CDCl3): δ 156.2 (ArC), 149.7 (ArCH), 136.8 (ArC), 131.9 
(ArCH), 128.8 (ArCH), 128.7 (ArCH), 127.4 (ArCH), 127.1 (ArCH), 122.1 (ArC), 117.2 
(ArCH).  
These are in accordance with literature data.7 
5.2.11 – Synthesis of  2-(4-(methylthio)phenyl) pyridine, 1k 
 
General procedure A was followed using: 2-bromopyridine (0.19 mL, 1.99 mmol), (4-
(methylthio)phenyl) boronic acid (555 mg, 3.3 mmol), [Pd(PPh3)4] (23 mg, 0.020 mmol), 
K2CO3 (0.55 g, 4 mmol) and EtOH (30 mL). Column chromatography (5% EtOAc/ 
Hexanes) yielded a pink solid, 1k, 85% (471 mg).  
Melting point: 50-52 °C. 
1H NMR (500 MHz, CDCl3): δ 8.67 (1H, dd, J = 4.9, 1.9 Hz, C(5)-H), 7.93 (2H, d, J = 
8.5 Hz, C(8)-H), 7.76 – 7.68 (2H, m, C(1)-H, C(2)-H), 7.34 (2H, d, J = 7.4 Hz, C(9)-H), 
7.21 (1H, ddd, J = 7.0, 4.9, 1.3 Hz, C(6)-H), 2.53 (3H, s, C(12)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 156.8 (ArC), 149.6 (ArCH), 139.8 (ArC), 136.8 
(ArCH), 136.0 (ArC), 127.2 (ArCH), 126.4 (ArCH), 121.9 (ArCH), 120.1 (ArCH), 15.6 
(-SCH3).  
These are in accordance with literature data.8  
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5.3 – Optimisation for the meta alkylation of primary substrates 
 
Proton NMR conversions were taken from the ortho diagnostic protons. Two products 
were formed over the course of the reaction (competing ortho and meta selectivity, 
predominantly meta product) lead to 1H NMR conversions being indicative of combined 
yield of alkylated products. Ortho:meta calculated using the corresponding benzyl peaks: 
ortho δ 3.82 ppm (s, 2H): meta δ 3.70 ppm (s, 2H). Major product consistent with meta 
substituted product and is fully characterised later (Section 5.3.3). Minor isomer 
consistent with the ortho substituted product. An example of the 1H NMR spectrum of the 
ortho substituted product is shown in Figure 18. Conversion by 1H NMR of Crude 
Reaction Mixture: Signal at 7.93 ppm (1H, s) from meta product and signal at 8.02 – 7.98 
(2H, m) from starting material used for conversion calculation.  
% Conversion from Starting Material =  
2 × ∫ Starting Material (ortho)
∫ meta Product (ortho)
 × 100 
The ratio of ortho:meta product was then calculated using the ratio of the benzyl peaks of 
each product, as denoted above. 




Additive Base Solvent Conversion (%) 
(IY) (m:o) 
1 RuCl3·xH2O 1-AdCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 18 
2 [RuCl2(benzene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 12 
3 [RuCl2(PPh3)3] 1-AdCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 17 
4 [RuH(CO)(PPh3)3] 1-AdCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 0 
5 Grubbs 1st Gen 1-AdCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 20 
6 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 61 (38) (9:1) 
7 [RuCl2(p-cymene)]2 KOAc [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 0 
8 [RuCl2(p-cymene)]2 9-AnthCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 7 
9 [RuCl2(p-cymene)]2 PhCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 37 
10 [RuCl2(p-cymene)]2 PivCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 61 
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11 [RuCl2(p-cymene)]2 Piv-Val-OH [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 16 
12 [RuCl2(p-cymene)]2 MesCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 58 
13 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] Na2CO3 1,4-Dioxane 59 
14 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] Ag2CO3 1,4-Dioxane 20 
15 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] Cs2CO3 1,4-Dioxane 62 
16 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] AdCO2Na 1,4-Dioxane 28 
17 [RuCl2(p-cymene)]2 1-AdCO2H Ni(OAc)2·4H2O K2CO3 1,4-Dioxane 0 
18 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(DME)] K2CO3 1,4-Dioxane 0 
19 [RuCl2(p-cymene)]2 1-AdCO2H [NiBr2(PPh3)2] K2CO3 1,4-Dioxane 59 (33) (8:1) 
20 [RuCl2(p-cymene)]2 1-AdCO2H [Ni(COD)2] K2CO3 1,4-Dioxane 0 
21 [RuCl2(p-cymene)]2 1-AdCO2H [Ni(acac)2] K2CO3 1,4-Dioxane 0 
22 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(dppe)] K2CO3 1,4-Dioxane trace 
23 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(dppf)] K2CO3 1,4-Dioxane trace 
24 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PCy3)2] K2CO3 1,4-Dioxane 5 
25 [RuCl2(p-cymene)]2 1-AdCO2H Ni(NO3)2·6H2O K2CO3 1,4-Dioxane 0 
26 [RuCl2(p-cymene)]2 1-AdCO2H NiCl2·6H2O K2CO3 1,4-Dioxane 0 
27 [RuCl2(p-cymene)]2 1-AdCO2H Ni(SO4)2·6H2O K2CO3 1,4-Dioxane 11 
28 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 2-MeTHF 12 
29 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 H2O 0 
30 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 MePh 3 
31 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 MeCN 0 
32 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 DCE 26 
33 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 NMP 2 
34 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 DME 22 
35 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 t-BuOMe 33 
36 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 Cumene 11 
37 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 Diglyme 17 
38 [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 t-amylOH 48 
39a [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 43 
40b [RuCl2(p-cymene)]2 1-AdCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 0 
41 - 1-AdCO2H [NiCl2(PPh3)2] K2CO3 1,4-Dioxane 0 
42 [RuCl2(p-cymene)]2 1-AdCO2H - K2CO3 1,4-Dioxane 19* 
43 [RuCl2(p-cymene)]2 MesCO2H PPh3 K2CO3 1,4-Dioxane 60 (58) (19:1) 
44 [RuCl(OAc)(p-cymene)] - PPh3 K2CO3 1,4-Dioxane 12 
45 [Ru(OAc)2(p-cymene)] - PPh3 K2CO3 1,4-Dioxane 15 
46 [Ru(O2CAd)2(p-cymene)] - PPh3 K2CO3 1,4-Dioxane 20 
47 [Ru(O2CMes)2(p-cymene)] - PPh3 K2CO3 1,4-Dioxane 23 
48 [RuCl2(p-cymene)]2 MesCO2H PCy3 K2CO3 1,4-Dioxane 0 
49 [RuCl2(p-cymene)]2 MesCO2H dppe K2CO3 1,4-Dioxane <5 
50 [RuCl2(p-cymene)]2 MesCO2H dppf K2CO3 1,4-Dioxane <5 
51 [RuCl2(p-cymene)]2 MesCO2H P(4-(CF3)(C6H4))3 K2CO3 1,4-Dioxane 21 
52 [RuCl2(p-cymene)]2 MesCO2H P(4-F(C6H4))3 K2CO3 1,4-Dioxane 38  
53 [RuCl2(p-cymene)]2 MesCO2H PCy3 K2CO3 1,4-Dioxane <5 
54 [RuCl2(p-cymene)]2 PhCO2H PPh3 K2CO3 1,4-Dioxane 23 
55 [RuCl2(p-cymene)]2 AdCO2H PPh3 K2CO3 1,4-Dioxane 29 
56 [RuCl2(p-cymene)]2 KOAc PPh3 K2CO3 1,4-Dioxane 54 
57 [RuCl2(p-cymene)]2 PivCO2H PPh3 K2CO3 1,4-Dioxane 57 
58 [RuCl2(p-cymene)]2 Piv-Val-OH PPh3 K2CO3 1,4-Dioxane <5 
59 [RuCl2(p-cymene)]2 MesCO2H PPh3 Na2CO3 1,4-Dioxane 40 
60 [RuCl2(p-cymene)]2 MesCO2H PPh3 Ag2CO3 1,4-Dioxane 17 
61 [RuCl2(p-cymene)]2 MesCO2H PPh3 Cs2CO3 1,4-Dioxane 33 
62 [RuCl2(p-cymene)]2 MesCO2H PPh3 H2KPO4 1,4-Dioxane 0 
63 [RuCl2(p-cymene)]2 - PPh3 KOAc 1,4-Dioxane 13 
64 [RuCl2(p-cymene)]2 NaCO2Ad PPh3 K2CO3 1,4-Dioxane 21 
65 [RuCl2(p-cymene)]2 MesCO2H PPh3 K2CO3 2-MeTHF 15 
66 [RuCl2(p-cymene)]2 MesCO2H PPh3 K2CO3 H2O 0 
67 [RuCl2(p-cymene)]2 MesCO2H PPh3 K2CO3 MePh 26 
68 [RuCl2(p-cymene)]2 MesCO2H PPh3 K2CO3 MeCN 0 
69 [RuCl2(p-cymene)]2 MesCO2H PPh3 K2CO3 NMP 0 
70 [RuCl2(p-cymene)]2 MesCO2H PPh3 (10 mol.%) K2CO3 1,4-Dioxane 67 (47) (19:1) 
71 [RuCl2(p-cymene)]2 MesCO2H PPh3 (50 mol.%) K2CO3 1,4-Dioxane 68 (46) (>20:1) 
72 [RuCl2(p-cymene)]2 MesCO2H PPh3 (100 mol.%) K2CO3 1,4-Dioxane 6 
73b [RuCl2(p-cymene)]2 MesCO2H PPh3 K2CO3 1,4-Dioxane 0 
74c [RuCl2(p-cymene)]2 1-AdCO2H NiCl2·6H2O + 
PPh3 
K2CO3 1,4-Dioxane 53 (30) (9:1) 
a Reaction done in air b 100 °C * 1:1 (ortho:meta)  
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Figure 18: Example spectrum of mixed ortho and meta alkylation products, with the ortho and meta peaks used to 
determine the regioselectivity shown.   
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5.4 – Scope of Ruthenium Catalysed meta C-H Alkylation of Primary 
Substrates 
5.4.1 – General Procedure A for the Formation of ethyl 2-(3-(pyridin-2-yl) phenyl) 
acetates 
 
To an oven dried, argon purged carousel tube equipped with magnetic stirrer was added 
[RuCl2(p-cymene)]2 (15 mg, 0.025 mmol), 1-adamantane carboxylic acid (27 mg, 0.15 
mmol), [NiCl2(PPh3)2] (33 mg, 0.05 mmol), K2CO3 (138 mg, 1.0 mmol), phenylpyridine 
derivative (0.5 mmol), 1,4-dioxane (1.5 mL) and ethyl bromoacetate (0.17 mL, 1.5 mmol). 
The carousel tube was then sealed and refluxed in a carousel reactor at 120 °C for 16 h. 
After cooling to room temperature, the reaction mixture was dry loaded onto silica and 
purified by flash chromatography (40/60 Petroleum Ether/ Ethyl Acetate) to yield the 
desired product.   
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5.4.2 – General procedure B for the formation of ethyl 2-(3-(pyridine-2-yl) phenyl) 
acetates 
 
To an oven dried, argon purged carousel tube equipped with magnetic stirrer was added 
[RuCl2(p-cymene)]2 (15 mg, 0.025 mmol), 2,4,6-trimethylbenzoic acid (25 mg, 0.15 
mmol), PPh3 (26 mg, 0.10 mmol), K2CO3 (138 mg, 1.0 mmol), the substrate molecule (0.5 
mmol), 1,4-dioxane (1.5 mL) and ethyl bromoacetate (0.17 mL, 1.5 mmol). The carousel 
tube was then sealed and refluxed in a carousel reactor at 120 °C for 16 h. After cooling 
to room temperature, the reaction mixture was dry loaded onto silica and purified by flash 
chromatography (40/60 Petroleum Ether/ Ethyl Acetate) to yield the desired product.   
5.4.3 – Synthesis of ethyl 2-(3-(pyridin-2-yl)phenyl)acetate, 1.1 
 
General procedure A was followed using the following compounds: 2-phenylpyridine 
(0.07 mL, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-cymene)]2 (15 
mg, 0.025 mmol), [NiCl2(PPh3)2] (33 mg, 0.05 mmol), 1-adamantanecarboxylic acid (27 
mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column 
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chromatography (10% EtOAc/ hexanes) yielded the title compound as a colourless oil, 
1.1, 38% (45 mg). 
*When general conditions B were used with the following reagents: PPh3 (26 mg, 0.1 
mmol) and 2,4,6-trimethylbenzoic acid (25 mg, 0.15 mmol) were used instead of 
[NiCl2(PPh3)2] and 1-adamantanecarboxylic acid respectively, the title compound was 
obtained as a colourless oil, 54% (69 mg). 
1H NMR (500 MHz, CDCl3): δ 8.68 (1H, dd, J = 5.0, 1.2 Hz, C(5)-H), 7.93 (1H, s, C(8)-
H), 7.87 (1H, d, J = 7.8 Hz, C(12)-H), 7.75 – 7.69 (2H, m, C(10)-H, C(11)-H), 7.43 (1H, 
dd, J = 7.7, 5.4 Hz, C(1)-H), 7.35 (1H, d, J = 7.7 Hz, C(2)-H), 7.21 (1H, ddd, J = 5.4, 5.0, 
2.8 Hz, C(6)-H), 4.15 (2H, q, J = 7.1 Hz, C(17)-H), 3.70 (2H, s, C(13)-H), 1.25 (3H, t, J 
= 7.1 Hz, C(18)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.6 (C=O), 157.3 (ArC), 149.7 (ArCH), 139.8 
(ArC), 136.8 (ArC), 134.8 (ArCH), 129.9 (ArCH), 129.0 (ArCH), 128.0 (ArCH), 125.7 
(ArCH), 122.3 (ArCH), 120.7 (ArCH), 61.0 (O-CH2), 41.5 ((C=O)-CH2-), 14.3 (CH3) 
HR-MS  (ESI) m/z: calculated for C15H15NO2 requires 264.1000 for [M+Na]
+ found 
264.1005. 
FTIR (thin film): νmax = 3021, 2160, 2029, 1729, 1587, 1464, 1369, 1335 cm
-1.  
5.4.4 - Synthesis of ethyl 2-3-(1H-pyrazol-1-yl)phenyl)acetate, 1.2 
 
General procedure B was followed using the following compounds: 1-phenylpyrazole 
(0.07 mL, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-cymene)]2 (15 
mg, 0.025 mmol), [NiCl2(PPh3)2] (33 mg, 0.05 mmol), 1-adamantanecarboxylic acid (27 
mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column 
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chromatography (10% EtOAc/ hexanes) yielded the title compound as a yellow oil, 1.2, 
58% (67 mg).  
*When general conditions A were used with the following reagents: PPh3 (26 mg, 0.1 
mmol) and 2,4,6-trimethylbenzoic acid (25 mg, 0.15 mmol) were used instead of 
[NiCl2(PPh3)2] and 1-adamantanecarboxylic acid respectively, the title compound was 
obtained as a colourless oil, 39% (45 mg). 
1H NMR (500 MHz, CDCl3): δ 7.92 (1H, d, J = 2.3 Hz, C(11)-H), 7.70 (1H, d, J = 1.5 
Hz, C(9)-H), 7.65 (1H, t, J = 1.5 Hz, C(1)-H), 7.58 (1H, dd, J = 8.1, 1.2 Hz, C(5)-H), 7.38 
(1H, d, J = 8.1 Hz, C(3)-H), 7.20 (1H, dd, J = 8.1, 1.5 Hz, C(4)-H), 6.45 (1H, d, J = 2.3 
Hz, C(10)-H), 4.15 (2H, q, J = 7.1 Hz, C(16)-H), 3.66 (2H, s, C(12)-H), 1.25 (3H, t, J = 
7.1 Hz, C(17)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.0 (C=O), 141.1 (ArCH), 140.4 (ArC) 129.5 
(ArC), 127.3 (ArCH), 126.8 (ArCH), 126.1 (ArCH), 120.2 (ArCH), 117.8 (ArCH), 107.6 
(ArCH), 61.0 (O-CH2-CH3), 41.2 ((C=O)-CH2-), 14.6 (O-CH2-CH3).  
HR-MS (ESI) m/z: calculated for C13H14N2O2 requires 253.0953 for [M+Na]
+ found 
253.0960. 
FTIR (thin film): νmax = 2981, 2254, 2161, 2031, 1730, 1610, 1595, 1520, 1502, 1476, 
1454, 1394, 1370, 1331 cm-1.  
5.4.5 – Synthesis of ethyl 2-(3-(pyrimidin-2-yl)phenyl)acetate, 1.3 
 
General procedure B was followed using the following compounds: 2-phenylpyrimidine 
(78 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-cymene)]2 (15 
mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-trimethylbenzoic acid (25 mg, 0.15 
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mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column chromatography 
(10% EtOAc/ hexanes) yielded the title compound a colourless oil, 1.3, 36% (44 mg). 
1H NMR (500 MHz, CDCl3): δ 8.79 (2H, d, J = 4.8 Hz, C(1)-H, C(5)-H), 8.37 (1H, d, J 
= 1.6 Hz, C(8)-H), 8.35 (1H, dd, J = 7.4, 1.6 Hz, C(12)-H), 7.48 – 7.41 (2H, m, C(10)-H, 
C(11)-H), 7.17 (1H, t, J = 4.8 Hz, C(6)-H), 4.16 (2H, q, J = 7.1 Hz, C(17)-H), 3.71 (2H, 
s, C(13)-H), 1.24 (3H, t, J = 7.1 Hz, C(18)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.6 (C=O), 164.6 (ArC), 157.3 (2C, ArCH), 138.0 
(ArC), 134.7 (ArC), 131.8 (ArCH), 129.2 (ArCH), 129.0 (ArCH), 127.0 (ArCH), 119.3 
(ArCH), 61.0 (O-CH2-CH3), 41.5 ((C=O)-CH2-), 14.3(O-CH2-CH3). 
HR-MS (ESI) m/z: calculated for C14H14N2O2 requires 243.1134 for [M+H]
+ found 
243.1121. 
FTIR (thin film): νmax = 2981, 2252, 2165, 2025, 1730, 1603, 1568, 1556, 1498, 1454, 
1374 cm-1.  
5.4.6 – Synthesis of ethyl 2-(3-(5-fluoropyridin-2-yl)phenyl)acetate, 1.4 
 
General procedure B was followed using the following compounds: 5-fluoro-2-
phenylpyridine (87 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2 (15 mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-trimethylbenzoic acid 
(25 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column 
chromatography (10% EtOAc/ hexanes) yielded the title compound a colourless oil, 1.4, 
23% (30 mg). 
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1H NMR (500 MHz, CDCl3): δ 8.54 (1H, d, J = 2.9 Hz, C(5)-H), 7.88 (1H, t, J = 1.5 Hz, 
C(9)-H), 7.84 – 7.79 (1H, m, C(13)-H), 7.72 (1H, ddd, J = 8.8, 4.2, 0.4 Hz, C(12)-H), 7.49 
– 7.45 (2H, m, C(1)-H, C(11)-H), 7.43 (1H, t, J = 7.5 Hz, C(2)-H), 4.17 (2H, q, J = 7.1 
Hz, C(18)-H), 3.70 (2H, s, C(14)-H), 1.26 (3H, t, J = 7.1 Hz, C(19)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.6 (C=O), 159.0 (d, J = 256.2 Hz, (ArC-F), 153.7, 
(d, J = 3.9 Hz, ArC), 138.9 (ArCH), 137.9 (d, J  = 23.5 Hz, ArCH), 134.9 (ArC), 130.0 
(ArCH), 129.2 (ArCH), 128.0 (ArCH), 125.7 (ArCH), 123.7 (d, J = 18.5 Hz, ArCH), 
121.6 (d, J = 4.3 Hz, ArCH), 61.1 (O-CH2-CH3), 41.5 ((C=O)-CH2-), 14.4 (O-CH2-CH3). 
19F NMR (470 MHz, CDCl3): δ -129.64 – -129.69 (m, 1F).  
HR-MS (ESI) m/z: calculated for  C15H14NO2F requires 260.1087 for [M+H]
+ found 
260.1085. 
FTIR (thin film): νmax = 2981, 1733, 1580 cm
-1. 
5.4.7 – Synthesis of ethyl 2-(3-(5-ethylpyrimidin-2-yl)phenyl)acetate, 1.5 
 
General procedure B was followed using the following compounds: 5-ethyl-2-
phenylpyrimidine (92 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2  (15 mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-trimethylbenzoic acid 
(25 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column 
chromatography (10% EtOAc/ hexanes) yielded the title compound as a colourless oil, 
1.5, 29% (39 mg). 
1H NMR (500 MHz, CDCl3): δ 8.62 (2H, d, J = 3.5 Hz, C(1)-H, C(5)-H), 8.34 – 8.32 
(1H, m, C(8)-H), 8.31 (1H, dd, J = 7.6, 1.5 Hz, C(12)-H), 7.44 (1H, t, J = 7.6 Hz, C(11)-
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H), 7.39 (1H, dd, J = 7.6, 1.5 Hz, C(10)-H), 4.15 (2H, q, J = 7.1 Hz, C(17)-H), 3.70 (2H, 
s, C(13)-H), 2.65 (2H, q, J = 7.6 Hz, C(19)-H), 1.28 (3H, t, J = 7.6 Hz, C(20)-H), 1.24 
(3H, t, J = 7.1 Hz, C(18)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.6 (C=O), 162.5 (ArC), 156.7 (2C, ArCH), 138.0 
(ArC), 134.6 (ArC), 134.3 (ArCH), 131.3 (ArCH), 128.9 (ArCH), 128.9 (ArCH), 126.7 
(ArCH), 60.9 (O-CH2-CH3), 41.5((C=O)-CH2-), 23.5(ArC-CH2-CH3), 15.0 (ArC-CH2-
CH3), 14.3 (O-CH2-CH3).  
HR-MS (ESI) m/z: calculated for C16H18N2O2 requires 293.1266 for [M+Na]
+ found 
293.1276. 
FTIR (thin film): νmax = 2971, 1731, 1586, 1544 cm
-1.  
5.4.8 – Synthesis of ethyl 2-(3-(4-methylpyrimidin-2-yl)phenyl)acetate, 1.6 
 
General procedure B was followed using the following compounds: 4-methyl-2-
phenylpyrimidine (85 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2 (15 mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-trimethylbenzoic acid 
(25 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column 
chromatography (10% EtOAc/ hexanes) yielded the title compound as a colourless oil, 
1.6, 29% (37 mg). 
1H NMR (500 MHz, CDCl3): δ 8.62 (1H, d, J = 5.2 Hz, C(1)-H), 8.37 – 8.36 (1H, m, 
C(9)-H), 8.34 (1H, dd, J = 7.4, 1.6 Hz, C(13)-H), 7.47 – 7.39 (2H, m, C(11)-H, C(12)-H), 
7.02 (1H, d, J = 5.2 Hz, C(6)-H), 4.15 (2H, q, J = 7.1 Hz, C(23)-H), 3.71 (2H, s, C(19)-
H), 2.56 (3H, s, C(18)-H), 1.24 (3H, t, J = 7.1 Hz, C(24)-H).  
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13C{1H} NMR (126 MHz, CDCl3): δ 171.6 (C=O), 167.3 (ArC), 164.2 (ArC), 156.8 
(ArCH), 138.2 (ArC), 134.5 (ArC), 131.5 (ArCH), 129.2 (ArCH), 128.8 (ArCH), 127.0 
(ArCH), 118.7 (ArCH), 60.9 (O-CH2-CH3), 41.5 ((C=O)-CH2-), 24.5 (ArC-CH3), 14.3 
(O-CH2-CH3).  
HR-MS (ESI) m/z: calculated for C15H16N2O2 requires 279.1109 for [M+Na]
+ found 
279.1101. 
FTIR (thin film): νmax = 2981, 1731, 1573, 1554 cm
-1.  
5.4.9 – Synthesis of ethyl 2-(3-(4-methylpyridin-2-yl)phenyl)acetate, 1.7 
 
General procedure B was followed using the following compounds: 4-methyl-2-
phenylpyridine (85 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2  (15 mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-trimethylbenzoic acid 
(25 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column 
chromatography (10% EtOAc/ hexanes) yielded the title compound a colourless oil, 1.7, 
26% (33 mg). 
1H NMR (500 MHz, CDCl3): δ 8.53 (1H, d, J = 4.9 Hz, C(9)-H), 7.91 (1H, t, J = 1.4 
Hz, C(1)-H), 7.88 – 7.84 (1H, m, C(5)-H), 7.57 – 7.50 (1H, m, C(4)-H), 7.42 (1H, t, J = 
7.6 Hz, C(3)-H), 7.36 – 7.30 (1H, m, C(12)-H), 7.08 – 7.02 (1H, m, C(10)-H), 4.16 (2H, 
q, J = 7.1 Hz, C(18)-H), 3.70 (2H, s, C(14)-H), 2.40 (3H, s, C(13)-H), 1.25 (3H, t, J = 
7.1 Hz, C(19)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.7 (C=O), 157.2 (ArC), 149.5 (ArCH), 147.9 
(ArC), 139.9 (ArCH), 134.7 (ArC), 129.8 (ArCH), 129.0 (ArCH), 128.0 (ArCH), 125.8 
(ArCH), 123.3 (ArCH), 121.7 (ArCH), 61.0 (O-CH2-CH3), 41.5 ((C=O)-CH2-), 21.3 
(ArC-CH3), 14.3 (O-CH2-CH3).  
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HR-MS (ESI) m/z: calculated for C16H17NO2 requires 278.1157 for [M+Na]
+ found 
278.1179.  
FTIR (thin film): νmax = 2980, 1731, 1601 cm
-1.   
5.4.10 – Synthesis of ethyl 2-(2-methoxy-5-(4-methylpyridin-2-yl)phenyl)acetate, 
1.8 
 
General procedure B was followed using the following compounds: 2-(4-
methoxyphenyl)-4-methylpyridine (100 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 
mmol), [RuCl2(p-cymene)]2  (15 mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-
trimethylbenzoic acid (25 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane 
(1.5 mL). Column chromatography (10% EtOAc/ hexanes) yielded the title compound a 
colourless oil, 1.8, 30% (43 mg).  
1H NMR (500 MHz, CDCl3): δ 8.49 (1H, d, J = 5.0 Hz, C(1)-H), 7.89 (1H, dd, J = 8.5, 
2.3 Hz, C(11)-H), 7.85 (1H, d, J = 2.3 Hz, C(8)-H), 7.52 – 7.46 (1H, m, C()-H), 6.99 (1H, 
dd, J = 5.0, 0.8 Hz, C(2)-H), 6.95 (1H, d, J = 8.5 Hz, C(10)-H), 4.16 (2H, q, J = 7.1 Hz, 
C(14)-H), 3.87 (3H, s, C(16)-H), 3.69 (2H, s, C(12)-H), 2.39 (3H, s, C(6)-H), 1.25 (3H, t, 
J = 7.1 Hz, C(15)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.9 (C=O), 158.5 (ArC), 157.0 (ArC), 149.4 
(ArCH), 132.0 (ArCH), 129.8 (ArC), 127.2 (ArC), 123.6 (ArCH), 122.6 (ArCH), 120.9 
(ArCH), 110.7 (ArCH), 60.7 (O-CH2-CH3), 55.7 (O-CH3), 36.4 ((C=O)-CH2-ArC), 21.4 
(Ar-CH3), 14.4 ((C=O)-CH2-CH3).  
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FTIR (thin film): νmax = 2978, 1733, 1604, 1559 cm
-1.   
5.4.11 – Synthesis of ethyl 2-(2-methoxy-5-(pyridin-2-yl)phenyl)acetate, 1.11 
 
General procedure A was followed using the following compounds: 2-(4-methoxypenyl) 
pyridine (1c) (93 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2 (15 mg, 0.025 mmol), [NiCl2(PPh3)2] (33 mg, 0.05 mmol), 1-
adamantanecarboxylic acid (27 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-
dioxane (1.5 mL). Column chromatography (10% EtOAc/ hexanes) yielded the title 
compound as a colourless oil, 1.11, 47% (64 mg). 
*When general conditions B were used with the following reagents: PPh3 (26 mg, 0.1 
mmol) and 2,4,6-trimethylbenzoic acid (25 mg, 0.15 mmol) were used instead of 
[NiCl2(PPh3)2] and 1-adamantanecarboxylic acid respectively, the title compound was 
obtained as a colourless oil, 19% (26 mg). 
1H NMR (500 MHz, CDCl3): δ 8.64 (1H, ddd, J = 4.8, 1.8, 1.1 Hz, C(5)-H), 7.90 (1H, 
dd, J = 8.5, 2.3 Hz, C(12)-H), 7.87 (1H, d, J = 2.3 Hz, C(8)-H), 7.71 – 7.65 (1H, m, C(2)-
H), 7.16 (1H, ddd, J = 7.1, 4.8, 1.5 Hz, C(6)-H), 6.96 (1H, d, J = 8.5 Hz, C(11)-H), 4.17 
(2H, q, J = 7.1 Hz, C(17)-H), 3.87 (3H, s, C(20)-H), 3.70 (2H, s, C(13)-H), 1.25 (3H, t, J 
= 7.1 Hz, C(18)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.8 (C=O), 158.6 (ArC), 157.2 (ArC), 149.6 
(ArCH), 136.7 (ArCH), 131.9 (ArCH), 129.8 (ArC), 127.3 (ArC), 123.7 (ArCH), 121.5 
(ArCH), 120.0 (ArCH), 110.7 (ArCH), 60.8 (O-CH2-CH3), 55.8 (O-CH3), 36.4 ((C=O)-
CH2-), 14.4 (OCH2-CH3). 
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HR-MS (ESI) m/z: calculated for C16H17NO3 requires 294.1106 for [M+Na]
+ found: 
294.1127. 
FTIR (thin film): νmax = 3019, 2159, 2027, 1729, 1611, 1591, 1566, 1508, 1466 cm
-1. 
5.4.12 – Synthesis of ethyl 2-(2-(methylthio)-5-(pyridin-2-yl)phenyl)acetate, 1.12 
 
General procedure B was followed using the following compounds: 1-phenylpyrazole 
(0.07 mL, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-cymene)]2  (15 
mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-trimethylbenzoic acid (25 mg, 0.15 
mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column chromatography 
(10% EtOAc/ hexanes) yielded the title compound as a yellow oil, 1.11, 41% (41 mg).  
*When general conditions A were used with the following reagents: PPh3 (26 mg, 0.1 
mmol) and 2,4,6-trimethylbenzoic acid (25 mg, 0.15 mmol) were used instead of 
[NiCl2(PPh3)2] and 1-adamantanecarboxylic acid respectively, the title compound was 
obtained as a colourless oil, 29% (29 mg). 
1H NMR (500 MHz, CDCl3): δ 8.69 (1H, m, C(1)-H), 7.91 (1H, dd, J = 8.2, 2.1 Hz, 
C(11)-H), 7.80 – 7.72 (2H, m, C(7)-H, C(1)-H), 7.49 (1H, d, J = 8.3 Hz, C(3)-H), 7.37 
(1H, d, J = 8.3 Hz, C(4)-H), 7.25 – 7.21 (1H, m, C(2)-H), 4.18 (2H, q, J = 7.1 Hz, C(15)-
H), 3.85 (2H, s, C(13)-H), 2.51 (3H, s, C(12)-H), 1.26 (3H, t, J = 7.1 Hz, C(16)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.0 (C=O), 156.4 (ArC), 149.4 (ArCH), 149.1 
(ArC), 133.3 (ArC), 129.5 (ArC), 128.9 (ArCH), 127.4 (ArCH), 126.8 (ArCH), 126.3 
(ArCH), 122.3 (ArCH), 120.4 (ArCH), 61.0 (O-CH2-CH3), 39.5 ((C=O)-CH2-), 16.3 (S-
CH3), 14.1 (O-CH2-CH3).  
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FTIR (thin film): νmax = 2182, 2009, 1730, 1589, 1466, 1433 cm
-1.  
5.4.13 – Synthesis of ethyl 2-(5-(pyridin-2-yl)-2-(trifluoromethyl)phenyl)acetate, 
1.13 
 
General procedure B was followed using the following compounds: 2-(4-
(trifluoromethyl)phenyl) pyridine (1d) (112 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 
1.5 mmol), [RuCl2(p-cymene)]2 (15 mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-
trimethylbenzoic acid (25 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane 
(1.5 mL). Column chromatography (10% EtOAc/ hexanes) yielded the title compound as 
a yellow oil, 1.13, 56% (87 mg). 
*When general conditions A were used with the following reagents: [NiCl2(PPh3)2]  (33 
mg, 0.05 mmol) and 1-adamantanecarboxylic acid (27 mg, 0.15 mmol) were used instead 
of PPh3 and 2,4,6-trimethylbenzoic acid respectively, the title compound was obtained as 
a colourless oil, 20% (31 mg). 
1H NMR (500 MHz, CDCl3): δ 8.72 (1H, ddd, J = 4.8, 1.7, 1.1 Hz, C(5)-H), 8.05 (1H, s, 
C(8)-H), 7.99 (1H, dd, J = 8.2, 0.8 Hz, C(12)-H), 7.82 – 7.73 (3H, m, C(1)-H, C(11)-H, 
C(2)-H), 7.30 (1H, ddd, J = 6.7, 4.8, 2.0 Hz, C(6)-H), 4.18 (2H, q, J =7.1 Hz, C(17)-H), 
3.91 (2H, d, J = 0.9 Hz, C(13)-H), 1.25 (3H, t, J = 7.1 Hz, C(18)-H). 
13C NMR: Is not reported due to complex splitting making the spectrum peaks difficult 
to differentiate from each other. 
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19F NMR (470 MHz, CDCl3): δ -59.91 (3F, s).  
HR-MS  (ESI) m/z: calculated for C16H14NO2F3 requires 310.1055 for [M+H]
+ found 
310.1097. 
FTIR (thin film): νmax = 3021, 2314, 2161, 2030, 1731, 1590, 1469, 1421, 1370, 1328, 
1317 cm-1.  
5.4.14 – Synthesis of ethyl 2-(5-((pyridin-2-yl)-2-(trifluoromethoxy)phenyl)acetate, 
1.14 
 
General procedure B was followed using the following compounds: 2-(4-
(trifluoromethoxy) phenyl) pyridine (1g) (120 mg, 0.5 mmol), ethyl bromoacetate (0.17 
mL, 1.5 mmol), [RuCl2(p-cymene)]2 (15 mg, 0.025 mmol), [NiCl2(PPh3)2] (33 mg, 0.05 
mmol), 1-adamantanecarboxylic acid (27 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 
1,4-dioxane (1.5 mL). Column chromatography (10% EtOAc/ hexanes) yielded the title 
compound a brown oil, 1.14, 37% (60 mg).  
1H NMR (500 MHz, CDCl3): δ 8.68 (1H, ddd, J = 4.9, 1.8, 1.0 Hz, C(15)-H), 8.00 (1H, 
d, J = 2.3 Hz, C(1)-H), 7.92 (1H, dd, J = 8.6, 2.3 Hz, C(5)-H), 7.77 – 7.74 (1H, m, C(4)-
H), 7.72 (1H, t, J = 1.0 Hz, C(17)-H), 7.48 – 7.44 (1H, m, C(18)-H), 7.35 (1H, dd, J = 8.6, 
1.8 Hz, C(16)-H), 4.18 (2H, q, J = 7.1 Hz, C(23)-H), 3.82 (2H, s, C(19)-H), 1.25 (3H, t, J 
= 7.1 Hz, C(24)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 171.0 (C=O), 158.2 (ArC), 155.8 (ArC), 149.7 
(ArCH), 149.0 (ArCH), 136.6 (ArCH), 131.2 (ArC), 130.5 (q, O-CF3), 127.2 (ArC), 123.9 
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(ArCH), 122.1 (ArCH), 120.5 (ArCH), 119.5 (ArCH), 60.8 (O-CH2-CH3), 39.2 ((C=O)-
CH2), 14.1 (CH2-CH3). 
19F NMR (470 MHz, CDCl3): δ -57.72 (3F). 
HR-MS (ESI) m/z: calculated for C16H14F3NO3 requires 348.0823 for [M+Na]
+  found 
348.0828.  
FTIR (thin film): νmax = 2986, 2159, 2009, 1733, 1612, 1588, 1567, 1504, 1467, 1433, 
cm-1.  
5.4.15 – Synthesis of ethyl 2-(2-ethoxy-2-oxoethyl)-4-(pyridin-2-yl)benzoate, 1.15 
 
General procedure A was followed using the following compounds: ethyl 4-(pyridin-2-
yl) benzoate (1e) (113 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2 (15 mg, 0.025 mmol), [NiCl2(PPh3)2] (33 mg, 0.05 mmol), 1-
adamantanecarboxylic acid (27 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-
dioxane (1.5 mL). Column chromatography (10% EtOAc/ hexanes) yielded the title 
compound as a brown oil, 1.15, 37% (58 mg).  
*When general conditions B were used with the following reagents: PPh3 (26 mg, 0.1 
mmol) and 2,4,6-trimethylbenzoic acid (25 mg, 0.15 mmol) were used instead of 
[NiCl2(PPh3)2] and 1-adamantanecarboxylic acid respectively, the title compound was 
obtained as a colourless oil, 36% (56 mg). 
1H NMR (500 MHz, CDCl3): δ 8.71 (1H, dd, J = 4.8, 1.4 Hz, C(5)-H), 8.12 (1H, d, J = 
8.1 Hz, C(11)-H), 7.94 (1H, dd, J = 8.1, 1.9 Hz, C(12)-H), 7.91 (1H, d, J = 1.9 Hz, C(8)-
H), 7.78–7.76 (2H, m, C(1)-H, C(2)-H), 7.27 (1H, dd, J = 4.8, 3.5 Hz, C(6)-H), 4.35 (2H, 
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q, J = 7.1 Hz, C(17)-H), 4.16 (2H, q, J = 7.1 Hz, C(23)-H), 4.11 (2H, s, C(13)-H), 1.39 
(3H, t, J = 7.1 Hz, C(24)-H), 1.25 (3H, t, J = 7.1 Hz, C(18)-H).    
13C{1H} NMR (126 MHz, CDCl3): δ 171.5 (C=O), 167.1 (C=O), 156.1 (ArC), 150.0 
(ArCH), 142.8 (ArC), 137.0 (ArC), 136.6 (ArCH), 131.7 (ArCH), 130.8 (ArCH), 130.5 
(ArC), 125.7 (ArCH), 123.0 (ArCH), 121.1 (ArCH), 61.2 (-CH2-), 60.9 (-CH2-), 41.1 
((C=O)-CH2-), 14.4 (-CH3), 14.3 (-CH3).  
HR-MS (ESI) m/z: calculated for C18H19NO4 requires 314.1392 for [M+H]
+ found 
314.1410.  
FTIR (thin film): νmax = 3020, 2162, 2033, 1717, 1589, 1467, 1369 cm
-1.  
5.4.16 – Synthesis of ethyl 2-(4-(pyridin-2-yl)-[1,1’-biphenyl]-2-yl)acetate, 1.16 
 
General procedure B was followed using the following compounds: 2-([1,1’-biphenyl]-4-
yl) pyridine (1f) (116 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2 (15 mg, 0.025 mmol), [NiCl2(PPh3)2] (33 mg, 0.05 mmol), 1-
adamantanecarboxylic acid (27 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-
dioxane (1.5 mL). Column chromatography (10% EtOAc/ hexanes) yielded the title 
compound as a brown oil, 1.16, 16% (26 mg). 
1H NMR (500 MHz, CDCl3): δ 8.72 – 8.70 (1H, m, C(15)-H), 8.01 (1H, d, J = 1.8 Hz, 
C(1)-H), 7.94 (1H, dd, J = 8.0, 1.8 Hz, C(5)-H), 7.78–7.77 (1H, m, C(4)-H), 7.56–7.52 
(1H, m, C(17)-H), 7.46–7.34 (6H, m, C(9)-H, C(10)-H, C(11)-H, C(12)-H, C(13)-H, 
C(18)-H), 7.24 (1H, ddd, J = 6.3, 4.9, 2.5 Hz, C(16)-H), 4.07 (2H, q, J = 7.1 Hz, C(23)-
H), 3.69 (2H, s, C(19)-H), 1.19 (3H, t, J = 7.1 Hz, C(24)-H).  
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13C{1H} NMR (126 MHz, CDCl3): δ 171.8 (C=O), 156.6 (ArC), 149.6 (ArCH), 143.2 
(ArCH), 140.7 (ArC), 136.8 (ArCH), 132.4 (ArC), 130.7 (ArC), 129.2 (ArC), 129.0 
(ArCH), 128.8 (ArCH), 128.2 (ArCH), 127.3 (ArCH), 127.2 (ArCH), 126.1 (ArCH), 
125.6 (ArCH), 122.2 (ArCH), 120.6 (ArCH), 60.8 (O-CH2-CH3) 39.1 ((C=O)-CH2), 14.1 
(CH2-CH3).  
HR-MS (ESI) m/z: calculated for C21H19NO2 requires 340.1313 for [M+Na]
+ found 
340.1308. 
FTIR (thin film): νmax = 3020, 2159, 1979, 1729, 1589, 1467, 1432, 1365, 1335 cm
-1.  
5.4.17 – Synthesis of ethyl 2-(2-fluoro-5-(pyridin-2-yl)phenyl)acetate, 1.17 
 
General procedure A was followed using the following compounds: 2-(4fluorophenyl) 
pyridine (1e) (113 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2 (15 mg, 0.025 mmol), [NiCl2(PPh3)2] (33 mg, 0.05 mmol), 1-
adamantanecarboxylic acid (27 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-
dioxane (1.5 mL). Column chromatography (10% EtOAc/ hexanes) yielded the title 
compound as a brown oil, 1.17, 42% (55 mg).  
*When general conditions B were used with the following reagents: PPh3 (26 mg, 0.1 
mmol) and 2,4,6-trimethylbenzoic acid (25 mg, 0.15 mmol) were used instead of 
[NiCl2(PPh3)2] and 1-adamantanecarboxylic acid respectively, the title compound was 
obtained as a colourless oil, 39% (51 mg). 
1H NMR (500 MHz, CDCl3): δ 8.67 (1H, ddd, J = 4.8, 1.8, 1.1 Hz, C(15)-H), 7.94 (1H, 
dd, J = 7.4, 2.3 Hz, C(1)-H), 7.88 (1H, ddd, J = 7.4, 4.8, 1.2 Hz, C(5)-H), 7.76 – 7.71 (1H, 
m, C(4)-H), 7.68 (1H, dd, J = 7.4, 1.1 Hz, C(17)-H), 7.22 (1H, ddd, J = 7.4, 4.8, 1.1 Hz, 
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C(18)-H), 7.18 – 7.13 (1H, m, C(16)-H), 4.18 (2H, q, J = 7.1 Hz, C(23)-H), 3.74 (2H, d, 
J = 0.8 Hz, C(19)-H), 1.26 (3H, t, J = 7.1 Hz, C(24)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 170.7 (C=O), 162.0 (d, J = 249.4 Hz, ArC-F), 156.4 
(ArC), 149.8 (ArCH), 137.0 (ArCH), 135.7 (d, J = 3.4 Hz, ArC), 130.4 (d, J = 4.5 Hz, 
ArCH), 127.8 (d, J = 8.6 Hz, ArCH), 122.2 (ArCH), 122.1 (d, J = 16.4 Hz, ArC), 120.4 
(ArC), 115.8 (d, J = 22.4 Hz, ArCH), 61.2 (O-CH2-CH3), 35.0 (d, J = 2.7 Hz, ((C=O)-
CH2), 14.3 (CH2-CH3).  
19F NMR (470 MHz, CDCl3): δ -116.97 – -117.30 (1F, m).  
HR-MS (ESI) m/z: calculated for C15H14FNO2 requires 282.0906 for [M+Na]
+ found 
282.0908. 
FTIR (thin film): νmax = 3020, 2161, 2033, 1730, 1592, 1506, 1496, 1434, 1370 cm
-1. 
5.4.18 – Synthesis of ethyl 2-(2-chloro-5-(pyridin-2-yl)phenyl)acetate, 1.18 
 
General procedure B was followed using the following compounds: 2-(4-chlorophenyl) 
pyridine (1i) (94 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2 (15 mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-trimethylbenzoic acid 
(25 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column 
chromatography (10% EtOAc/ hexanes) yielded the title compound as a yellow oil, 1.18, 
52% (72 mg). 
*When general conditions A were used with the following reagents: PPh3 (26 mg, 0.1 
mmol) and 2,4,6-trimethylbenzoic acid (25 mg, 0.15 mmol) were used instead of 
[NiCl2(PPh3)2] and 1-adamantanecarboxylic acid respectively, the title compound was 
obtained as a colourless oil, 48% (66 mg). 
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1H NMR (500 MHz, CDCl3): δ 8.68 (1H, ddd, J = 4.8, 1.8, 1.1 Hz, C(15)-H), 7.96 (1H, 
d, J = 2.2 Hz, C(1)-H), 7.84 (1H, dd, J = 8.3, 2.2 Hz, C(5)-H), 7.77–7.73 (1H, m, C(4)-
H), 7.71 (1H, dd, J = 8.3, 1.1 Hz, C(17)-H), 7.48 (1H, d, J = 8.3 Hz, C(18)-H), 7.24 (1H, 
ddd, J = 8.3, 4.8, 1.1 Hz, C(16)-H), 4.19 (2H, q, J = 7.1 Hz, C(23)-H), 3.85 (2H, s, C(19)-
H), 1.27 (3H, t, J = 7.1 Hz, C(24)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 170.6 (C=O), 156.2 (ArC), 149.9 (ArCH), 138.3 
(ArCH), 137.0 (ArCH), 135.6 (ArC), 133.1 (ArC), 130.1 (ArCH), 129.9 (ArCH), 127.1 
(ArCH), 122.6 (ArCH), 120.6 (ArCH), 61.2 (O-CH2-CH3), 39.5 ((C=O)-CH2-), 14.3 
(OCH2-CH3). 
HR-MS (ESI) m/z: calculated for C15H14ClNO2 requires 276.0791 for [M+H]
+  found 
276.0799.  
FTIR (thin film): νmax = 2981, 2158, 2039, 1731, 1589, 1465, 1430, 1369, 1334 cm
-1. 
5.4.19 – Synthesis of ethyl 2-(2-bromo-5-(pyridin-2-yl)phenyl)acetate, 1.19 
 
General procedure A was followed using the following compounds: 2-(4-bromophenyl) 
pyridine (1j) (117 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2 (15 mg, 0.025 mmol), [NiCl2(PPh3)2] (33 mg, 0.05 mmol), 1-
adamantanecarboxylic acid (27 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-
dioxane (1.5 mL). Column chromatography (10% EtOAc/ hexanes) yielded the title 
compound as a green oil, 1.19, 23% (37 mg). 
1H NMR (500 MHz, CDCl3): δ 8.71 (1H, dt, J = 4.8, 1.4 Hz, C(15)-H), 8.02 (1H, d, J = 
1.9 Hz, C(1)-H), 7.94 (1H, dt, J = 8.0, 1.9 Hz, C(5)-H), 7.77 (1H, d, J = 8.0 Hz, C(4)-H), 
7.57 – 7.54 (1H, m, C(17)-H), 7.39 – 7.33 (1H, m, C(18)-H), 7.25 – 7.24 (1H, m, C(16)-
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H), 4.09 (2H, q, J = 7.1 Hz, C(23)-H), 3.66 (2H, s, C(19)-H), 1.20 (3H, t, J = 7.1 Hz, 
C(24)-H). 
13C{1H} NMR (126 MHz, CDCl3): δ 171.6 (C=O), 156.7 (ArC), 149.7 (ArCH), 136.8 
(ArC), 131.4 (ArC), 130.9 (ArCH), 130.5 (ArCH), 129.2 (ArCH), 128.2 (ArCH), 125.7 
(ArCH), 122.3 (ArC), 120.6 (ArCH), 60.9 (O-CH2-CH3), 39.1 ((C=O)-CH2-), 14.1 (O-
CH2-CH3). 
HR-MS (ESI) m/z: calculated for C15H14ClNO2 requires 276.0791 for [M+H]
+  found 
276.0799.  
FTIR (thin film): νmax = 2980, 2358, 2164, 2030, 1927, 1729, 1586, 1464, 1432, 1389, 
1368 cm-1.   
5.4.20 – Synthesis of ethyl 2-(2-methoxy-5-(pyrimidin-2-yl)phenyl)acetate, 1.22 
 
General procedure B was followed using the following compounds: 2-(4-methoxyphenyl) 
pyrimidine (93 mg, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-
cymene)]2 (15 mg, 0.025 mmol), PPh3 (26 mg, 0.1 mmol), 2, 4, 6-trimethylbenzoic acid 
(25 mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). Column 
chromatography (10% EtOAc/ hexanes) yielded the title compound as a colourless oil, 
1.22, 30% (41 mg). 
1H NMR (500 MHz, CDCl3): δ 8.73 (2H, d, J = 4.8 Hz, C(1)-H, C(5)-H), 8.37 (1H, dd, J 
= 8.6, 2.3 Hz, C(12)-H), 8.29 (1H, d, J = 2.3 Hz, C(8)-H), 7.09 (1H, t, J = 4.8 Hz, C(6)-
H), 6.96 (1H, d, J  = 8.6 Hz, C(11)-H), 4.16 (2H, q, J = 7.1 Hz, C(19)-H), 3.88 (s, C(18)-
H), 3.70 (2H, s, C(14)-H), 1.24 (3H, t, J = 7.1 Hz, C(20)-H). 
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13C{1H} NMR (126 MHz, CDCl3): δ 171.7 (C=O), 164.5 (ArC), 160.0 (ArC), 157.2 
(ArCH), 131.1 (ArC), 130.0 (ArCH), 129.0 (ArC), 123.5 (ArCH), 118.4 (ArCH), 110.4 
(ArCH), 60.7 (O-CH2-CH3), 55.7 (O-CH3), 36.3 ((C=O)-CH2-), 14.3 (O-CH2-CH3). 
HR-MS (ESI) m/z: calculated for C15H16N2O3 requires 273.1239 for [M+H]
+ found 
273.1223.  
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5.5 – Mechanistic experiments for the meta alkylation with primary 
substrates 
5.5.1 – Radical Inhibitor experiments  
 
General procedure B was followed using the following compounds: 2-phenylpyridine 
(0.07 mL, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-cymene)]2  (15 
mg, 0.025 mmol), [NiCl2(PPh3)2] (33 mg, 0.05 mmol), 1-adamantanecarboxylic acid (27 
mg, 0.15 mmol), K2CO3 (138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). To each reaction 
was then added TEMPO: 30 mol.% (0.10 mmol, 16 mg), 100 mol.% (1.0 mmol, 156 mg) 
and 300 mol.% (3.00 mmol, 469 mg) or BHT: 30 mol.% (0.10 mmol, 22 mg), 100 mol.% 
(1.0 mmol, 220 mg) and 300 mol.% (3.0 mmol, 660 mg). 
After stirring for 16 h, an aliquot was taken from each reaction and analysed via 1H NMR 
to determine the reaction conversion. The results are shown in the table below. 
Entry Radical inhibitor used Equivalents Conversion (%) 
1 TEMPO 0.1 51 
2 TEMPO 1.0 34 
3 TEMPO 3.0 <5 
4 BHT 0.1 39 
5 BHT 1.0 27 
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5.5.2 – Testing Phosphonium salt as active coupling species in situ 
 
General procedure A was followed using the following compounds: 2-phenylpyridine 
(0.07 mL, 0.5 mmol), (2-ethoxy-2-oxoethyl)triphenylphosphonium bromide (644 mg, 1.5 
mmol), [RuCl2(p-cymene)]2 (15 mg, 0.025 mmol), KOAc (15 mg, 0.15 mmol), K2CO3 
(138 mg, 1 mmol) and 1,4-dioxane (1.5 mL). 
After stirring for 16 h, an aliquot was taken and then analysed via 1H NMR, which showed 
zero conversion of the starting material. 
5.5.3 – Mercury drop test 
 
General procedure B was followed using the following compounds: 2-phenylpyridine 
(0.07 mL, 0.5 mmol), ethyl bromoacetate (0.17 mL, 1.5 mmol), [RuCl2(p-cymene)]2 (15 
mg, 0.025 mmol), 2, 4, 6-trimethylbenzoic acid (25 mg, 0.15 mmol), PPh3 (26 mg, 0.1 
mmol), K2CO3 (138 mg, 1 mmol), 1,4-dioxane (1.5 mL) and Hg (0.50 mmol, 100 mg). 
After stirring for 16 h, an aliquot was taken and then analysed via 1H NMR, which showed 
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5.6 – Synthesis of carbazole and tryptamine substrates for testing 
5.6.1 – Synthesis of N-(2-(1H-indol-3-yl)ethyl)pyrimidin-2-amine, 2a 
 
To a 50 mL round-bottomed flask, charged with magnetic stirrer bar was added: 
tryptamine (5 mmol, 801 mg), 2-chloropyrimidine (5 mmol, 573 mg), KF (10 mmol, 581 
mg) and water (5 mL). A condenser was then attached, and the reaction refluxed at 100 
°C for 16 hours. After allowing to cool back to room temperature, NaHCO3 (sat.) (aq.) 
(120 mL) was added to quench the reaction and the product extracted with EtOAc (3 × 80 
mL). The combined organic extracts were then dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure to yield crude product. This was then purified by 
flash chromatography (20% EtOAc/hexanes) to yield the title compound as a pale yellow 
crystalline solid, 2a, 61% (725 mg).  
1H NMR (500 MHz, CDCl3): δ 8.29 (2H, d, J = 4.8 Hz, C(15)-H, C(17)-H), 8.01 (1H, s, 
N(12)-H), 7.66 (1H, dd, J = 8.0, 1.0 Hz, C(4)-H), 7.35 (1H, d, J = 8.2 Hz, C(7)-H), 7.21 
(1H, ddd, J = 8.2, 7.0, 1.0, C(6)-H), 7.13 (1H, ddd, J = 8.0, 7.0, 1.0 Hz, C(5)-H), 7.03 
(1H, d, J = 2.3 Hz, C(1)-H), 6.54 (1H, t, J = 4.8 Hz, C(16)-H), 5.56 (1H, s, N(9)-H), 3.78 
(2H, td, J = 6.8, 5.8 Hz, C(11)-H), 3.10 (2H, td, J = 6.9, 0.9 Hz, C(10)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 162.3 (ArC), 158.0 (ArCH), 136.4 (ArC), 127.4 
(ArC), 122.1 (ArCH), 122.0 (ArCH), 119.4 (ArCH), 118.8 (ArCH), 113.2 (ArC), 111.2 
(ArCH), 110.5 (ArCH), 41.5 (NH-CH2-CH2), 25.3 (NH-CH2-CH2). 
Melting Point: 164 – 166 °C.  
This data is in accordance with literature precedent.12 
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5.6.2 – Synthesis of N-(2-(1H-indol-3-yl)ethyl)-5-chloropyrimidin-2-amine, 2b 
 
To a 50 mL round-bottomed flask, charged with magnetic stirrer bar was added: 
tryptamine (5 mmol, 801 mg), 2,5-dichloropyrimidine (5 mmol, 745 mg), KF (10 mmol, 
581 mg) and water (5 mL). A condenser was then attached, and the reaction refluxed at 
100 °C for 16 hours. After allowing to cool back to room temperature, NaHCO3 (sat.) (aq.) 
(120 mL) was added to quench the reaction and the product extracted with EtOAc (3 × 80 
mL). The combined organic extracts were then dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure to yield crude product. This was then purified by 
flash chromatography (20% EtOAc/hexanes) to yield the title compound as a pale 
pink/red crystalline solid, 2b, 53% (722 mg).  
1H NMR (500 MHz, CDCl3): δ 8.23 (2H, s, C(15)-H, C(17)-H), 8.02 (1H, s, N(12)-H), 
7.64 (1H, d, J = 7.8 Hz, C(4)-H), 7.38 (1H, d, J = 8.1 Hz, C(7)-H), 7.21 (1H, ddd, J = 8.1, 
7.0, 1.1 Hz, C(6)-H), 7.13 (1H, ddd, J = 8.1, 7.0, 1.1 Hz, C(5)-H), 7.03 (1H, d, J = 2.3 Hz, 
C(1)-H), 3.77 (2H, q, J = 6.6 Hz, C(11)-H), 3.09 (2H, td, J = 6.6, 0.8 Hz, C(10)-H). 
13C{1H} NMR (126 MHz, CDCl3): δ 160.6 (ArC), 156.2 (2C, ArCH), 136.4 (ArC), 127.3 
(ArC), 122.2 (ArCH), 122.0 (ArCH), 119.5 (ArC), 118.8 (ArCH), 118.7 (ArCH), 113.1 
(ArC), 111.2 (ArCH), 41.8 (NH-CH2-CH2), 25.2 (NH-CH2-CH2). 
HR-MS (ESI) m/z: calculated for C14H13N4Cl requires 273.0902 for [M+H]
+ found 
273.0896.  
FTIR (thin film): νmax = 3262, 3121, 2919, 2873, 2853, 1918, 1877, 1603, 1570, 1478, 
1441, 1384, 1352 cm-1. 
Melting Point: 156 – 157 °C. 
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5.6.3 – Synthesis of 2-(1H-indol-3-yl)-N-(pyridin-2-ylmethyl)ethan-1-ammonium 
chloride, 2c 
 
To a 100 mL round bottomed flask was added: tryptamine (10 mmol, 1.60 g), 2-
formylpyridine (10.5 mmol,  1.125 g) and MeOH (10 mL). This mixture was allowed to 
stir for 10 minutes, before adding NaBH4 (10.5 mmol, 397 mg) in one portion. The 
reaction was then left to stir at room temperature for 4 hours, before the addition of 6 M 
HCl (aq.) (20 mL). The reaction mixture was then evaporated to dryness under reduced 
pressure. The remaining residue was redissolved in H2O (20 mL) and washed with CHCl3 
(3 × 15 mL), and the aqueous layer then basified by addition of sat. NaHCO3 (aq.) before 
then washing again with CHCl3 (3 × 20 mL). The combined organic extracts were then 
dried over MgSO4, filtered and concentrated under reduced pressure to yield a pale-yellow 
oil. This was then purified by first adding HCl/EtOH to precipitate out a solid, which was 
then collected by vacuum filtration. This was then recrystallised from hot methanol to 
yield the title compound as a dark brown crystalline solid, 2c, 86% (2.46 g).  
1H NMR (500 MHz, D2O): δ 8.64 (1H, d, J = 4.7 Hz, C(18)-H), 8.28 (1H, td, J =7.4, 3.6 
Hz, C(16)-H), 7.79 (2H, d, J = 7.4 Hz, C(15)-H, C(17)-H), 7.62 – 7.59 (1H, m, C(4)-H), 
7.53 (1H, d, J = 8.2 Hz, C(7)-H), 7.32 (1H, s, C(1)-H), 7.28 (1H, dd, J = 8.2, 6.9 Hz, C(6)-
H), 7.17 (1H, dd, J = 8.2, 6.9 Hz, C(5)-H), 4.54 (2H, s, C(13)-H), 3.54–3.51 (2H, t, J = 
7.1 Hz, C(11)-H), 3.26 (2H, t, J = 7.1 Hz, C(10)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 146.4 (ArC), 145.4 (ArCH), 143.7 (ArCH), 136.3 
(ArC), 126.5 (ArC) 126.4 (ArCH), 124.3 (ArCH), 122.2 (ArCH), 119.4 (ArCH), 118.1 
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Melting Point: 107 – 109 °C. 
This data is in accordance with literature precedent.13 
5.6.4 – Synthesis of 3-((2-(1H-indol-3-yl)ethyl)amino)propanenitrile, 2d 
 
To an oven dried 50 mL round bottomed flask charged with magnetic stirrer was added: 
tryptamine (10 mmol, 1.60 g) and acrylonitrile (24 mL). A reflux condenser was then 
attached, and the reaction heated at 80 °C for 16 h. After this time the reaction mixture 
was concentrated under reduced pressure and the residue redissolved in Et2O (50 mL) and 
then HCl in EtOH (50 mL) was added to precipitate the desired product. This precipitate 
was collected by vacuum filtration and watched with several portions of Et2O (3 × 40 
mL). The precipitate was then recrystallised from hot EtOH to yield the title compound 
as an off white crystalline solid, 2d, 64% (1.37 g). 
1H NMR (500 MHz, D2O): δ 7.57 (1H, d, J = 7.9 Hz, C(4)-H), 7.42 (1H, d, J = 8.2 Hz, 
C(7)-H), 7.21 (1H, s, C(1)-H), 7.17 (1H, ddd, J = 8.2, 7.0, 1.2 Hz, C(6)-H), 7.08 (1H, ddd, 
J = 8.2, 7.0, 1.2 Hz, C(5)-H), 3.33 (2H, t, J = 7.2 Hz, C(14)-H), 3.30 (2H, t, J = 6.8 Hz, 
C(11)-H), 3.11 (2H, t, J = 7.2 Hz, C(13)-H), 2.84 (2H, t, J = 6.8 Hz, C(10)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 136.3 (Ar-C), 126.2 (Ar-C), 124.2 (Ar-C), 122.2 
(Ar-C), 119.4 (Ar-C), 118.1 (Ar-C), 117.4 (C≡N), 112.0 (Ar-C), 108.5 (Ar-C), 47.9 (NH-
CH2-CH2-ArC), 42.5 (CH2-CH2-CN), 21.4 (NH-CH2-CH2-ArC), 14.6 (CH2-CH2-CN). 
HR-MS (ESI) m/z: calculated for C13H15N3 requires 214.1339 for [M+H]
+ found 
214.1347.  
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Melting Point: 193 – 195 °C.  
5.6.5 – Synthesis of 9-(pyrimidin-2-yl)-9H-carbazole, 2e 
 
To a 50 mL oven dried round bottomed flask charged with magnetic stirrer was added 
9H-carbazole (10 mmol, 1.670 g) and DMF (10 mL). The reaction was then cooled to 0 
°C and NaH added to the suspension (60 wt.% in H2O, 11 mmol, 430 mg) and the reaction 
stirred at this temperature for a further hour. After this time 2-chloropyrimidine (12 mmol, 
1.380 g) was added in one portion to the flask. A reflux condenser was then fitted, and the 
reaction heated at 150 °C for 16 h. After allowing to cool back to room temperature after 
this time the reaction was poured into brine (150 mL) and the product then extracted with 
EtOAc (3 × 150 mL). The combined organic phases were then dried over MgSO4, filtered 
and concentrated under reduced pressure to yield crude product. This was then purified 
by flash chromatography (1% EtOAc/hexanes → 10% EtOAc/hexanes), the product 
containing fractions were then concentrated under reduced pressure and the residue 
recrystallised from hot EtOH. This yielded the title compound as a white, needle like 
crystalline solid, 2e, 36% (881 mg).  
1H NMR (500 MHz, CDCl3): δ 8.86 (2H, d, J = 8.5 Hz, C(5)-H, C(8)-H), 8.84 (2H, d, J 
= 4.8 Hz, C(14)-H, C(16)-H), 8.09 (2H, dd, J = 7.8, 0.8 Hz, C(2)-H, C(11)-H), 7.52 (2H, 
ddd, J = 8.5, 7.2, 1.4 Hz, C(4)-H, C(9)-H), 7.40–7.36 (2H, m, C(3)-H, C(10)-H), 7.12 
(1H, t, J = 4.8 Hz, C(15)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 159.2 (ArC), 157.9 (2C, ArCH), 139.2 (2C, ArC), 
126.6 (2C, ArCH), 125.8 (2C, ArCH), 122.3 (2C, ArC), 119.5 (ArCH), 116.2 (2C, ArC), 
116.0 (2C, ArCH).  
Melting Point: 157 – 159 °C.  
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This data is in accordance with literature precedent.10 
5.6.6 – Synthesis of 9-(pyridin-2-yl)-9H-carbazole, 2f 
 
To a 100 mL round bottomed flask, charged with magnetic stirrer bar was added the 
following: N-phenylpyridin-2-amine (85 mg, 0.50 mmol), potassium 
phenyltrifluoroborate (368 mg, 2.0 mmol), palladium (ii) acetate (11 mg, 0.05 mmol), 
silver acetate (250 mg, 1.5 mmol), benzoquinone (54 mg, 0.5 mmol), DMSO (0.14 mL, 
2.0 mmol) and 1,4-Dioxane (50 mL). A reflux condenser was then attached to the flask 
and the reaction heated at 140 °C for 2 days under air. After allowing to cool to room 
temperature, the reaction was filtered through a short pad of celite, eluting with DCM. 
The filtrate was then washed with water (3 × 30 mL) and the combined aqueous layers 
washed with DCM (3 × 30 mL). All the combined organic layers were then dried over 
MgSO4, filtered and concentrated under reduced pressure to yield crude product. This was 
then purified by flash chromatography (hexanes → 0.5% EtOAc/hexanes →1% 
EtOAc/hexanes) to yield the title compound as a pale-yellow oil, 2f, 54% (66 mg).  
1H NMR (500 MHz, CDCl3): δ 8.74 (1H, dd, J = 4.9, 2.0, 0.8 Hz, C(5)-H), 8.13 (2H, d, 
J = 7.8 Hz, C(10)-H, C(13)-H), 7.93 (1H, td, J = 7.8, 2.0 Hz, C(3)-H), 7.85 (2H, dd, J = 
8.2, 0.8 Hz, C(7)-H, C(16)-H), 7.65 (1H, d, J = 8.2 Hz, C(2)-H), 7.46–7.43 (2H, m, C(9)-
H, C(14)-H), 7.35–7.29 (3H, m, C(4)-H, C(8)-H, C(15)-H). 
13C{1H} NMR (126 MHz, CDCl3): δ 151.9 (ArC), 149.8 (ArCH), 139.5 (ArCH), 138.2 
(2C, ArC), 126.3 (2C, ArCH), 124.3 (2C, ArCH), 121.4 (2C, ArCH), 120.9 (ArCH), 120.1 
(2C, ArCH), 118.9 (2C, ArCH), 111.0 (ArCH). 
This data is in accordance with literature precedent.9 
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5.7 – Optimisation for the C-4 alkylation of 9-(pyrimidin-2-yl)-9H-
carabazoles 
 
Proton NMR conversions were taken from the labelled diagnostic protons. No other 
observable by-products were formed during the reaction and no observed starting material 
decompositions led to 1H NMR conversions being indicative of yield of alkylated product.  
Entry Ruthenium  
Catalyst 
Base Acid Acid Eq. Solvent Conversion (%) 
(IY) 
1 [RuCl2(p-cymene)]2 KOAc AcOH 2 1,4-Dioxane 68 (48) 
2 [RuCl2(benzene)]2 KOAc AcOH 2 1,4-Dioxane < 5 
3 RuCl3·xH2O KOAc AcOH 2 1,4-Dioxane 0 
4 RuCl2(PPh3)3 KOAc AcOH 2 1,4-Dioxane 11 
5 [Ru(1,10-phen)3]·2Cl- KOAc AcOH 2 1,4-Dioxane 0 
6 [Ru(OAc)2(p-cymene)] KOAc AcOH 2 1,4-Dioxane 63 (36) 
7 [Ru(O2CAd)2(p-cymene)] KOAc AcOH 2 1,4-Dioxane 21 
8 [RuCl(OAc)(p-cymene)] KOAc AcOH 2 1,4-Dioxane 52 (30) 
9 [RuCl2(p-cymene)]2 K2CO3 AcOH 2 1,4-Dioxane 0 
10 [RuCl2(p-cymene)]2 K3Citrate AcOH 2 1,4-Dioxane 45 
11 [RuCl2(p-cymene)]2 K2Oxalate AcOH 2 1,4-Dioxane 0 
12 [RuCl2(p-cymene)]2 K2Tartrate AcOH 2 1,4-Dioxane 5 
13 [RuCl2(p-cymene)]2 KHCO2 AcOH 2 1,4-Dioxane 25 
14 [RuCl2(p-cymene)]2 Piv-Val-OH AcOH 2 1,4-Dioxane < 5 
15 [RuCl2(p-cymene)]2 NaCO2Ad AcOH 2 1,4-Dioxane 58 
16 [RuCl2(p-cymene)]2 KCO2Mes AcOH 2 1,4-Dioxane 71 (54) 
17 [RuCl2(p-cymene)]2 KCO2Mes MesCO2H 2 1,4-Dioxane 64 (51) 
18 [RuCl2(p-cymene)]2 KCO2Mes AdCO2H 2 1,4-Dioxane 66 (50) 
19 [RuCl2(p-cymene)]2 KCO2Mes HCl 2 1,4-Dioxane 17 
20 [RuCl2(p-cymene)]2 KCO2Mes TFA 2 1,4-Dioxane 15 
21 [RuCl2(p-cymene)]2 KCO2Mes HCO2H 2 1,4-Dioxane 34 
22 [RuCl2(p-cymene)]2 KCO2Mes AcOH 2 2-MeTHF 55 
23 [RuCl2(p-cymene)]2 KCO2Mes AcOH 2 Toluene 0 
24 [RuCl2(p-cymene)]2 KCO2Mes AcOH 2 MeCN 72(55) 
25 [RuCl2(p-cymene)]2 KCO2Mes AcOH 2 Benzene 39 
26 [RuCl2(p-cymene)]2 KCO2Mes AcOH 2 AcOH 31 
27 [RuCl2(p-cymene)]2 KCO2Mes AcOH 2 2-Butanone 55 
28 [RuCl2(p-cymene)]2 KCO2Mes AcOH 2 DME 49 
29 [RuCl2(p-cymene)]2 KCO2Mes AcOH 2 DCE 38 
30 [RuCl2(p-cymene)]2 KCO2Mes AcOH 0.5 1,4-Dioxane 80 
31 [RuCl2(p-cymene)]2 KCO2Mes AcOH 1 1,4-Dioxane 84 (68) 
32 [RuCl2(p-cymene)]2 KCO2Mes AcOH 4 1,4-Dioxane 68 
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33 [RuCl2(p-cymene)]2 KCO2Mes AcOH 8 1,4-Dioxane < 5 
34 [RuCl2(p-cymene)]2 KCO2Mes – – 1,4-Dioxane 53 
351  [Ru(CO2Mes)2(p-cymene)] KCO2Mes AcOH 1 1,4-Dioxane 91 (76) 
362 [RuCl2(p-cymene)]2 KCO2Mes AcOH 1 1,4-Dioxane 61 
1 – 10 mol.% [Ru] 2 –100 °C 
5.8 - Scope of Ruthenium Catalysed C-4 C-H Alkylation of Carbazole 
Substrates 
5.8.1 – General Procedure C for the synthesis of methyl 2-methyl-2-(9-(pyrimidin-
2-yl)-9H-carbazol-4-yl)alkylate substrates  
 
To an oven-dried carousel tube was charged with the relevant carbazole derivative (0.25 
mmol), [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) or [RuCl2(p-cymene)]2 (8 mg, 
0.0125 mmol) and potassium 2,4,6-trimethylbenzoate (102 mg, 0.5 mmol). The reaction 
vessel was then sealed with a Teflon cap and  1,4-dioxane (1 mL), acetic acid (0.02 mL, 
0.25 mmol), and the relevant coupling partner (0.75 mmol) were then added via syringe 
to the vessel. The reaction was then heated to 120 °C and refluxed for 16 h. After this time 
the reaction was allowed to cool to ambient temperature, before diluting with EtOAc (20 
mL) and NaHCO3 (sat) (aq.) (20 mL). The organic layer was then extracted and the 
aqueous layer then washed with further EtOAc (2 × 20 mL). The combined organic layers 
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were then dried over anhydrous MgSO4, filtered and then concentrated in vacuo. The 
crude residue was then dry loaded onto silica and purified by flash chromatography (40-
60 Petroleum ether/Ethyl acetate), to yield pure C4-alkylated structures.  
5.8.2 – Synthesis of ethyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbazol-4-
yl)propanoate, 2.1 
 
General procedure C was followed using the following compounds: 9-(pyrimidin-2-yl)-
9H-carbazole (2e) (61 mg, 0.25 mmol), [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) 
and ethyl 2-bromo-2-methylpropanoate (0.12 mL, 0.75 mmol). Column chromatography 
(1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a white solid, 2.1, 76% 
(68 mg).  
*When [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol) was used instead of [Ru(CO2Mes)2(p-
cymene)], the title compound was obtained as a white solid, 68% (61 mg). 
1H NMR (500 MHz, CDCl3): δ 8.87 (2H, d, J = 4.8 Hz, C(14)-H, C(16)-H), 8.69 (2H, d, 
J = 8.4 Hz, C(2)-H, C(11)-H), 8.02 (1H, d, J = 8.1 Hz, C(8)-H), 7.48–7.44 (3H, m, C(4)-
H, C(9)-H, C(10)-H), 7.34–7.32 (1H,  m, C(3)-H), 7.17 (1H, t, J = 4.8 Hz, C(15)-H), 4.04 
(2H, q, J = 7.1 Hz, C(21)-H), 1.88 (6H, s, C(18)-H, C(19)-H), 0.95 (3H, t, J = 7.1 Hz, 
C(22)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 178.3 (C=O), 158.7 (ArC), 158.0 (ArCH), 140.0 
(ArCH), 139.5 (ArC), 139.0 (ArC), 126.0 (ArCH), 125.7 (ArCH), 124.5 (ArCH), 123.5 
(ArCH), 123.2 (ArCH), 121.8 (ArC), 119.5 (ArC), 116.7 (ArCH), 114.4 (ArCH), 113.7 
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HR-MS (ESI) m/z: calculated for C22H21N3O2 requires 360.1707 for [M+H]
+ found 
360.1715. 
FTIR (thin film): νmax = 3040, 2983, 2874, 2164, 1725, 1580, 1564, 1427 cm
-1.  
Melting Point: 130 – 133 °C. 
5.8.3 – Synthesis of methyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbozol-4-
yl)propanoate, 2.2 
 
General procedure C was followed using the following compounds: 9-(pyrimidin-2-yl)-
9H-carbazole (2e) (61 mg, 0.25 mmol), [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol) and 
methyl 2-bromo-2-methylpropanoate (0.10 mL, 0.75 mmol). Column chromatography 
(1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a white solid, 2.2, 70% 
(60 mg).  
*When [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) was used instead of [RuCl2(p-
cymene)]2, the title compound was obtained as a white solid, 65% (56 mg). 
1H NMR (500 MHz, CDCl3): δ 8.85 (2H, d, J = 4.8 Hz, C(14)-H, C(16)-H), 8.74–8.66 
(2H, m, C(2)-H, C(11)-H), 7.54–7.45 (1H, m, C(8)-H), 7.45–7.41 (2H, m, C(3)-H, C(10)-
H), 7.38–7.32 (1H, m, C(4)-H), 7.23 (1H, ddd, J = 7.9, 6.5, 1.9 Hz, C(9)-H), 7.14 (1H, t, 
J = 4.8 Hz, C(15)-H), 3.53 (3H, s, C(21)-H), 1.91 (6H, s, C(18)-H, C(19)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 179.1 (C=O), 158.8 (ArC), 158.2 (ArCH), 140.1 
(ArCH), 139.5 (ArC), 139.1 (ArC), 126.1 (ArCH), 125.9 (ArCH), 124.6 (ArCH), 123.3 
(ArCH), 123.2 (ArCH), 122.1 (ArC), 119.5 (ArC), 116.9 (ArCH), 114.6 (ArCH), 114.0 
(ArC), 52.7 (O-CH3), 47.1 ((C=O)-C-(CH3)2), 27.2 ((C=O)-C-(CH3)2).  
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HR-MS (ESI) m/z: calculated for C21H19N3O2 requires 346.1550 for [M+H]
+ found 
346.1583. 
FTIR (thin film): νmax = 2981, 1726, 1561 cm
-1. 
Melting Point: 162 – 165 °C. 
5.8.4 – Synthesis of tert-butyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbazol-4-
yl)propanoate, 2.3 
 
General procedure C was followed using the following compounds: 9-(pyrimidin-2-yl)-
9H-carbazole (2e) (61 mg, 0.25 mmol), [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) 
and tert-butyl 2-bromo-2-methylpropanoate (0.14 mL, 0.75 mmol). Column 
chromatography (1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a 
white solid, 2.3, 92% (89 mg).  
*When [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol) was used instead of [Ru(CO2Mes)2(p-
cymene)], the title compound was obtained as a white solid, 72% (70 mg). 
1H NMR (500 MHz, CDCl3): δ 8.84 (2H, d, J = 4.8 Hz, C(14)-H, C(16)-H), 8.72–8.63 
(2H, m, C(2)-H, C(11)-H), 8.18–8.15 (1H, m, C(8)-H), 7.50–7.43 (2H, m, C(3)-H, C(10)-
H), 7.40 (1H, dd, J = 7.7, 1.0 Hz, C(9)-H), 7.36–7.31 (1H, m, C(4)-H), 7.13 (1H, t, J = 
4.8 Hz, C(15)-H), 1.89 (6H, s, C(18)-H, C(19)-H), 1.27 (9H, s, C(22)-H, C(23)-H, C(24)-
H).  
13C{1H} NMR (126 MHz, CDCl3): δ 177.2 (C=O), 158.8 (ArC), 158.1 (ArCH), 140.1 
(2C, ArCH), 139.1 (ArC), 126.0 (ArC), 125.8 (ArCH), 124.6 (ArCH), 124.5 (ArCH), 
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123.3 (ArCH), 121.7 (ArC), 119.7 (ArC), 116.7 (ArCH), 114.4 (ArCH), 113.6 (ArC), 80.9 
(O-C(CH3)3), 47.8 ((C=O)-C(CH3)2-), 27.8 (-CH3), 26.9 (-CH3).  
HR-MS (ESI) m/z: calculated for C24H25N3O2 requires 388.1947 for [M+H]
+ found 
388.2069. 
FTIR (thin film): νmax = 2981, 1717, 1561 cm
-1. 
Melting Point: 180 – 183 °C.  
5.8.5 – Synthesis of benzyl 2-methyl-2-(9-pyrimidin-2-yl)-9H-carbazol-4-
yl)propanoate, 2.4 
  
General procedure C was followed using the following compounds: 9-(pyrimidin-2-yl)-
9H-carbazole (2e) (61 mg, 0.25 mmol), [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) 
and benzyl 2-bromo-2-methylpropanoate (0.13 mL, 0.75 mmol). Column 
chromatography (1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a 
white solid, 2.4, 74% (78 mg).  
*When [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol) was used instead of [Ru(CO2Mes)2(p-
cymene)], the title compound was obtained as a white solid, 51% (54 mg). 
1H NMR (500 MHz, CDCl3): δ 8.88 (2H, d, J = 4.8 Hz, C(14)-H, C(16)-H), 8.69 (2H, dd, 
J =8.3, 1.1 Hz, C(2)-H, C(11)-H), 7.96 (1H, ddd, J = 8.3, 1.1, 0.6 Hz, C(8)-H), 7.48 (1H, 
dd, J = 8.3, 7.6 Hz, C(3)-H), 7.43–7.40 (1H, m, C(10)-H), 7.22–7.15 (5H, m, C(23-27)-
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13C{1H} NMR (126 MHz, CDCl3): δ 178.4 (C=O), 163.5 (ArC), 158.4 (ArCH), 139.6 
(ArC), 139.1 (ArC), 128.6 (ArCH), 128.2 (ArCH), 126.4 (ArCH), 126.0 (ArC), 125.9 
(ArC), 124.8 (ArCH), 123.6 (ArCH), 123.5 (ArCH), 122.3 (ArC), 119.9 (ArCH), 117.1 
(ArCH), 114.8 (ArCH), 114.2 (ArC), 67.2 (O-CH2-Ar), 47.4 ((C=O)-C(CH3)2), 27.4 
((C=O)-C(CH3)2). 
HR-MS (ESI) m/z: calculated for C27H23N3O2 requires 422.1870 for [M+H]
+ found 
422.1943. 
FTIR (thin film): νmax = 2968, 1718, 1583, 1563 cm
-1.  
Melting Point: 112 – 116 °C. 
5.8.6 – Synthesis of cyclohexyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-carbazol-4-
yl)propanoate, 2.5 
 
General procedure C was followed using the following compounds: 9-(pyrimidin-2-yl)-
9H-carbazole (2e) (61 mg, 0.25 mmol), [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) 
and cyclohexyl 2-bromo-2-methylpropanoate (147 mg, 0.75 mmol). Column 
chromatography (1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a 
colourless solid, 2.5, 74% (76 mg).  
*When [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol) was used instead of [Ru(CO2Mes)2(p-
cymene)], the title compound was obtained as a colourless solid, 54% (55 mg). 
1H NMR (500 MHz, CDCl3): δ 8.88 (2H, d, J = 4.8 Hz, C(14)-H, C(16)-H), 8.68 (2H, 
ddd, J = 8.2, 3.4, 1.1 Hz, C(2)-H, C(11)-H), 8.05 (1H, dd, J = 8.2, 1.1 Hz, C(8)-H), 7.49–
7.44 (1H, m, C(10)-H), 7.43–7.39 (1H, m, C(3)-H), 7.30 (1H, ddd, J = 8.2, 7.2, 1.1 Hz, 
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C(9)-H), 7.14 (1H, s, C(4)-H), 4.81–4.73 (1H, m, C(21)-H), 1.87 (6H, s, C(18)-H, C(19)-
H), 1.56 (3H, broad, -CH2-), 1.45–1.32 (3H, m, -CH2-), 1.22–1.00 (4H, m, -CH2-).   
13C{1H} NMR (126 MHz, CDCl3): δ 178.2 (C=O), 163.3 (ArC), 158.2 (ArCH), 139.4 
(ArC), 135.9 (ArC), 128.4 (ArC), 128.0 (ArCH), 126.2 (ArCH),  125.8 (ArCH), 124.6 
(ArCH), 123.4 (ArCH), 122.1 (ArCH), 119.7 (ArCH), 116.9 (ArCH), 114.6 (ArCH), 
114.0 (ArC), 67.0 (O-CH-CH2), 47.2((C=O)-C-(CH3)2), 27.2 ((C=O)-C-(CH3)2), 27.1 
(CH2), 25.3 (CH2), 24.6 (CH2). 
HR-MS (ESI) m/z: calculated for C26H27N3O2 requires 436.1995 for [M+Na]
+ found 
436.2027. 
FTIR (thin film): νmax = 2929, 2855, 1718, 1570 cm
-1.  
5.8.7 – Synthesis of methyl 1-(9-(pyrimidin-2-yl)-9H-carbazol-4-yl)cyclohexane-1-
carboxylate, 2.6 
 
General procedure C was followed using the following compounds: 9-(pyrimidin-2-yl)-
9H-carbazole (2e) (61 mg, 0.25 mmol), [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) 
and methyl 1-bromocyclohexane-1-carboxylate (0.75 mmol, 0.12 mL). Column 
chromatography (1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a 
white solid, 2.6, 42% (40 mg).  
*When [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol) was used instead of [Ru(CO2Mes)2(p-
cymene)], the title compound was obtained as a white solid, 35% (33 mg). 
1H NMR (500 MHz, CDCl3): δ 8.89 (2H, d, J = 4.8 Hz, C(14)-H, C(16)-H), 8.66–8.61 
(2H, m, C(2)-H, C(11)-H), 8.10–8.06 (1H, m, C(8)-H), 7.52–7.46 (2H, m, C(3)-H, C(10)-
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H), 7.45 (1H, ddd, J = 8.4, 7.1, 1.2 Hz, C(9)-H), 7.43–7.41 (1H, m, C(4)-H), 7.20 (1H, t, 
J = 4.8 Hz, C(15)-H), 3.49 (3H, s, C(27)-H), 2.48 (5H, s, C(20)-H, C(21)-H, C(25)-H), 
1.81 (4H, s, C(22)-H, C(24)-H), 1.26 (2H, s, C(23)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 178.6 (C=O), 158.3 (ArC), 140.5 (ArCH), 139.1 
(ArC), 138.5 (ArC), 125.9 (ArC), 125.8 (ArC), 124.7 (ArCH), 124.2 (ArCH), 123.4 
(ArCH), 122.0 (ArCH), 121.9 (ArCH), 117.0 (ArCH), 114.3 (ArCH), 113.5 (ArC), 52.5 
(O-CH3), 50.9 ((C=O)-CH-), 34.0 (-CH2-), 25.9 (-CH2-), 22.8 (-CH2-). 
HR-MS (ESI) m/z: calculated for C24H23N3O2 requires 386.1870 for [M+H]
+ found 
386.1922.  
FTIR (thin film): νmax = 2955, 2932, 2362, 2165, 2034, 1718, 1560 cm
-1.  
Melting Point: 182 – 185 °C. 
5.8.8 – Synthesis of (perfluorophenyl) methyl 2-methyl-2-(9-(pyrimidin-2-yl)-9H-
carbazol-4-yl) propanoate, 2.9 
 
General procedure C was followed using the following compounds: 9-(pyrimidin-2-yl)-
9H-carbazole (2e) (61 mg, 0.25 mmol), [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol) and 
(perfluorophenyl) methyl 2-bromo-2-methyl propanoate (260 mg, 0.75 mmol). Column 
chromatography (1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a 
white solid, 2.7, 41% (52 mg).  
*When [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) was used instead of [RuCl2(p-
cymene)]2, the title compound was obtained as a white solid, 39% (50 mg). 
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1H NMR (500 MHz, CDCl3): δ 8.88 (2H, d, J = 4.8 Hz, C(14)-H, C(16)-H), 8.69 (2H, dd, 
J = 10.8, 8.4 Hz, C(2)-H, C(11)-H), 7.78 (1H, d, J = 8.1 Hz, C(8)-H), 7.49 (1H, t, J = 8.0 
Hz, C(10)-H), 7.43–7.38 (1H, m, C(3)-H), 7.18 (1H, t, J = 4.8 Hz, C(15)-H), 7.12 (1H, t, 
J = 8.4 Hz, C(4)-H), 5.06 (2H, s, C(21)-H), 1.89 (6H, s, C(18)-H, C(19)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 177.8 (C=O), 158.8 (ArC), 158.2 (ArC), 145.5 (ddd, 
J = 251.3, 11.3, 7.7, 4.0 Hz, C(24/26)), 143.0 – 140.2 (m, ArFC), 140.1 (ArC), 139.0 
(ArC), 138.8 (ArC), 138.4 – 135.7 (m, ArFC), 126.3 (ArC), 125.6 (ArC), 124.1 (ArC), 
123.0 (ArC), 122.9 (ArC), 121.5 (ArC), 119.5 (ArC), 116.9 (ArC), 114.7 (ArC), 114.2 
(ArC), 109.2 (td, J = 17.5, 3.7 Hz, C(22)), 53.9 (O-CH2-ArF), 47.1 ((C=O)-C(CH3)2), 29.8 
((C=O)-C(CH3)2). 
19F NMR (470 MHz, CDCl3): δ -141.85 (2F, dd, J = 22.4, 8.3 Hz, C(23)-F, C(27)-F), -
153.06 (1F, s, C(25)-F), -161.99 (2F, m, C(24)-F, C(26)-F).  
HR-MS (ESI) m/z: calculated for C27H18F5N3O2 requires 512.1392 for [M+H]
+ found 
512.1426.  
FTIR (thin film): νmax = 2959, 1742, 1661, 1570, 1509 cm
-1. 
Melting Point: 165 – 168 °C. 
5.8.9 – Synthesis of methyl 2-(6-bromo-9-(pyrimidin-2-yl)-9H-carbazol-4-yl)-2-
methylpropanoate, 2.10 
 
General procedure C was followed using the following compounds: 3-bromo-9-
(pyrimidin-2-yl)-9H-carbazole (81 mg, 0.25 mmol), [RuCl2(p-cymene)]2 (8 mg, 0.0125 
mmol) and methyl 2-bromo-2-methylpropanoate (0.10 mL, 0.75 mmol). Column 
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chromatography (1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a 
white solid, 2.7, 54% (57 mg).  
*When [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) was used instead of [RuCl2(p-
cymene)]2, the title compound was obtained as a white solid, 49% (52 mg). 
1H NMR (500 MHz, CDCl3): δ 8.81 (2H, d, J = 4.8 Hz, C(14)-H, C(16)-H), 8.71 (1H, dd, 
J = 8.4, 1.0 Hz, C(2)-H), 8.62 (1H, d, J = 8.9 Hz, C(11)-H), 8.09 (1H, d, J = 1.9 Hz, C(8)-
H), 7.55 (1H, dd, J = 8.9, 1.9 Hz, C(10)-H), 7.52 (1H, dd, J = 8.4, 7.6 Hz, C(3)-H), 7.43 
(1H, dd, J = 7.6, 1.0 Hz, C(4)-H), 7.14 (1H, t, J = 4.8 Hz, C(15)-H), 3.68 (3H, s, C(21)-
H), 1.89 (6H, s, C(18)-H, C(19)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 178.3 (C=O), 158.5 (ArC), 158.2 (ArCH), 140.5 
(ArC), 139.8 (ArC), 137.8 (ArCH), 128.4 (ArCH), 126.9 (ArC), 126.4 (ArCH), 125.7 
(ArCH), 122.1 (ArC), 119.8 (ArCH), 117.0 (ArCH), 116.4 (ArCH), 115.0 (ArC), 114.4 
(ArC), 52.6 (O-CH3), 47.1 ((C=O)-C(CH3)2), 27.1 ((C=O)-C(CH3)2). 
HR-MS (ESI) m/z: calculated for C21H18N3O2Br requires 423.0482 for [M+Na]
+ found 
423.0554.  
FTIR (thin film): νmax = 2981, 1728, 1567 cm
-1. 
Melting Point: 183 – 185 °C. 
5.8.10 – Synthesis of methyl 2-(6-chloro-9-(pyrimidin-2-yl)-9H-carbazol-4-yl)-2-
methylpropanoate, 2.11 
 
General procedure C was followed using the following compounds: 3-bromo-9-
(pyrimidin-2-yl)-9H-carbazole (81 mg, 0.25 mmol), [RuCl2(p-cymene)]2 (8 mg, 0.0125 
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mmol) and methyl 2-bromo-2-methylpropanoate (0.10 mL, 0.75 mmol). Column 
chromatography (1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a 
white solid, 2.7, 60% (57 mg).  
*When [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) was used instead of [RuCl2(p-
cymene)]2, the title compound was obtained as a white solid, 71% (67 mg). 
1H NMR (500 MHz, CDCl3): δ 8.82 (2H, d, J = 4.8 Hz, C(14)-H, C(16)-H), 8.69 (2H, dd, 
J = 8.4, 1.0 Hz, C(2)-H, C(11)-H), 7.95 (1H, s, C(8)-H), 7.51 (1H, d, J = 8.4 Hz, C(10)-
H), 7.47–7.37 (2H, m, C(3)-H, C(10)-H), 7.14 (1H, d, J = 4.9 Hz, C(15)-H),  3.66 (3H, s, 
C(21)-H), 1.89 (6H, s, C(18)-H, C(19)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 178.3 (C=O), 158.5 (ArC), 158.2 (ArCH), 140.6 
(ArC), 139.7 (ArC), 137.5 (ArCH), 127.4 (ArCH), 126.9 (ArC), 125.8 (ArCH), 125.7 
(ArCH), 122.7 (ArC), 122.3 (ArCH), 119.8 (ArCH), 117.0 (ArCH), 116.0 (ArC), 114.4 
(ArC), 52.6 (O-CH3), 47.1 ((C=O)-C(CH3)2), 27.1 ((C=O)-C(CH3)2). 
HR-MS (ESI) m/z: calculated for C21H18N3O2Cl requires 402.0988 for [M+Na]
+ found 
402.0918.  
FTIR (thin film): νmax = 2981, 1728, 1567 cm
-1. 
Melting Point: 200 – 203 °C. 
5.8.11 – Synthesis of methyl 2-methyl-2-(3,6,8-trichloro-9-(pyrimidin-2-yl)-9H-
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General procedure C was followed using the following compounds: 1, 3, 6-trichloro-9-
(pyrimidin-2-yl)-9H-carbazole (87 mg, 0.25 mmol), [RuCl2(p-cymene)]2 (8 mg, 0.0125 
mmol) and methyl 2-bromo-2-methylpropanoate (0.10 mL, 0.75 mmol). Column 
chromatography (1% EtOAc→10% EtOAc/hexanes) yielded the title compound as a 
white solid, 2.7, 10% (11 mg).  
*When [Ru(CO2Mes)2(p-cymene)] (14 mg, 0.025 mmol) was used instead of [RuCl2(p-
cymene)]2, the title compound was obtained as a white solid, 7% (8 mg). 
1H NMR (500 MHz, CDCl3): δ 8.92 (2H, d, J = 4.9 Hz, C(14)-H, C(16)-H), 8.03 (1H, d, 
J = 1.8 Hz, C(8)-H), 7.59 (1H, d, J = 8.9 Hz, C(2)-H), 7.45–7.41 (2H, m, C(3)-H, C(10)-
H), 7.38 (1H, t, J = 4.9 Hz, C(15)-H), 3.63 (3H, s, C(21)-H), 2.08 (6H, s, C(18)-H, C(19)-
H).  
13C{1H} NMR (126 MHz, CDCl3): δ 178.2 (C=O), 158.9 (ArC), 158.0 (ArCH), 137.0 
(ArCH), 131.7 (2C, ArC), 127.7 (2C, ArC), 127.4 (ArC), 126.8 (2C, ArC), 123.9 (ArCH), 
122.8 (ArCH), 119.8 (ArCH), 119.2 (ArCH), 111.8 (ArC), 52.7 (O-CH3), 50.0 ((C=O)-
C(CH3)2), 27.8 ((C=O)-C(CH3)2). 
HR-MS (ESI) m/z: calculated for C21H18N3O2Cl3 requires 470.0200 for [M+Na]
+ found 
470.0162.  
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5.9 -  Mechanistic experiments for the C-4 alkylation of 9-
(pyrimidin-2-yl)-9H-carabazoles 
5.9.1 – Deuterium Labelling Experiment 
 
5.9.2 – TEMPO Experiments 
 
General procedure C was followed using the following compounds: 9-(pyrimidin-2-yl)-
9H-carbazole (2e) (61 mg, 0.25 mmol), [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol) and 
ethyl 2-bromo-2-methylpropanoate (0.12 mL, 0.75 mmol). To each reaction was then 
added TEMPO: 30 mol.% (0.075 mmol, 12 mg) and 100 mol.% (0.25 mmol, 39 mg).  
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Aliquots were then taken from each reaction and the conversion analysed via 1H NMR. 
Addition of 30 mol.% TEMPO gave a conversion of 66%, and the addition of 100 mol.% 
TEMPO gave a conversion of 15% to the C4 alkylated product.  
5.9.3 – Mercury Drop Test 
 
General procedure C was followed using the following compounds: 9-(pyrimidin-2-yl)-
9H-carbazole (2e) (61 mg, 0.25 mmol), [RuCl2(p-cymene)]2 (8 mg, 0.0125 mmol), ethyl 
2-bromo-2-methylpropanoate (0.12 mL, 0.75 mmol) and mercury (0.50 mmol, 100 mg).  
After reaction an aliquot was taken from the reaction vessel and analysed via 1H NMR 
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5.10 – para-Functionalisation of Aniline Derivatives 
5.10.1 – Optimisation for the para carboxylation of 5-chloro-N-phenylpyrimidin-2-
amine 
 
Proton NMR conversions were taken from the labelled diagnostic protons. No other 
observable by-products were observed during the reaction and no observed starting 
material decompositions lead to 1H NMR conversions being indicative of yield of 
alkylated product.  
Entry Catalyst loading 
 (mol.%) 
Solvent A Solvent B Solvent 
Ratio (a:b) 
Concentration (M) Conversion 
(%) (IY) 
1 RuCl3·xH2O (10) 1,4-Dioxane MeOH 1:1 0.17 34(20) 
2 [RuCl2(p-cymene)]2 (5) 1,4-Dioxane MeOH 1:1 0.17 20 
3 [Ru(CO2Mes)2(p-cymene)] (10) 1,4-Dioxane MeOH 1:1 0.17 0 
4 [Ru(CO2Ad)2(p-cymene)] (10) 1,4-Dioxane MeOH 1:1 0.17 13 
5 [Ru(OAc)2(p-cymene)] (10) 1,4-Dioxane MeOH 1:1 0.17 12 
6 [Fe(acac)3] (10) 1,4-Dioxane MeOH 1:1 0.17 19 
7 [Fe(NO3)3]·9H2O (10) 1,4-Dioxane MeOH 1:1 0.17 9 
8 [Fe(oxalate)3] (10) 1,4-Dioxane MeOH 1:1 0.17 16 
9 Fe2O3 (10) 1,4-Dioxane MeOH 1:1 0.17 29 (15) 
10 FeF3·3H2O (10) 1,4-Dioxane MeOH 1:1 0.17 <5 
11 FeBr3 (10) 1,4-Dioxane MeOH 1:1 0.17 <5 
12 FeCl3 (10) 1,4-Dioxane MeOH 1:1 0.17 33(23) 
13 FeCl3 (5) 1,4-Dioxane MeOH 1:1 0.17 37(18) 
14 FeCl3 (15) 1,4-Dioxane MeOH 1:1 0.17 26 
15 FeCl3 (20) 1,4-Dioxane MeOH 1:1 0.17 21 
16 FeCl3 (25) 1,4-Dioxane MeOH 1:1 0.17 18 
17 FeCl3 (30) 1,4-Dioxane MeOH 1:1 0.17 15 
18 FeCl3 (10) MeCN MeOH 1:1 0.17 0 
19 FeCl3 (10) DCE MeOH 1:1 0.17 <5 
20 FeCl3 (10) HFIP MeOH 1:1 0.17 17 
21 FeCl3 (10) 2-butanone MeOH 1:1 0.17 17 
22 FeCl3 (10) Ph-Me MeOH 1:1 0.17 17 
23 FeCl3 (10) TBME MeOH 1:1 0.17 0 
24 FeCl3 (10) 2-MeTHF MeOH 1:1 0.17 27(20) 
25 FeCl3 (10) H2O MeOH 1:1 0.17 0 
26 FeCl3 (10) DMA MeOH 1:1 0.17 0 
27 FeCl3 (10) 1,4-Dioxane MeOH 2:1 0.17 0 
28 FeCl3 (10) 1,4-Dioxane MeOH 4:1 0.17 0 
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29 FeCl3 (10) 1,4-Dioxane MeOH 5:1 0.17 0 
30 FeCl3 (10) 1,4-Dioxane MeOH 10:1 0.17 0 
31 FeCl3 (10) 1,4-Dioxane MeOH 1:2 0.17 25 
32 FeCl3 (10) 1,4-Dioxane MeOH 1:4 0.17 48(20) 
33 FeCl3 (10) 1,4-Dioxane MeOH 1:5 0.17 39(18) 
34 FeCl3 (10) 1,4-Dioxane MeOH 1:10 0.17 0 
35 FeCl3 (10) 1,4-Dioxane MeOH 1:1 1.0 <5 
36 FeCl3 (10) 1,4-Dioxane MeOH 1:1 0.50 44(23) 
37 FeCl3 (10) 1,4-Dioxane MeOH 1:1 0.25 10 
38 FeCl3 (10) 1,4-Dioxane MeOH 1:1 0.10 11 
39 FeCl3 (10) 1,4-Dioxane MeOH 1:1 0.01 <5 
40 ZnCl2 (10) 1,4-Dioxane MeOH 1:1 0.17 0 
41 AlCl3 (10) 1,4-Dioxane MeOH 1:1 0.17 0 
42 AgCl (10) 1,4-Dioxane MeOH 1:1 0.17 0 
43 Yb(OTf)(SO4) (10) 1,4-Dioxane MeOH 1:1 0.17 0 
44a FeCl3 (10) 1,4-Dioxane MeOH 1:1 0.17 <5 
45b FeCl3 (10) 1,4-Dioxane MeOH 1:1 0.17 14 
46c FeCl3 (10) 1,4-Dioxane MeOH 1:1 0.17 14 
47 - 1,4-Dioxane MeOH 1:1 0.50 <5 
a-90 °C, b-Reaction done under air, c-Reaction done under O2 atm.  
5.10.2 – Synthesis of 5-chloro-N-phenylpyrimidin-2-amine, 3a 
 
To a 1 L round-bottomed flask charged with magnetic stirrer bar was added the following: 
2,5-dichloropyrimidine (40 mmol, 5.96 g), aniline (60 mmol, 5.47 mL), AcOH (40 mL) 
and 1,4-dioxane (120 mL). A reflux condenser was then attached, and the reaction 
refluxed at 110 °C for 16 hours. After cooling to room temperature, the reaction mixture 
was concentrated under reduced pressure and the remaining residue redissolved in EtOAc 
(450 mL) and the solution washed with NaHCO3  (sat.) (aq.) (3 × 500 mL). The organic 
layer was then washed with brine (400 mL), dried over MgSO4, filtered and concentrated 
under reduced pressure to yield crude product. This was then purified by flash 
chromatography (1% EtOAc/hexanes → 5% EtOAc/hexanes → 10% EtOAc/hexanes). 
The product containing fractions were then recrystallised from hot EtOH to yield the title 
compound as a white crystalline solid, 3a, 36% (2.97 g). 
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1H NMR (500 MHz, CDCl3): δ 8.36 (2H, s, C(8)-H, C(10)-H), 7.58 (2H, dd, J = 8.6, 1.1 
Hz, C(1)-H, C(5)-H), 7.53 (2H, dd, J = 8.6, 7.4 Hz, C(2)-H, C(4)-H), 7.08 (1H, tt, J = 7.4, 
1.1 Hz, C(3)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 156.2 (ArCH), 129.0 (ArCH), 123.1 (ArC), 119.5 
(ArCH).  
Melting Point: 130 – 131 °C. 
These are in accordance with literature data..14 
5.10.3 – Synthesis of methyl 4-((5-chloropyrimidin-2-yl)amino)benzoate, 3.1 
 
To an oven-dried carousel tube charged with magnetic stirrer bar was added the following: 
5-chloro-N-phenylpyrimidin-2-amine (0.2 mmol, 41 mg), CBr4 (0.6 mmol, 199 mg), 
FeCl3 (0.02 mmol, 3 mg), MeOH (0.2 mL) and 1,4-dioxane (0.2 mL). The tube was then 
sealed with a Teflon capped and then evacuated and backfilled with argon three times. 
The reaction was then heated at 120 °C for 16 hours. After this time the reaction was 
quenched by addition of NaHCO3 (sat.) (aq.) (10 mL) and the product extracted with 
EtOAc (3 × 15 mL). The combined organic phases were then dried over MgSO4, filtered 
and concentrated under reduced pressure. The remaining residue was then purified by 
flash chromatography (10% EtOAc/hexanes) this yielded the title compound as a pale 
yellow solid, 3.1, 23% (12 mg).  
1H NMR (500 MHz, CDCl3): δ 8.41 (2H, s, C(10)-H, C(12)-H), 8.02 (2H, d, J = 8.4 Hz, 
C(1)-H, C(5)-H), 7.68 (2H, d, J = 8.4 Hz, C(2)-H, C(4)-H), 7.42 (1H, broad s, N-H), 3.90 
(3H, s, C(8)-H).  
 
 
206 | P a g e  
 
13C{1H} NMR (126 MHz, CDCl3): δ 166.7 (C=O), 157.5 (ArC), 156.2 (ArCH), 143.2 
(ArC), 131.1 (ArCH), 130.9 (ArCH), 124.0 (ArC), 117.8 (ArC), 51.9 (O-CH3).  
HR-MS (ESI) m/z: calculated for C12H10N3O2Cl requires 264.0534 for [M+H]
+ found 
264.0499.  
FTIR (thin film): νmax = 3320, 3020, 1697, 1595, 1575, 1520, 1421 cm
-1.  
Melting Point:  169 – 171 °C.  
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5.11 – Synthesis of Ruthenium Complexes 
5.11.1 – Synthesis of [Ru(CO2Mes)2 η6-(p-cymene)] (Mes = 2,4,6-trimethylbenzene) 
 
To an oven dried round-bottomed flask charged with stirrer bar was added [RuCl2(p-
cymene)]2  (1.000g, 1.63 mmol),  potassium 2, 4, 6-trimethylbenzoate (1.605 g, 7.82 
mmol). The flask was then sealed and evacuated and back-filled with argon three times. 
After this time dried and deoxygenated dichloromethane (20 mL) was added to the flask 
via a rubber septum.   The reaction was then stirred until the presence of Ru starting 
material was no longer observable by 1H NMR.  The reaction was then filtered through a 
celite pad. The filtrate was then collected and concentrated under reduced pressure to yield 
a red/orange solid as crude product. This was then recrystallised from dichloromethane/n-
hexane to yield the desired product as an orange crystalline solid, 88% (1.606 g). 
1H NMR (500 MHz, CDCl3): δ 6.68 (2H, s, C(7/19)-H, C(9/21)-H), 6.01 (2H, d, J = 5.7 
Hz,  C(1)-H, C(5)-H), 5.80 (2H, d, J = 5.7 Hz, C(2)-H, C(4)-H), 2.97 (1H, sept, J = 7.0 
Hz, C(8)-H), 2.36 (3H, s, C(7)-H), 2.19 (6H, s, C(13)-H, C(25)-H), 2.16 (12H, s, 
C(11/23)-H, C(12/24)-H), 1.43 (6H, d, J = 7.0 Hz, C(9)-H, C(10)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 182.9 (C=O), 137.3 (ArC), 135.1 (ArC), 134.4 
(ArCH), 127.8 (ArCH), 98.0 (ArC-CH(CH3)2), 92.1 (ArC-CH3), 78.9 (ArC-CH3), 78.1 
(ArC-CH3), 31.7 (ArC-CH3), 22.8 (ArC-CH3), 21.2 (ArC-CH3), 20.0 (ArC-CH3), 19.0 
(ArC-CH3).  
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FTIR (thin film): νmax = 3322, 3063, 2964, 2916, 2167, 2033, 1623, 1611, 1574, 1479, 
1436, 1403, 1326 cm-1.  
Melting Point: 146 – 148 °C (Decomp.). 
These are in accordance with literature data.15  
5.11.2 – Synthesis of [Ru(CO2Me)Cl η6-(p-cymene)] 
 
To an oven dried round-bottomed flask charged with stirrer bar was added [RuCl2(p-
cymene)]2  (612 mg, 1.0 mmol) and a condenser with rubber septum attached fitted to the 
flask. The flask was then evacuated and back-filled with argon three times. Acetic 
anhydride (20 mL, 212 mmol) and acetic acid (80 mL) were then added to the flask via 
the rubber septum and the reaction then heated under reflux at 120 oC for 4 h. After this 
time the reaction was allowed to cool, and the reaction mixture concentrated under 
reduced pressure and the remaining residue was recrystallised from n-hexane:acetone 
(5:1) at -20 °C. This yielded product as a bright red crystalline solid, 68% (120 mg).  
1H NMR (500 MHz, CDCl3): δ 5.48 (2H, d, J = 5.9 Hz, C(1)-H, C(5)-H), 5.34 (2H, d, J 
= 5.9 Hz, C(2)-H, C(4)-H), 2.93 (1H, hept, J = 6.9 Hz, C(8)-H), 2.17 (3H, s, C(7)-H), 1.55 
(3H, s, C(12)-H), 1.29 (6H, d, J = 6.9 Hz, C(9)-H, C(10)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 167.2 (C=O), 101.2 (ArC), 96.7 (ArC), 81.3 (ArCH), 
80.5 (ArCH), 30.6 (ArC-CH(CH3)2), 22.1 (ArC-CH(CH3)2), 18.9 (ArC-CH3). 
HR-MS (ESI) m/z: calculated for C12H17ClO2Ru requires 331.0039 for [M+H]
+ found 
331.0047. 
FTIR (thin film): νmax = 3055, 3031, 2960, 2927, 2867, 1739, 1496, 1448, 1389, 1379, 
1363 cm-1.  
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Melting Point: 135 – 137  °C. 
5.11.3 – Synthesis of [Ru(CO2Me)2 η6-(p-cymene)] 
 
To an oven dried round-bottomed flask charged with magnetic stirrer bar was added 
[RuCl2(p-cymene)]2 (153 mg, 0.25 mmol) and KOAc (196 mg, 2.00 mmol). The flask 
was then sealed and evacuated and back-filled with argon three times. Toluene (20 mL) 
was then added via the rubber septum. The reaction was then stirred for 16 h after which 
time the reaction was filtered through a short pad of celite using DCM as eluent, until the 
washings were no longer coloured. The filtrate was then concentrated under reduced 
pressure to yield a red solid, which was then recrystallised from n-hexane:acetone (5:1) 
at -20 °C. This yielded product as an orange crystalline solid, 56% (100 mg). 
1H NMR (500 MHz, CDCl3): δ 5.78 (2H, d, J = 5.7 Hz, C(1)-H, C(5)-H), 5.56 (2H, d, J 
= 5.7 Hz, C(2)-H, C(4)-H), 2.85 (1H, hept, J = 7.0 Hz, C(8)-H), 2.25 (3H, s, C(7)-H), 1.93 
(6H, s, C(12)-H,  C(14)-H), 1.35 (6H, d, J = 6.9 Hz, C(9)-H, C(10)-H). 
13C{1H} NMR (126 MHz, CDCl3): δ 184.4 (C=O), 114.4 (ArCH), 114.3 (ArCH), 110.0 
(ArC), 77.7 (O-CH3), 31.4 (ArC-CH(CH3)2), 23.8 (ArC-CH(CH3)2), 22.5 (ArC-
CH(CH3)2), 18.5 (ArC-CH3).  
Melting Point: 137 – 138  °C. 
These are in accordance with literature data.16 
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5.11.2 – Synthesis of [Ru(CO2Ad)2 η6-(p-cymene)] (Ad = Adamantane) 
 
To an oven dried round-bottomed flask charged with magnetic stirrer was added 
[RuCl2(p-cymene)]2  (1.00 g, 1.63 mmol) and sodium adamantanecarboxylate (1.45 g, 7.2 
mmol). The flask was then sealed with a rubber septum and the flask evacuated and back-
filled with argon three times. Toluene (35 mL) was then added via syringe into the flask 
through the rubber septum. The reaction was then stirred for 18 hours at ambient 
temperature, after which the mixture was filtered through a pad of celite with 
dichloromethane, until the washings were no longer coloured. The filtrate was then 
concentrated under reduced pressure to give a yellow solid and recrystallised from n-
hexane:acetone (5:1) at -20 °C. This yielded product as an orange solid, 60%, (1.17 g). 
1H NMR (500 MHz, CDCl3): δ 5.70 (2H, d, J = 5.8 Hz, C(1)-H, C(5)-H), 5.49 (2H, d, J 
= 5.8 Hz, C(2)-H, C(4)-H), 2.88 (1H, hept, J = 7.0 Hz, C(8)-H), 2.24 (3H, s, C(7)-H), 1.92 
(6H, d, J = 7.0 Hz, C(10)-H, C(11)-H), 1.74 (12H, d, J = 2.7 Hz, C(14/14’)-H, C(20/20’)-
H, C(22/22’)-H), 1.63 (12H, s, C(16/16’)-H, C(18/18’)-H, C(21/21’)-H), 1.34 (6H, d, J = 
6.9 Hz, C(15/15’)-H, C(17/17’)-H, C(19/19’)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 190.9 (C=O), 98.6 (ArC), 93.8 (ArC), 77.8 (2C, 
ArCH), 42.0 (-CH2-), 39.3 (-CH2-), 36.4 (-CH2-), 31.6 (ArC-CH(CH3)2), 28.2 (-CH-), 
22.6 (ArC-CH(CH3)2), 18.6 (ArC-CH3).  
Melting Point: 226 – 227 °C. 
These are in accordance with literature data.16 
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5.11.5 – Synthesis of (rac)-[RuCl(p-cymene)(C6H4-2-C5H4N-κ-C,N)] 
 
To an oven dried round bottomed flask charged with magnetic stirrer bar was added: 
[RuCl2(p-cymene)]2 (1.00 g, 1.63 mmol), 2-phenylpyridine (0.52 mL, 3.59 mmol) and 
NaOAc (335 mg, 4.08 mmol). The flask was then sealed with a rubber septum and 
evacuated and back-filled with argon three times before then adding dry dichloromethane 
(10 mL). The reaction was then stirred for 4 hours at ambient temperature, before then 
filtering the reaction mixture through a short plug of celite with dichloromethane until the 
washings were no longer coloured. The filtrate was then concentrated under reduced 
pressure to yield a red/brown gummy solid, this was then recrystallised from n-
hexane/dichloromethane. This yielded product as brown prism-like crystals, 81% (1.12 
g). 
1H NMR (500 MHz, CDCl3): δ 9.23 (1H, ddd, J =5.7, 1.2, 0.8 Hz, C(11)-H), 8.15 (1H, 
ddd, J = 7.6, 1.2, 0.5 Hz, C(17)-H), 7.73 – 7.70 (1H, m, C(14)-H), 7.66 (1H, ddd, J = 8.1, 
7.6, 1.5 Hz, C(19)-H), 7.61 (1H, dd, J = 7.6, 1.5 Hz, C(18)-H), 7.17 (1H, td, J = 7.6, 1.5 
Hz, C(20)-H), 7.07 – 7.01 (2H, m, C(12)-H, C(13)-H), 5.57 (1H, dd, J = 5.7, 1.2 Hz, 
C(2/4)-H), 5.56 (1H, dd, J = 5.9, 1.2 Hz, C(2/4)-H), 5.17 (1H, dd, J = 5.9, 1.2 Hz, C(1/5)-
H), 4.98 (1H, dd, J = 5.9, 1.2 Hz, C(1/5)-H), 2.44 (1H, hept, J = 7.0 Hz, C(8)-H), 2.05 
(3H, s, C(7)-H), 0.98 (3H, d, J = 7.0 Hz, C(9/10)-H), 0.88 (3H, d, J = 7.0 Hz, C(9/10)-H).   
13C{1H} NMR (126 MHz, CDCl3): δ 181.4 (ArC-Ru), 165.4 (ArC), 154.6 (ArCH), 143.3 
(ArC), 139.6 (ArCH), 136.6 (ArCH), 129.4 (ArCH), 123.8 (ArCH), 122.5 (ArCH), 121.3 
(ArCH), 118.8 (ArCH), 100.6 (ArC), 90.7 (ArC), 89.6 (ArCH), 84.1 (2C, ArCH), 82.2 
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HR-MS (ESI) m/z: calculated for C21H22NClRu requires 426.0562 for [M+H]
+ found 
426.0580. 
FTIR (thin film): νmax = 3039, 2959, 2920, 2862, 1600, 1578, 1546, 1478, 1386 cm
-1.  
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5.12 – Synthesis of Other Reagents  
5.12.1 – Synthesis of (2-ethoxy-2-oxoethyl)triphenylphosphonium bromide 
 
To a 100 mL round bottom flask charged with magnetic stirrer was added the following: 
ethyl bromoacetate (20.20 mmol, 2.23 mL), PPh3 (19.06 mmol, 5.00 g) and EtOAc (40 
mL). The flask was then equipped with a condenser and the reaction refluxed at 90 °C for 
16 h. After this time the reaction was filtered, and the precipitate washed with EtOAc and 
then dried using a Büchner funnel. The title compound was a collected as a white 
amorphous solid 96% (7.84 g). 
1H NMR (500 MHz, CDCl3): δ 7.92 (6H, ddd, J = 13.4, 8.5, 1.3 Hz, Ph-H), 7.81 – 7.76 
(3H, m, Ph-H), 7.68 (6H, td, J = 7.8, 3.6 Hz, Ph-H), 5.65 (2H, d, J = 13.7 Hz, P-CH2-
C=O), 4.05 (2H, q, J = 7.1 Hz, O-CH2-CH3), 1.08 (3H, t, J = 7.1 Hz, O-CH2-CH3).  
13C{1H} NMR (126 MHz, CDCl3): δ 172.5 (C=O), 138.0 (ArC), 135.0 (ArCH), 134.1 
(ArCH), 134.0 (ArCH), 130.2 (ArCH), 130.1 (ArCH), 110.0 (PPh3-CH2-), 62.5 (O-CH2-
CH3), 33.1 (O-CH2-CH3).  
31P NMR (202 MHz, CDCl3): δ 20.97 (1P, s). 
Melting Point: 152 – 154 °C. 
These are in accordance with literature data.17 
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To a 100 mL round bottomed flask, charged with magnetic stirrer bar was added: phenyl 
boronic acid (10 mmol, 1.22 g) and MeCN (40 mL). A solution of KF (40 mmol, 2.32 g) 
was then dissolved in H2O (4 mL) and this solution added in one portion. Once complete 
dissolution of the boronic acid was observed, another solution of L-(+)-tartaric acid (20.5 
mmol, 3.08 g) in THF (15 mL) was added dropwise to the reaction over a 10 min period. 
The reaction was then left for another 30 mins, after which time MeCN (10 mL) was 
added to dilute the reaction and the reaction then filtered. The precipitate collected was 
then washed with further MeCN (3 ×  50 mL). The combined filtrate washings were then 
concentrated under reduced pressure to yield the title compound as a white crystalline 
solid, 95% (1.75 g). 
1H NMR (500 MHz, CD3CN): δ 7.41 (2H, d, J = 7.1 Hz, o-Ph-H), 7.16 – 7.12 (2H, m, m-
Ph-H), 7.10 – 7.05 (1H, m, p-Ph-H). 
13C{1H} NMR (126 MHz, CD3CN): δ 131.3 (ArCH), 126.5 (ArCH), 125.3 (ArCH). The 
C-B signal was not observed due to quadrupolar relaxation.  
19F NMR (470 MHz, CD3CN): δ -142.36 (3F, 1:1:1:1 q, J = 52.8 Hz, -BF3)  
11B NMR (160 MHz, CD3CN): δ 3.34 (q, J = 55.1 Hz, -BF3). 
Melting Point: 297 – 298 °C. 
These are in accordance with literature data.18 
Note, this method renders the glassware used, operable after reaction. This is in 
comparison to other synthetic methods which render the glassware heavily etched.  
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To an oven dried 50 mL round bottomed flask charged with magnetic stirrer bar was 
added: 2-bromopyridine (20 mmol, 1.91 mL) and aniline (20 mmol, 1.83 mL). A 
condenser was then attached, and the reaction heated at 160 °C for 16 h.  After allowing 
to cool to room temperature NaHCO3 (sat.) (aq.) (200 mL) was added and the product 
extracted with EtOAc (3 × 200 mL). The combined organic layers were then washed with 
brine (150 mL), dried over MgSO4, filtered and concentrated under reduced pressure. This 
yielded a red solid which was purified by flash chromatography (40% EtOAc/hexanes) to 
yield pure the title compound as a pale red crystalline solid, 72% (2.46 g). 
1H NMR (500 MHz, CDCl3): δ 8.21 (1H, d, J = 3.9 Hz, C(8)-H), 7.48 (1H, ddd, J = 8.4, 
7.2, 1.9 Hz, C(10)-H), 7.34 (2H, d, J = 0.9 Hz, C(1)-H, C(5)-H), 7.33 (2H, s, C(2)H, C(4)-
H), 7.09 – 7.03 (2H, m , N-H, C(3)-H), 6.89 (1H, d, J = 8.4 Hz, C(11)-H), 6.73 (1H, ddd, 
J = 7.1, 5.0, 1.0 Hz, C(9)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 156.2 (ArC), 148.4 (ArCH), 140.6 (ArC), 137.7 
(ArCH), 129.3 (ArCH), 122.8 (ArCH), 120.4 (ArCH), 114.9 (ArCH), 108.2 (ArCH). 
Melting Point: 108 – 110 °C. 
These are in accordance with literature data.20 
5.12.4 – Synthesis of potassium 2,4,6-trimethylbenzoate (MesCO2K) 
 
To a 100 mL round bottomed flask, charged with magnetic stirrer was added: 2, 4, 6-
trimethylbenzoic acid (6.7 mmol, 1.10 g) and KOtBu (6.70 mmol, 752 mg) and MeOH 
(55 mL). The reaction was then stirred at room temperature for 4 hours. After this time 
the solvent was removed under reduced pressure to yield a sticky, white solid. This was 
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1H NMR (500 MHz, D2O): δ 6.92 (2H, s, C(4)-H, C(6)-H), 2.26 (3H, s, C(10)-H), 2.23 
(6H, s, C(8)-H, C(9)-H).  
13C{1H} NMR (126 MHz, D2O): δ 185.3 (C=O), 137.2 (ArC), 132.3 (ArC), 127.4 (ArCH), 
20.0 (ArC-CH3), 18.4 (ArC-CH3). 
Melting Point: 308 – 309 °C. 
5.12.5 – Synthesis of pivaloyl-L-valine (Piv-Val-OH) 
 
To an oven dried 250 mL round bottomed flask was added L-valine (2.69 g, 23 mmol), 
NaHCO3 (3.86 g, 46 mmol), H2O (60 mL) and CH2Cl2 (60 mL). The reaction was then 
cooled in an ice bath and allowed to stir for 10 mins. After this time the pivalic anhydride 
(6.09 mL, 30 mmol) was added dropwise using a syringe. After complete addition the 
reaction was allowed to head to room temperature and stirred for a further 4 hours. After 
completion the reaction was washed with Et2O (3 × 100 mL), after which the remaining 
aqueous layer was acidified to pH 2, and then washed with further Et2O (3 × 100 mL). 
The combined organic layers were then dried over MgSO4, filtered and then concentrated 
under reduced pressure, to yield crude product. This was then recrystallised from Et2O to 
yield the title compound as a white crystalline solid, 16% (721 mg).  
1H NMR (500 MHz, CDCl3): δ 6.17 (1H, d, J = 9.2 Hz, N-H), 4.55 (1H, dd, J = 8.4, 4.9 
Hz, C(2)-H), 2.25 (1H, sept, J = 6.9 Hz, C(8)-H), 1.23 (9H, d, J = 0.9 Hz, C(5)-H, C(6)-
H, C(7)-H), 0.97 (6H, dd, J = 6.9, 1.6 Hz, C(9)-H, C(10)-H).  
13C{1H} NMR (126 MHz, CDCl3): δ 179.1 (C=O), 175.6 (O=C-OH), 57.0 (NH-CH-
CO2H), 38.9 (C-(CH3)3), 31.0 (CH-(CH3)2), 19.0 (3C,C-(CH3)3), 17.7 (2C, CH-(CH3)2). 
Melting Point: 146 – 147 °C. 
These are in accordance with literature data.21  
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